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Abstract  
 
 Chronic wounds present a major unmet clinical problem. They arise from wounds that 
fail to progress through the normal phases of healing due to factors that compound healing 
such as vascular complications, or diabetes. Despite improvements in treatments for difficult 
wounds, the incidence of limb amputation remains high. Therefore there is a need for more 
active therapies. 
 
 Mesenchymal stem cells (MSCs) have the capacity to differentiate into multiple cell-
types, however they have also been shown to release a plethora of growth factors and 
cytokines which are beneficial to wound healing, consequently MSCs have shown to 
improve wound healing outcomes in a predominantly paracrine fashion. MSCs, for example, 
can increase angiogenesis/	   neovascularisation, modulate inflammatory responses, 
accelerate re-epithelialisation, and increase collagen deposition.     
 
 The first objective of the work was to develop a synthetic material based delivery 
method for MSCs that could be used in the clinic. Plasma polymerisation was used to 
surface-functionalise medical grade silicone with acrylic acid. The acid surface chemistry 
enhanced cell attachment to the silicone, and cells could effectively be transferred from the 
silicone to model wound beds comprised of decellularised dermis (DED). Once the cells 
were delivered they remained viable, and the acrylic acid surface chemistry was found not 
to affect the MSC phenotype or their functional capacity prior to cell delivery.   
  
 The second part of the project involved developing a 3-D wound model using tissue-
engineered (TE) skin, in which to assess the benefit of MSCs, and applying non-invasive 
imaging to monitor wound healing using optical coherence tomography (OCT). TE skin is 
reconstructed from DED by the addition of laboratory expanded fibroblasts and 
keratinocytes, and it possesses a functional epithelium. Full-thickness incisional wounds 
were created in TE skin, and fibrin clots containing cells could be inserted into the wound 
cavity; wounds healed after 14 days. OCT could clearly identity structural features of skin 
(including the dermis, epidermis and fibrin clot) with good correspondence to histology. 
Appropriate sampling of the wounds by OCT was determined, and consistency in identifying 
corresponding wound regions within a sample over time was addressed, so that wound 
volumes could be calculated and compared. 
 
Finally MSCs were introduced to the wound model. MSCs were found not to reduce 
the rate of wound closure in the dermal portion of the wound, however they did accelerate 
re-epithelialisation and this was detectable by OCT. Additionally, cytokine analysis was 
performed on the surrounding medium under wound conditions. In the presence of MSCs, 
wound medium contained more hepatocyte growth factor (HGF) and basic fibroblast growth 
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factor (bFGF). Elevated levels of these beneficial factors to wound healing were associated 
with an early onset of epithelialisation.    	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Chapter One:  
Literature Review 
1.1 The Structure of Skin  
 
 Skin is the largest human organ. It covers an area between 1.5 and 2 m2, comprises 
almost one sixth of a person's weight, and each square inch of skin is estimated to contain 
4.6 m of blood vessels, 3.6 m of nerves, 1500 nervous receptors, 350 sweat glands, and 
100 sebaceous glands (Marieb 2007). It is a heterogeneous tissue that is comprised of two 
GLVWLQFWVWUXFWXUHVWKHHSLGHUPLVDQGWKHGHUPLVDQGWKH\IRUPȝPDQG-4 mm of the 
VNLQ¶s thickness respectively (Figure 1.1). 
  
 
 
Figure 1.1. Structure of skin. Non-hairy and hairy regions (right and left). The epidermal 
invaginations are called rete ridges. (Figure from Wikipedia commons, May 2013.) 
 
 
 Skin provides many physiological functions which include: thermoregulation through 
sweat production from eccrine glands, diverting blood to and from its surface, and 
positioning hair follicles via erector pili muscles to trap insulative air; production of vitamin D 
ZKLFKLVHVVHQWLDOWRWKHERG\¶VDELOLW\WRXSWDNHGLHWDU\FDOFLXPDQGVKLHOGLQJDJDLQVWultra 
violet (UV) radiation via melanin production. However, its most important function is to 
provide a barrier between the 'inside' of the organism and the external environment for the 
purpose of protecting it against microbial invasion and excessive water loss (Figure 1.2).  
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Figure 1.2. Barrier function of skin. The figure depicts the epidermis. (Adapted from 
Proksch et al, 2008) 
Structure of the Epidermis   
 
 The epidermis constitutes the physical barrier of the skin and it is comprised of five 
layers from the basement membrane (BM) to the surface (Figure 1.3). Each layer will be 
discussed in turn starting from the layer closest to the BM. 
Stratum Germanitivum 
 
 The lowest layer of the epidermis, which is situated directly above the BM, is the 
stratum germanitium (SG). Within this layer germinative basal cells reside; these are 
proliferative keratinocytes that act as 'mother' cells, ensuring continuous regeneration of the 
epidermis as their daughter cells slowly migrate to the surface and undergo differentiation 
along the way. During this process, keratinocytes undergo dramatic changes in morphology 
due to alterations in their cytoskeletal architecture as a result of changes in the expression 
of keratin and filaggrin (Smith and Dale 1986). Keratins are a major group of water-insoluble 
structural proteins that are synthesised by keratinocytes. Keratins have a molecular weight 
ranging from 40-70 kD, however those between 56.5 and 67 kD are associated with more 
differentiated cells above the BM (keratinised epidermis) (Woodcockmitchell et al, 1982; 
Sun et al, 1983). Therefore, the expression of different types of keratins correlates with the 
extent to which a cell has differentiated (Tseng et al, 1982; Sun et al, 1983).  
 
 The predominant cell type within the germinative layer is keratinocytes, however there 
are others including melanocytes and Merkel cells. Up to 10 % of the cells in the SG are 
melanocytes, which are specialised dendritic cells that form a complex with approximately 
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36 keratinocytes and one Langerhans cell to form a 'melanin unit' (Fitzpatrick and 
Breathnach 1963; Montagna and Carlisle 1991). The function of melanocytes is to 
synthesise the dark, UV absorbing, pigment melanin in their melanosomes and transfer 
them to keratinocytes. Once inside keratinocytes, the melanosomes are degraded by 
lysosomal enzymes to release melanin, which accumulates as a nuclear 'cap' that is thought 
to shield the keratinocytes from the harmful effects of UV radiation, which may induce DNA 
damage (Montagna and Carlisle 1991). Hence, prolonged exposure to UV radiation darkens 
skin giving it a 'tanned' appearance due to increased production and transfer of melanin 
granules to the keratinocytes. Merkel cells are neuroendocrine cells that are normally 
located in the touch-sensitive areas of skin, such as the whisker follicles of the face, 
specialised epithelial structures of the hairy skin called touch domes, rete ridges and 
glabrous (hair-less) skin surfaces (Halata et al, 2003). The precise function of Merkel cells 
remains unknown, however they are suggested to be essential for mechanosensation 
(Borghi and Nelson 2009; Maricich et al, 2009).  
Startum Spinosum 
 
 Once basal cells begin to migrate towards the surface, they encounter the spinosus 
layer. This layer is characterised by polyhedral-shaped cells that contain large nuclei with 
prominent nucleoli, indicative of active protein synthesis. These cells begin to produce large 
amounts of the intermediate filament cytokeratin. These cytokeratin filaments then become 
bundled together to form tonofibrils that converge into desmosomes, and form tight 
junctions between the keratinocytes. Due to the µspikey¶ appearance of the tonofibrils, they 
DUHVRPHWLPHVUHIHUUHGWRDVµSULFNOHV¶KHQFHWKHVWUDWXPVSLQRVXPLVRIWHQUHIHUUHGWRDV
WKHµSrLFNOHFHOOOD\HU¶,WLVDOVRZLWKLQWKis layer that membrane-bounded vacuoles (Odland 
bodies), which contain the precursors to the epidermal lipids, become evident. The prickle 
cell layer also contains Langerhans cells. These star-shaped immune cells serve to uptake 
antigens that have entered the epidermis and present them to the immunocompetent T-cells 
of the regional lymph nodes (Romani et al, 2010). 
Stratum Granulosum 
 
 The stratum granulosum is comprised of three to five layers of keratinocytes that are 
in the late stages of differentiation, and it is here that migrating keratinocytes lose their 
polyhedral morphology, becoming more flattened, and begin producing proteins required for 
cornification such as K1 and K10 keratin filaments. Additionally, dense basophilic granules 
of keratohyline begin to appear within the cells of this layer, and it is the presence of these 
granules from which the layer derives its name. These keratohyaline granules are rich in 
profilagrin, a 400-kDa precursor protein which is cleaved to form the 37-kDa peptides of 
filaggrin which aggregates keratin filaments into tight bundles, leading to the cells becoming 
flattened squames (Candi et al, 2005; Palmer et al, 2006). Together, filaggrin and keratin 
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constitute the greatest portion of epidermal proteins, comprising between 80-90 % (by 
mass) of the epidermal proteins (Candi et al, 2005). 
 
 Cells within this region also synthesise the structural proteins, loricrin, involucrin, 
trichohyalin and small proline-rich proteins (SPRPs), which are all elements of the cornified 
envelope (Rinnerthaler et al, 2013). Lamellated granules that contain water-repellant polar 
lipids, glycosphingolipids, and free sterols, which are transferred to the extracellular space 
via exocytosis triggered by the increased calcium concentration in the region, also 
accumulate in the granular cells (Downing et al, 1987; Oren et al, 2003). These lipids are 
then modified and arranged into intercellular lamellae, which lay parallel to the cell surfaces.  
Stratum Corneum 
 
 The outer most part of the epidermis is the stratum corneum (SC). It is composed 
from a continuous sheet of 20-30 layers of corneocytes, and it accounts for up to 3/4 of the 
thickness of the epithelium (Marieb and Hoehn, 2007). Corneocytes are fattened, anuclear 
epithelial cells, that are encased by a cornified envelope of cross-linked proteins, and 
embedded in an intracellular matrix of hydrophobic non-polar lipids, which are organised as 
lamellar layers. The cornified envelope (CE) is a tough polymeric structure, consisting of a 
lipid envelope and a protein envelope that forms above and below the cytoplasmic 
membrane respectively (Candi et al, 2005). The protein element of the CE is derived from a 
range of proteins including: involucrin, loricrin, trichohyalin (Nemes and Steinert 1999), 
which become cross-linked via transglutaminases to form both disulphide and N-epsilon-
(gamma-gluramul)lysine isopeptide bonds; thus proteins impart mechanical strength to the 
epidermis (Koch et al, 2000; Segre 2006). For example, the dermis of loricrin-deficient mice 
was found to be more susceptible to mechanical stress (Koch et al, 2000), and mutations in 
some of the genes encoding CE proteins have been implicated in a number of 
keratodermas (skin disorders characterised by horny-like structures) (Ishida-Yamamoto and 
Iizuka 1998). 
 
 The lipid envelope is a specialised membrane that replaces the outer membrane layer 
of the bi-layered plasma membrane (Swartzendruber et al, 1987), and it is built from lipids 
that are extruded into the extracellular space from lamellar granules where they are 
synthesised (Kalinin et al, 2002). The proteins involucrin, envoplakin and peroplakin then 
form covalent linkages with the lipid envelope to integrate the cells with the intercellular lipid 
lamellae (Marekov and Steinert 1998), and together they reinforce the epidermal barrier. In 
addition corneodesmosomes, specialised desmosomes that connect adjacent corneocytes, 
form tight junctions which are important for SC cohesion and thus barrier function 
(Descargues et al, 2005). On the basal side of the cells, adhesion junctions serve to 
maintain epithelial integrity under shear stress. Thus, the SC is the principle barrier to the 
penetration of damaging agents such as chemicals and microbes, and it is capable of 
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withstanding mechanical forces and providing water impermeability to the skin (Madison 
2003).  
 
 
 
Figure 1.3. Composition of the Epidermis. Note- The stratum lucidium is a thin translucent 
layer of dead keratinocytes that is only present in areas of thick skin where it helps to 
reduce friction and shear forces between the stratum corneum and the stratum granulosum.  
(Image adapted from jessicamilleratomy.com). 
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Structure of the Dermis 
 
 The dermis is a dense layer of specialised connective tissue that primarily functions 
to support the epidermis, however it also provides substantial mechanical protection to the 
body and binds together all superficial structures. It is comprised of an extracellular matrix 
(ECM) consisting of GAGs, elastins and collagen fibres. Collagen and GAGs can associate 
with large volumes of water and give the dermis its gel-like properties that are considered to 
impart the intrinsic tension of skin and act as a barrier to foreign particles (Marieb and 
Hoehn 2007). Collagen also gives the dermis its structural integrity due to the protein's 
fibrous nature, whilst elastin confers elasticity to the skin. The principle cell type resident in 
the dermis is the fibroblast and these cells produce and maintain the ECM through the 
synthesis of elastin and collagen. There are 28 different types of collagens within the 
collagen family, however the main collagen in dermis is type I, which accounts for 
approximately 75-80 % of the collagen content in the tissue (Epstein and Munderloh 1978).  
 The deepest region of the dermis is the reticular layer, and in this region sweat 
(ecrrine) glands, mechanoreceptors and blood vessels can be found (Figure 1). Superior to 
the reticular dermis is the papillary dermis, which is characterised by finger-like projections, 
called papillae, that interdigitate with the overlaying epidermis; in between the dermal 
papillae are rete ridges which contain pockets of basal keratinocytes. Together the papillae 
and ridges increase the surface area (SA) between the dermis and the epidermis. These 
structures are important for two reasons. Firstly, small blood vessels run through the dermal 
papillae that supply oxygen and nutrients to hair follicles and the cells of the lower 
epidermis; a high SA greatly increases exchange of nutrients and waste products. 
Secondly, it helps prevent the epidermis from separating from the dermis by providing a 
greater area for sites of anchorage between these two layers.      
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1.2. Wound Healing 
 
 Because skin serves as a protective barrier, any breach in its integrity must be rapidly 
and efficiently repaired. To this end, skin has a remarkable capacity to heal itself following 
tissue damage from insult and injury. It is a complex phenomenon that can be broadly 
characterised into four distinct but overlapping phases, which proceed over the time course 
described in Figure 1.4. 
 
 
 
Figure 1.4. Phases of wound healing. (Figure adapted from Shechter and Schwartz 2013). 
Haemostasis 
 
 Skin wounds cause disruption to the blood vessels, leading to blood loss.  
Immediately following endothelial cell injury, prevention of local haemorrhage is achieved 
through blood platelet activation and the initiation of the coagulation cascade. The resulting 
blood clot serves to form a plug to terminate bleeding, and acts as a temporary barrier to the 
external environment. It also functions to provide a provisional matrix for the invasion of new 
capillaries (this happens around 4 days post-injury), which endows the neostroma with a 
granular appearance; hence it is named granulation tissue.  
 
 The clot consists of platelets embedded in a mesh of cross-linked fibres derived 
from the plasma proteins fibrinogen, fibronectin, vitronectin and thrombospondin, which are 
cleaved by the enzyme thrombin (Clark 2001). This fibrin mesh serves to stabilise the 
SODWHOHWSOXJEHFDXVHDFWLYDWHGSODWHOHWVH[SUHVVWKHLQWHJULQVĮIIbȕ3), which allows them to 
interface with fibrin (Fang et al, 2005). In addition activated platelets secrete a number of 
growth factors such as platelet-derived growth factor (PDGF) and epidermal growth factor 
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(EGF); these factors stimulate activation of fibroblasts to produce collagen, GAGs and 
proteoglycans (Bauer et al, 1985; Brissett and Hom 2003). 
Inflammatory Phase 
 
 Inflammation is a controlled vascular and cellular response to injury that sets the 
stage for tissue regeneration by clearing dead tissue and foreign materials. The 
inflammatory response is characterised by an increase in vasopermeability, vessel dilation, 
and leukocyte infiltration (Stadelmann et al, 1998). The infiltration of granulocytes and 
monocytes are regulated by a diverse range of chemo-attractants such as the cleavage 
products of blood derived fibrinogen and fibrin (Richardson et al, 1976; Gross et al, 1997), 
but also ECM components including collagen (Postlethwaite and Kang 1976), elastin 
(Senior et al, 1980) and fibronectin (Clark et al, 1998). Additionally, transforming growth 
factor beta (TGF-ȕ) also acts as a chemo-attractant (Barshavit et al, 1990).   
 
 Post-injury monocytes attach to the endothelium of blood vessels at the site of injury 
and migrate through the vessel wall into the ECM (Diegelmann et al, 1981); and they 
eliminate contaminating bacteria via phagocytosis. Granulocytes are a collection of 
polymorphonuclear leukocytes (PMN), which include neutrophils. Neutrophils are the first 
leukocyte cells to populate the wound. They protect the wound from infection by killing 
bacteria through the production and release of toxic reactive oxygen species (ROS). They 
also release lysosomal enzymes together with neutral proteases that debride the wound 
(Segal 2005). However, ROS cause minor collateral damage to cells in their vicinity which 
further stimulates inflammation.  
 
 Following the acute phase of inflammation, macrophages become the predominant 
cell type within the leukocyte population at the wound site. Macrophages have multiple roles 
in wound healing. For instance, macrophages promote further recruitment and activation of 
leukocytes to the wound thus, promoting inflammation. However, they also induce apoptosis 
in irreparable cells and clear the wound of apoptotic cells (including neutrophils), which 
paves the way for the resolution of inflammation. In addition, macrophages undergo a 
phenotypic transition to a reparative state, whereby they stimulate both fibroblast and 
keratinocyte migration and activation, and angiogenesis through secreting a plethora of 
macrophage-derived growth factors (Table 1.1). Thus, they promote tissue regeneration and 
the proliferative phase of healing (Meszaros et al, 2000; Mosser and Edwards 2008; Guo 
and DiPietro 2010). 
 
 Lymphocytes are the last leukocyte population to enter the wound, and their numbers 
increase during the late proliferative phase/ early remodeling phase. The role of 
lymphocytes however is less clear and is the subject of much research (Guo and DiPietro 
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2010). For example, a delayed T-lymphocyte infiltration, in combination with a decreased T-
lymphocyte count in the wound site, has been associated with impaired wound healing 
(Swift et al, 2001). However, others have reported that lymphocyte-deficient mice showed 
lesser scar formation (Gawronska-Kozak et al, 2006). Dendritic epidermal T-cells (DETCs) 
are thought to regulate many aspects of wound healing including inflammation resolution 
and pathogen defense. They are activated by stressed or damaged keratinocytes, and in 
response they produce fibroblast growth factor-7 (FGF-7), keratinocyte growth factors, and 
insulin-like growth factor 1 (IGF-1), to support keratinocyte proliferation and survival; and 
mice deficient in DETCs exhibit delayed wound closure and decreased peri-wound 
keratinocyte proliferation (Jameson and Havran 2007; Mills et al, 2008).    
Proliferative Phase 
 
 Fibroblasts appear in the wound 2-3 days post-wounding, and dominate the wound 
cell population. They are sourced from fibrocytes in connective tissue and perivascular 
region, and there is also evidence that bone marrow stem cells contribute to the wound 
fibroblast population (Opalenik and Davidson 2005). Fibroblasts form an amorphous gel 
composed of GAGs and proteoglycans called 'ground substance', and it plays an important 
role in the deposition and aggregation of collagen fibres. Initially, fibroblast activity is 
devoted to proliferation and migration; thereafter they are dedicated to the synthesis of 
extracellular collagen. The tensile strength of the reforming tissue correlates with collagen 
content, and during the proliferative phase, collagen production from fibroblasts continually 
increases for approximately 3 weeks until homeostasis is achieved (i.e. the rate of collagen 
synthesis and degradation becomes equal) (Stadelmann et al, 1998). Approximately one 
week into wound healing, a proportion of wound fibroblasts are stimulated to transform into 
a contractile phenotype, becoming myofibroblasts characterised by the expression of 
smooth muscle actin (Gabbiani et al, 1971). Myofibroblasts adhere to one another as well 
as the wound margins via secure intercellular attachments, and they generate strong 
contractile forces at the wound margins, drawing the wound edges closer together 
(Montandon et al, 1977). The fibroblast-myofibroblast transformation is largely as a result of 
TGF-ȕ (Desmouliere et al, 1993) and mechanical tension generated from forces resisting 
wound contraction (Grinnell 1994). 
 
 Angiogenesis occurs throughout the proliferative phase to meet the increased 
metabolic demands from the tissue, and support the provisional matrix, which is rich in 
fibroblasts, leucocytes, endothelial cells and myofibroblasts. Angiogenesis results from the 
migration and proliferation of endothelial cells, and it is initiated by tissue destruction and 
hypoxia. Subsequently, angiogenesis is stimulated by growth factors such as, basic 
fibroblast growth factor (also known as FGF-2), vascular endothelial growth factor (VEGF), 
TGF-ȕ, which are secreted by macrophages, keratinocytes and endothelial cells (Martin 
Nathan	  Walker	  (2013)	   	   Chapter	  One	  
	   10	  
1997). Additionally, angiogenesis is dependent on proteolytic activity of plasmin and matrix 
metalloproteinases (MMPs) (Singer and Clark, 1999). Both MMP-2 and MMP-9 are 
expressed in endothelial cells (Mirastschijski et al, 2002; Hieta et al, 2003); and these 
gelatinases are essential for digesting constituents of the vascular BM, which is a key factor 
for new blood vessel generation in both physiologic and tumorigenic states (Itoh et al, 1998; 
Bergers et al, 2000; Kato et al, 2001). 
   
 Wound re-epithelialisation is established by a sequence of mobilisation, mitosis, and 
differentiation of epidermal cells, and it begins within hours after injury. Wounding disrupts 
the BM to which keratinocytes are DWWDFKHGYLDWKHLULQWHJULQVĮȕ4) to laminin. This triggers 
cells at the leading edge to express new integrins for fibronectiQ Įȕ Įȕ6) and 
YLWURQHFWLQĮȕ5), as well as relocalise collagen receptors (Įȕ1), so that they can 'grasp' 
and migrate across the provisional wound matrix (Cavani et al, 1993; Breuss et al, 1995). 
Subsequently, keratinocytes at the wound edge lose their basal polarity and extend 
pseudopodia from their baso-lateral sides into the wound. Keratinocytes then dissect 
through the clot along the interface between the clot and the healthy dermis to discard the 
eschar from the viable tissue (Clark et al, 1982). In order to do this, the leading-edge 
keratinocytes must dissolve the fibrin via a variety of proteases. The main fibrinolytic 
enzyme plasmin, derived from the clot itself, is only activated in the presence of tissue-type 
plasminogen activator (tPA) or urokinase-type plasminogen activator (uPA); the production 
of both activators is up-regulated in migrating keratinocytes (Grondahlhansen et al, 1988; 
Romer et al, 1994). Once the wound gap is closed, the BM and the cellular contacts are re-
established, and keratinocytes differentiate thus reconstituting the multi-layered epidermis 
(Figure 1.5.). 
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Figure 1.5. The late inflammatory/ early proliferative phase of wound healing. The 
granulation tissue is rich in newly sprouted blood vessels, and fibroblasts begin to proliferate 
and synthesise collagen and ECM components. Keratinocytes of the leading-edge (shown 
in yellow), begin to re-epithelialise by firstly migrating underneath the eschar to separate it 
from the underlying regenerating tissue. Figure adapted from (Shechter and Schwartz 2013)    
Maturation Phase 
 
 Remodeling or maturation is the process by which collagen fibres are reorganised 
into a more defined lattice structure by mechanical forces. Remodeling begins 
approximately 3 weeks after injury and continues for up to two years, during this time the 
wound continues to increase in tensile strength. The majority of the collagen laid down early 
in the healing process is type III which is gradually replaced by type I collagen until the 
normal 4:1 ratio of collagen I to III is re-established, while the GAGs are steadily degraded 
until they reach normal concentrations. After a period of four weeks wounds typically 
reached 70 % of the strength of undamaged tissue, thereafter a plateau is gradually 
reached and the new tissue never exceeds 80 % of the strength of normal skin (Madden 
and Peacock 1968). In the final stages of remodeling, the high density of new blood vessels 
regresses via endothelial cell apoptosis, while myofibroblasts and fibroblasts also withdraw 
from the wound in a similar fashion. Lastly, the hypertrophic epidermal layer that was 
produced becomes progressively thinner.   
 
 In summary, wound healing is a highly coordinated programme that requires the 
participation of different cell types and it is mediated not only by cell-ECM contacts, 
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intracellular contacts and changes in mechanical stress, but also by a plethora of growth 
factors and cytokines that regulate cell behavior. By raising antibodies against specific 
growth factors, or by knocking out growth factors using genetically modified animals, many 
authors have demonstrated how crucial growth factors and cytokines are to wound healing. 
For example, experimental depletion of FGF-2 almost completely blocks angiogenesis 
(Broadley et al, 1989; Chmielowiec et al, 2007), and mice lacking receptors for hepatocyte 
growth factor fail to re-epithelialise (Chmielowiec et al, 2007). For a comprehensive 
overview of such studies I refer the reader to reviews by Werner and Grose, and Baum and 
Arpey (Werner and Grose 2003; Baum and Arpey 2005). Tables 1 and 2 list the most 
extensively characterised growth factors and cytokines essential to wound healing, and the 
cells from which they originate and their function. 
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Table 1.1. Growth factors in wound healing. 
 
Growth Factor Major Source Biological Activity 
CTGF Platelets 
Fibroblasts 
Endothelial cells 
Fibroplasia 
ECM production 
Angiogenesis 
Mediates action of TGF-B on collagen synthesis 
 
EGF Platelets Keratinocyte proliferation and migration 
Endothelial cell proliferation 
ECM deposition 
FGF-1 Keratinocytes Pleiotropic mitogen 
ECM production 
 
FGF-2 (bFGF) Keratinocytes 
Fibroblasts 
Macrophages 
Endothelial cells 
Pleiotropic mitogen 
Angiogenesis 
ECM production 
 
HB-EGF Keratinocytes 
Macrophages 
Keratinocyte proliferation and migration 
Fibroblast proliferation 
 
HGF/SF Fibroblasts, 
Keratinocytes 
Epithelialisation 
Angiogenesis  
Leukocyte recruitment 
 
IGF-1 Platelets  
Fibroblasts 
Keratinocytes 
Epithelialisation 
ECM Production 
KGF Dermal 
Fibroblasts 
Keratinocyte proliferation and differentiation 
PDGF Platelets 
Macrophages  
Keratinocytes 
Chemoattractant for macrophages & fibroblasts 
Macrophage activation 
Fibroplasia 
ECM production 
Contraction 
 
TGF-Į Macrophages 
Neutrophils  
Keratinocytes 
Similar to EGF but more potent angiogenic action  
TGF-ȕ Platelets 
Macrophages 
Keratinocytes 
Fibroblasts 
Fibroplasia 
ECM production 
Reduced scaring 
Collagen synthesis 
Contraction 
Macrophage recruitment 
 
VEGF Keratinocytes 
Macrophages 
Angiogenesis 
Vascular permeability 
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Table 1.2. Cytokines in wound healing. 
 
Cytokine Major Source Biological Activity 
Proinflammatory   
TNF-Į Macrophages 
Keratinocytes 
Neutrophil migration and cytotoxicity 
ECM degradation 
Expression of growth factors 
 
IL-1 Macrophages 
Keratinocytes 
Fibroblast and keratinocyte chemotaxis 
Collagen synthesis 
Expression of growth factors 
 
IL-2 T-cells Increases fibroblast infiltration and metabolism 
 
IL-6 Macrophages 
Neutrophils 
Fibroblasts 
Fibroblast proliferation and hepatic acute-phase 
protein synthesis 
IL-8 Macrophages 
Fibroblasts 
Macrophage and Neutrophil chemotaxis 
Keratinocyte maturation 
 
Ȗ-interferon T-cells  
Macrophages 
Macrophage and nuetrophil activation  
Retards collagen synthesis and cross-linking, 
and stimulates collagenase activity 
 
Anti-inflammatory   
IL-4 T-cells 
 
Inhibition of TNF, IL-1, and IL-6 production; 
fibroblast proliferation; and collagen synthesis 
 
IL-10 T-cells 
Macrophages 
Keratinocytes 
Inhibition of TNF, IL-1, and IL-6 production and 
inhibits macrophage and PMN activation 
 
Key 
 
CTGF, connective tissue growth factor; ECM, extracellular matrix; FGF, fibroblast growth 
factor; HB-EGF, heparin binding epidermal growth factor; HGF/SF, Hepatocyte growth 
factor/ scatter factor; IL, Interleukins; IGF, Insulin-like growth factor; KGF, keratinocyte 
growth factor; PDGF, Platelet-derived growth factor, TGF, transforming growth factor; TNF, 
Tumour necrosis factor; VEGF, vascular endothelial growth factor. 
 
 (The information within table 1 and 2 are adapted from reviews by (Martin 1997; 
Stadelmann et al, 1998; Lobmann et al, 2005; Toriseva and Kahari 2009) references within). 
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1.3. Chronic Wounds 
The Problem of Chronic Wounds 
 
 Chronic wounds (CWs) are by definition 'wounds that have failed to progress through 
the normal stages of wound healing and therefore enter a pathological state of 
inflammation. As a result, the healing process is delayed, or incomplete, and does not 
proceed in a coordinated manner, subsequently resulting in a poor anatomical and 
functional outcome' (Lazarus et al, 1994). CWs are a major cause of disability and often 
relapse following treatment. The aetiology of non-healing wounds is varied, however the 
majority (70 %) are caused by ischemia secondary to diabetes, venous stasis, and pressure 
(Nwomeh et al, 1998). Common problems caused by CW include: chronic pain extrudate 
and odour which dispose people to loss of sleep; loss of mobility, which may limit work 
capacity and lead to social isolation; and the psychological wellbeing of the person can be 
negatively affected (Herber et al, 2007). Additional complications such as wound infections 
may lead to the development of abscesses, cellulitis, gangrene, osteomyelitis and sepsis 
and even malignant transformation (Eltorai et al, 2002). 
 
 With respect to diabetes, patients with the disease have a 12-25 % lifetime risk of 
developing a diabetic foot ulcer (DFU) (Abbott et al, 2005; Singh et al, 2005), and 5-8 % 
require amputation within 1 year (Jonasson et al, 2008; Prompers et al, 2008). In fact 
complications of DFUs are the primary cause of non-traumatic lower extremity amputations 
with DFUs preceding approximately 85 % of such amputations (Larsson et al, 1998; 
Miyajima et al, 2006). Furthermore amputation secondary to DFUs is associated with a high 
morbidity and mortality rate, with a survival rate as low as 31 % for major limb amputees. 	  
  
 At present 4.6 % of the UK's population are diagnosed with diabetes, and 
approximately 200,000 of those patients present with DFUs annually. This amounts to an 
annual cost of 2.3-3.1 billion pounds in treatments (at 2005-6 costs), which represents 
around 3 % of the NHS healthcare expenditure budget (Posnett 2007). However this is set 
to rise as obesity is becoming more prevalent in the UK population, and diabetes onset is 
associated with obesity (Guo and DiPietro 2010). Globally, the incidence of diabetes 
mellitus is 347 million, however it is predicted that diabetes will affect 439 million people (7.7 
% of the global population) by 2030 (Shaw et al, 2010; Danaei et al, 2011). The risk of 
developing DFUs is also age related, with 85 % of diabetics presenting with DFUs of these 
cases occurring in individuals aged over 65 (Guo and Dipietro, 2010). Therefore with the 
UK's ageing population and the rising incidence of diabetes, the burden of chronic wounds 
is a mounting issue facing health care.  
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Summary of the Diabetic Wound Environment 
 
 The pathogenesis of DFU is complicated and multi-factorial, resulting from the 
combined effects of both local and systemic abnormalities. In summary, the main factors to 
consider are sustained hypoxia, cellular dysfunction, impaired angiogenesis and 
neovascularisation, elevated levels of MMPs, oxidative damage, decreased host immune 
resistance, and neuropathy (Figure 1.6.).  
 
 
 
Figure1.6. Factors impairing wound healing. ROS- reactive oxygen species; AGEs- 
advanced glycation end products (Figure adapted from Gou et al, 2010). 
Hypoxia 
 
 In common with venous stasis disease and pressure-related chronic wounds DFUs 
are notably hypoxic, and as a result ischemia may contribute to 30-40 % of DFUs. (Jiang et 
al, 2012). Tissue oxygen tensions in CWs for example have been measured to lie between 
5 and 20 mm Hg, which is far lower than the typical oxygen tension from normoxic tissue, 
which lies in the region of 30 to 50 mm Hg (Tandara and Mustoe 2004). Diabetes is 
characterised by endothelial dysfunction attributed to defects in nitric oxide synthase 3 
(eNOS3), and it is thought to promote vascular disease leading to micro and macrovascular 
defects resulting in impaired vascular blood flow and hypoxia (Calles-Escandon and Cipolla 
2001; Versari et al, 2009). Recently, Wei et al provided evidence that diabetes-related 
vascular defects are linked to the absence of fatty acid synthase (FAS), of which levels are 
substantially reduced in diabetics (Wei et al, 2011).  
 
 Temporary hypoxia following tissue injury plays an essential role in stimulating the 
early phase of tissue repair by amplifying the inflammatory response, and stimulating 
macrophages, fibroblasts and keratinocytes to produce cytokines and GFs (PDGF, TFG-ȕ, 
VEGF, TNF-Į and endothelin-1), which promote angiogenesis, cell proliferation, migration 
and chemotaxis (Bishop 2008; Rodriguez et al, 2008). Transient hypoxia also increases the 
production of reactive oxygen species (ROS), which are understood to act as cellular 
messengers to stimulate wound healing. However, chronic hypoxia delays wound healing 
because sustained ROS elevation causes additional tissue damage and, more importantly, 
without adequate tissue oxygenation the increased metabolic demands of a tissue in a state 
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of reparation cannot be met, thus wound healing is impaired  (Bishop, 2008; Rodriguez et 
al, 2008). 
 
 Angiogenesis in DFUs is also impaired which perpetuates wound hypoxia. Insufficient 
angiogenesis is thought to result from endothelial cell progenitor cell (EPC) mobilisation 
from bone marrow and, homing to the wound site being impaired in diabetics. Additionally, 
the primary angiogenic factor VEGF is released in decreased amounts in individuals with 
diabetes (Brem and Tomic-Canic 2007; Gallagher et al, 2007; Quattrini et al, 2008). In light 
of this, preclinical studies have shown that administration of exogenous VEGF improves 
repair outcomes (Kirchner et al, 2003; Galiano et al, 2004b). In light of the above, it is not 
surprising that diabetic patients with ischemic foot ulcers have the worst prognosis of all 
chronic skin wound patients (Jiang et al, 2012).  
Hyperglycaemia 
 
 Hyperglycaemia accelerates the formation of advanced glycation end-products 
(AGEs), and with their receptors is associated with impaired wound healing (Huijberts et al, 
2008). Hyperglycaemia also affects the stability and activation of the transcription factor 
hypoxia inducible factor-Į+,)-Į+,)-Į up-regulates the transcription of multiple genes 
required for successful wound healing, and when its action is suppressed the production of 
PDGF, VEGF and TGF-ȕwhich are essential to angiogenesis, are reduced (Botusan et al, 
2008).  
Dysfunctional Cell Types 
 
 Diabetes impairs the function of immune cells and skin-derived cells at the wound 
site. The combined effect of defective T-cell immunity, leukocyte chemotaxis, phagocytosis, 
reduced bactericidal capacity, and impaired cytokine production leads to poor bacterial 
clearance, which can often result in infection which complicates wound healing by 
prolonging inflammation (via TNF-Į and IL-1) and consequently elevating MMP activation. 
(Loots et al, 1998; Geerlings and Hoepelman 1999). Bacteria that survive in infected 
wounds form biofilms, which are 'complex communities of bacteria embedded in a self-
secreted extracellular polysaccharide matrix' (Edwards and Harding 2004); and such 
biofilms provide a microenvironment that is more resistant to conventional antibiotics. Thus, 
the bacterial burden plays an important role in the chronicity of ulcers. Furthermore, 
keratinocytes and fibroblasts from diabetic wounds show a reduced migratory capability, 
diminished response to growth factors, and increased apoptosis (Loots et al, 1999). 
Abnormal Cytokine Profile 
 
 Inflammation in acute wounds serves to prepare the wound for healing by clearing 
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cell debris, destroying pathogens and activating fibroblasts, and in normal wounds it is a 
self-limiting process. In contrast, diabetic wounds are associated with a chronic 
inflammatory environment (Pradhan et al, 2009). The inflammatory response in such 
wounds is exacerbated by factors such as tissue trauma from pressure, bacterial 
overgrowth, leukocyte trapping or ischemic-reperfusion injury, which perpetuates 
inflammation leading to what is described as 'pathologic inflammation' (Menke et al, 2007b). 
Unlike acute wounds, factors such as TNF-Į which stimulate inflammation by enhancing 
neutrophil migration, tend to predominate (Mast and Schultz 1996), thus neutrophils remain 
present within CWs for the duration of healing (Armstrong and Lavery 1998; Apelqvist et al, 
2008). Large numbers of activated neutrophils results in the accumulation of excessive 
amounts of MMPs in the wound fluid (Nwomeh et al, 1998); for instance, neutrophil elastase 
is present in CWs at a concentration 10-fold higher than that of acute surgical wounds 
(Yager et al, 1997). In turn this leads to ECM degradation being favoured since MMP 
DFWLYLW\LVQRWEDODQFHGE\µtissue inhibitors of MMPs' (TIMPs) unlike normal wounds (Yager 
et al, 1996; Lobmann et al, 2002)(. Thus, DFUs are environments where proteolysis is both 
elevated and disregulated. Elevated expression of MMPs further compounds wound healing 
by degrading growth factors and their receptors, thus suppressing the mitogenic potential of 
the wound environment (Lobmann et al, 2002; Nwoweh et al, 1998). This effect may 
contribute to the observation that factors stimulatory to cell proliferation and matrix 
deposition such as PDGF, EGF, FGF2 and TGF-ȕ are much reduced in concentration 
compared to acute wound fluid (Cooper et al, 1994). In accordance with this, it has been 
demonstrated that wound fluid from CWs interferes with cell proliferation, and fails to 
stimulate DNA synthesis in fibroblast cultures (Bennett and Schultz 1993), suggesting that 
the activity of the above growth factors is essential to normal wound healing. Furthermore, 
not only is the inflammatory cytokine profile altered within CWs, but fibroblast function is 
also altered. For example, fibroblasts isolated from CWs are reported to undergo premature 
senescence and display an impaired migratory capacity in response to GFs (Brem and 
Tomic-Canic 2007). Conversely, a subset of fibroblasts in the CW has been found to enter a 
hyper-synthetic mode, whereby collagen is produced and deposited en mass, however due 
to excess MMPs it is degraded faster than it is produced (Menke et al, 2007b). 
Neuropathy 
 
 Diabetes causes neurovascular defects, and over time this causes neuronal damage. 
Damaged nociceptive fibres which may result, can lead to the inability of such fibres to 
generate an electrical stimulus in response to micro injury/ trauma, therefore resulting in 
decreased pain perception. As a consequence, diabetic patients may be unaware 
sustaining of minor injuries to the foot, such as splinters and blisters, and therefore they 
may not pay minor wounds attention which increases the likelihood of them becoming 
worsened through additional trauma or infection (Zou et al, 2012). Furthermore, sensory 
Nathan	  Walker	  (2013)	   	   Chapter	  One	  
	   19	  
nerves can modulate the wound milieu by releasing neuropeptides (nerve growth factor, 
substance P and calcitonin gene-related peptide), which stimulate chemotaxis, cell 
proliferation, and growth factor production. Sensory nerves also exhibit a level of control 
over leukocyte infiltration, with denervated skin showing reduced levels of leukocyte 
infiltration and rates of healing (Galkowska et al, 2006).. 
Other Contributory Factors 
 
 There are many other systemic factors besides diabetes that can affect how 
wounds heal, these include: age, stress, smoking, alcohol consumption, nutrition obesity 
and medication. All of which have been recently reviewed by Guo and Dipietro, and I refer 
the reader to their article for further information regarding these additional (Guo and 
Dipietro, 2010).  
 
Treatments for Chronic Wounds 
 
 Although the type of treatment that is opted for depends on the type of chronic 
wound, there are basic procedures that are common to all, such as regular wound 
debridement and pressure off-loading. Compression bandages form an essential and 
effective part of the treatment of venous ulcers, whereas DFUs often require glycemic 
control, antibiotics and even skin grafting (Werdin et al, 2008). Recent advances in 
understanding CW pathology and developments in bio/nanotechnology have accelerated 
the production of novel therapies (Dissemond 2006; Jiang et al, 2011). 
Wound Dressings 
 
 Typical wound dressings include alginates, hyaluronic acid, hydrogels, hydrocolloids, 
collagen, semi-impermeable membranes, and silver dressings (Dissemond, 2006). However 
bioactive dressings and tissue-engineered (TE) skin substitutes also show promise. 
Bioactive dressings combine cells, matrices or growth factors, and they are able to 
modulate the process of wound healing via tissue interactions, and examples include keratin 
dressings (Pechter et al, 2012; Tang et al, 2012) and Promogran (Systagenix Wound 
Management, Inc). TE substitutes include Dermagraft (Advanced BioHealing, Inc), Apligraf 
(Organogenesis Corp), which are FDA approved for the treatment of venous leg ulcers and 
DFUs (Sussman et al, 2003; (Zaulyanov and Kirsner 2007). However, a single type of 
dressing is not sufficient for the management of all types CWs, and few are suited to 
intervention at any stage in wound healing (Sussman et al, 2003). 
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Negative Pressure Therapy 
 
 Negative pressure therapy (NPT) is a therapeutic technique whereby a vacuum is 
used to remove wound exudates (Evans and Land 2001), helping to improve interstitial fluid 
control, restore blood flow and reduce bacterial load (Armstrong et al, 2005). A recent 
systematic review by Xie et al (2010), reported that NPT is beneficial for in the treatment of 
DFUs is consistent, however the same could not be said for other types of chronic wounds. 
The review also found NPT not to cause any significant complications (Xie et al, 2010). 
However, side effects such as pain and fluid loss, and the risk of bleeding, limit its use to 
small wounds (Fan et al, 2010). In relation to pressure treatments, Piaggesi et al 
demonstrated pressure casts to be effective at reducing wound size (Piaggesi et al, 2003). 
Ten patients were fitted with casts to provide pressure off-loading to the areas surrounding 
their DFUs, and compared to patients without such casts and with comparable lesions, 
wounds were found to have significantly reduced in size after 20 days. In addition, they 
discovered histopathological differences between the two groups. Compared to ulcers from 
patients without the casts, ulcers from cast-treated patients showed fibroblast and newly 
formed capillaries to be prevalent as opposed to inflammatory elements. Thus changes in 
the wound environment were associated with the increase in wound healing (Piaggesi et al, 
2003). 
Hyperbaric Oxygen Therapy 
 
 Hyperbaric oxygen therapy (HBOT) is a treatment designed to increase the supply 
of oxygen to wounds that are not responding to conventional treatments. HBOT involves the 
patient breathing in pure oxygen in a room that is pressurised up to three times that of 
atmospheric pressure. Under these conditions the partial pressure for oxygen in tissues is 
increased since the blood plasma can transport significant amounts of oxygen in addition to 
oxygen transport via heamoglobin. This may mobilise stem/progenitor cells from the bone 
marrow, via nitric oxide-dependent mechanism, which can aid wound healing and may 
account for patient cases which suggest recovery of damaged tissues by HBOT (Thom et 
al, 2006). A recent systematic review concluded, that in relation to DFUs, HBOT only 
provides an initial benefit to wound healing, because after long term follow-up HBOT did not 
reduce the amputation rates. Furthermore, no evidence was found to suggest HBOT was 
effective to treat venous and pressure ulcers and its use is restricted by the requirement of 
specialist equipment and expertise.(Kranke et al, 2012). 
Growth Factors 
 
 Since cytokines/ GFs orchestrate wound healing events such as cellular proliferation, 
differentiation, migration, and metabolism, and given there is an inherent lack of theses 
factors in CWs, much investigation has been conducted into the use of exogenous 
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cytokines and growth factors to ameliorate wound healing. Numerous animal studies have 
demonstrated that local application of growth factors (PDGF, FGF2, TGF-ȕ 9(*) FDQ
accelerate wound healing in both normal and healing-impaired models (Lynch et al, 1989; 
Puolakkainen et al, 1995; Davidson et al, 1997; Loots et al, 2002; Galiano et al, 2004b). In 
1986 Knightington et al conducted one of the first clinical trials whereby an autologous 
mixture of platelet-derived releasates (PDGF, TGF-ȕ, PDAF, PDEGF and other unknown 
factors) was applied to chronic wounds. The authors reported the addition of these factors  
increased  wound healing over the control group (Knighton et al, 1986). Pressure ulcers and 
venous stasis ulcers have also been treated similarly and yielded positive effects (Robson 
1997). Currently, human recombinant PDGF is the only efficacious preparation that is 
approved for clinical use in diabetic foot ulcers by the US Food and Drug Administration 
(FDA) (Steed et al, 1995; Smiell et al, 1999). Despite this it has not found widespread use 
because many CWs fail to respond (Menke et al, 2007a); this may be due to the presence 
of proteases capable of degrading PDGF and TGF-ȕ and patient variability in the protease 
activity in the wound environment (Yager et al, 1997).  
 
 GFs alone however will not work in the long-term if the underlying pathology is not 
addressed; GFs only serve as local stimulators for healing by aiding the wound to surmount 
an otherwise hostile and inhibitory environment (Greenhalgh 1996; Stadelmann et al, 1998). 
Therefore, in addition to treating the immediate wound environment, efforts must also be 
made to abate systemic contributing factors such as arterial insufficiency, venous 
hypertension, vasculitis, edema, diabetes and infection, prior to GF treatment (Lobmann et 
al, 2005). However, not all CWs respond to GFs even if the underlying pathology is 
managed. This could be due to the inherent heterogeneity within the CW population, which 
makes conducting randomised controlled trials difficult, and therefore can make clinical data 
hard to evaluate (Lobmann et al, 2005).   
MMP Inhibitors  
 
 Given that elevated protease activity is a characteristic of CWs, the deleterious 
effects of excessive MMPs may be dampened through the local application of protease 
inhibitors (Menke et al, 2007a). One such inhibitor doxycycline, which competitively blocks 
MMPs and the TNF-Į converting enzyme, has been shown in a randomised controlled 
clinical trial to improve wound healing in DFUs (Chin et al, 2003). Concomitantly, 
doxycycline also reduces inflammation by decreasing nitric oxide synthesis (Lamparter et al, 
2002). An alternative approach is to apply a dressing to the wound that is composed of 
protease substrates such as gelatin or collagen (Veves et al, 2002; Vin et al, 2002). Such 
dressings outcompete the endogenous collagens for their degradative enzymes, thus 
shielding them in a concentration-dependent manner from them.  
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Stem Cells 
 
 Mesenchymal stem cells (MSCs) resident in the bone marrow have been shown to 
positively interact with the cells of the wound environment, and produce a wealth of 
beneficial growth factors and cytokines to stimulate wound healing through angiogenesis, 
fibroblast proliferation and keratinocyte migration and by calming wound inflammation. A 
review of the role of MSCs in wound therapy is presented in section 1.4. 	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1.4. Mesenchymal Stem Cells 
 
 MSCs hold great promise in regenerative medicine and in the treatment of cutaneous 
wounds because, in addition to their multipotent differentiative capacity, they can stimulate 
the wound environment via paracrine actions, through the release of trophic and 
Immunomodulatory factors (Hocking and Gibran 2010; Sorrell and Caplan 2010; O'Loughlin 
et al, 2011; Chen et al, 2012; Jiang et al, 2012; Mulder et al, 2012). Importantly, these cells 
can be sourced and easily extracted from a variety of tissues (both autologous and 
allogeneic) and remain stable when expanded in culture. The minimum criteria, established 
in 2006 by the International Cell Society (Dominici et al, 2006), to qualify cells as MSCs in 
vitro is as follows:  
 
1) The cells must be adherent to tissue culture plastic when maintained in standard 
conditions. 
2) The cells must express CD105, CD73 and CD90, and lack the expression of CD45, 
CD43, CD14 and human leukocyte antigen (HLA)-DR surface molecules. 
3) The cells must be multipotent and differentiate to osteoblasts, adipocytes, and 
chondrocytes in vitro.  
 
 The first evidence for the existence of mesenchymal progenitor cells arose during the 
ODWH¶VDQGHDUO\19¶VZKHQ)ULHGHQVWLHQDQGFROOHDJXHVLGHQWLILHGDVPDOl fraction of 
fibroblast-like bone marrow (BM) cells that adhered to and proliferated on tissue culture 
substrates (Friedens.Aj et al, 1968; Friedens.Aj et al, 1974). Such cells readily generated 
single cell derived colonies and were originally referred to as colony forming unit fibroblasts 
(CFU-F), subsequently CFU-Fs were demonstrated to be a heterogeneous population of 
non-heamatopoietic stem cells that reside in the marrow stoma. Hence, these cells are 
referred to as mesenchymal stem, progenitor, or stromal cells (Horwitz et al, 2005). These 
cells were later shown to differentiate in vitro into multiple cell types of the mesenchymal 
lineage, such as adipocytes, oesteoblasts, and chrondrocytes, hence these cells are 
described as mesenchymal stromal/progenitor cells (Pittenger et al, 1999) (Figure 1.7.). 
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Figure 1.7. Differentiative capacity of BM-MSCs, (Figure reproduced from Caplan et al, 
2005).  
 
 However their differentiative capacity is not restricted solely to the mesenchymal 
lineage; they show a propensity to become a variety of other unrelated cell types including: 
retinal cells, neural cells, astrocytes, hepatocytes, and pancreatic cells (Pountos and 
Giannoudis 2005). Additionally, it is now widely accepted that most postnatal organs and 
tissues in the body have a resident population of multipotent MSC-like cells including, 
adipose tissue, synovial membranes, bone, skin, pancreas, blood, fetal liver, lung and 
umbilical cord blood, pericytes synovial fluid, muscle, dermis, deciduous teeth, trabecular 
bone, infrapatella fat pad, articular cartilage, periosteum (Si et al, 2011). However BM-
derived MSCs are the best characterised MSCs and were used in the experimental sections 
of this thesis, therefore they will be the subject of this review. 
 
MSCs in Wound Healing 
Pre-clinical Studies 
 
 Much pre-clinical work has been undertaken over the last 20 years using animal 
models to investigate the effects of bone marrow MSCs in cutaneous wound healing. A 
notable pre-clinical study performed by Wu et al found MSCs to enhance wound healing in 
both normal and healing-impaired genetically diabetic mice (db/db mice). Full-thickness 
dermal excisional wounds were made in both groups of mice and allogeneic GFP-labeled 
murine MSCs were injected around the wound bed. As controls, either allogeneic neonatal 
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dermal fibroblasts or vehicle medium were added to wounds. Their results demonstrated 
that the MSC-treated wounds exhibited accelerated wound closure, with increased re-
epithelialization, cellularity, and angiogenesis vs. the controls (Wu et al, 2007). Table 1.3 
highlights noteworthy pre-clinical studies in relation to CWs to date and summarises their 
outcomes. 
 
 In addition, several studies have found that MSCs not only accelerate wound 
healing, but they also improve the quality of repair of incisional wounds, resulting in healed 
tissue with notably reduced scaring, and an enhanced wound tensile strength (Stoff et al, 
2009)  and wound breaking strength (McFarlin et al, 2006; Kwon et al, 2008). For example, 
it is reported that following incisional injury, a rabbit's skin only achieves 40 % of the tensile 
strength of uninjured tissue after 120 days. However, Stoff et al showed that after treating 
rabbit incisional wounds with human MSCs, the skin regained 52 % of the tensile strength of 
uninjured skin at day 80 after surgery and treatment, while untreated wounds regained only 
31 % of their original strength by this time (Stoff et al, 2008). Although the authors did not 
state why this result occurred, others have associated an immediate increase in collagen in 
the wound bed with the increase in wound breaking strength (McFarlin et al, 2006; Kwon et 
al, 2008). The mechanism by which collagen secretion is increased by the presence of 
MSCs is currently under investigation (Zou et al, 2012). 
 
 Importantly, there have also been studies evaluating the use of whole bone marrow 
aspirate (BMA) to ameliorate poor wound healing (Tateishi-Yuyama et al, 2002; Badiavas 
and Falanga 2003; Yamaguchi et al, 2005). However BMA is a heterogeneous population of 
cells consisting of both mesenchymal and haematopoietic progenitor cells, therefore it is not 
clear from these studies which population is the contributing party. To test the hypothesis 
that MSCs from BM are the major contributors to wound healing, Javazon et al  (2007) 
compared the effects of BMA to a purified population of MSCs from the BMA on wound 
healing in mice. Their results showed MSCs significantly accelerated wound closure, 
enhanced re-epithelialisation, granulation tissue formation, and increased blood vessel 
density at the wound site compared with control wounds treated with BMA or PBS alone. 
They also showed that 7 days after treating the wounds, higher frequencies of MSCs 
remained in the wound compared to BMA cells, demonstrating that MSCs engraft to the 
wound site (Javazon et al, 2007). 
 
 Murine models have been crucial for advancing the understating of wound healing, 
however there are fundamental physiological and anatomical differences between mouse 
and human skin. Murine skin is similar to human skin in that it consists of three layers 
(epidermis, dermis and hypodermis), however the chief difference in regard to wound 
healing, is that murine skin contains a unique thin layer of muscle called the panniculosus 
layer which produces rapid wound contraction following injury. By contrast, human wounds 
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heal primarily via granulation tissue and re-epitheialisation, with limited contracture. 
However, splints can be sutured to excisional murine wounds to prevent the contraction of 
the panniculosus carnosus, thus allowing healing to proceed in a fashion that better 
recapitulates healing in man (Galiano et al, 2004a). An additional difference is that rete 
ridges are absent from murine skin, although similar structures often become apparent 
during wound healing (pseudoepitheliomatous/ pseudocarcinomatous hyperplasia) 
(Sundberg et al, 2004). There are also gender differences between male and female murine 
skin. For example, the dermis of male skin is much thicker than female skin, and exhibits a 
thicker epidermis and hypodermis, consequently male skin is 40% stronger than female skin 
(Azzi et al, 2005). These differences are important to consider when assessing the 
translational relevance of mouse studies. Therefore to truly evaluate the potential of MSCs 
in wound healing, clinical studies are essential. 
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Table 1.3. The use of MSCs in pre-clinical studies. 
Wound Cell type Delivery Outcome Reference 
FTDW (1.5 x 1.5 cm) 
F344/JCI nude rats 
Human BM MSCs 
(Allogeneic) 
Dermal substitute, soaked in bFGF 
(5 x 106 cells) 
Accelerated wound healing. 
Human pancytokeratin was detected- 
possible trans-differentiation. 
(Nakagawa et 
al, 2005) 
Incisional wounds (5 cm)  
Rat (Sprague-Dawley) 
 
Rat BM MSC  
(Allegeneic) 
IV injection (5 x 106 cells) and local 
injection along wound margins  
(6 x 106 cells) 
Both methods of administration increased 
Wound breaking strength (WBS).  
Increased collagen production and 
neovascularisation 
(McFarlin et al, 
2006) 
FTDW (1 x 1.5 cm) 
Diabetic mice  
Murine BM MSCs  
(Allogeneic) 
Topical Fibrin spray  Accelerated wound healing (Falanga et al, 
2007) 
FTDW (8 mm) 
Diabetic mice (Lepr db/db) 
Tested BMA vs. BM MSCs 
(Allogeneic- murine) 
Injection into wound bed 
(7.5 x 105 cells) 
Enhanced epithelial gap closure/ 
accelerated reepitheilalisation. 
Increased granulation tissue area 
Increased blood vessel density (CD31+) 
at wound site 
(Javazon et al, 
2007) 
FTDW (6 mm)  
(C57BL/6, BALB/c db/db 
mice 
 
Murine BM MSCs 
(Allogenenic) 
1 x 106 cells (70 % injected 
intradermally at 4 sites, 30 % in 
growth factor reduced matrigel).  
 
Accelerated wound closure, with 
increased re-epithelialization, cellularity, 
and angiogenesis in both models. MSCs, 
colocalised with keratin and formed 
glandular structures, suggesting epithelial 
transdifferentiation  
Ang 1, VEGF found in higher levels in 
vivo 
(Wu et al, 2007) 
FTDW (1.5 x 1.5 cm) 
New Zealand White Rabbit 
Rabbit BM MSCs 
(Autologous and 
Allogeneic)  
Human amniotic membrane seeded 
with (HAM) (2x105 cells) vs. 
injection (6.6 x 106 cells). 
HAM +MSCs showed improved healing 
over injected MSCs 
-Thinner epidermis mature differentiation, 
plus recovered skin appenagages in 
dermal layer.  
Cell origin made no difference.  
(Kim et al, 2009) 
TFDW (10 mm)  
C57BL/6 mice 
 
 
 
 
 
BM MSCs 
 
IV injection (1 x 106 cells) Reduced wound area. 
Local injection of chemoattractant  
increased the number of MSCs engrafted 
into the wound form IV administration and 
accelerated wound closure all the more. 
GFP MSCs co-localized with endotheial 
and pericyte markers.  
(Sasaki et al, 
2008) 
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Full-thickness incisional 
wounds (3cm long) and 
sutured. 
New Zealand White Rabbit  
Human BM MCSs 
(Allogeneic) 
 
Intradermal injection around wound 
site- 1.5 x 106 cells 
 
Inhibited scar formation and increased 
tensile strength of the wounds above 
controls  
(Stoff et al, 
2008) 
 
Incisional wounds (5 cm) 
Strptozotocin-induced 
diabetic Sprague-Dawley 
rats 
 
Rat BM MSCs 
(Allogeneic) 
Systemic IV injection (1.5 x 106 cells 
each day for 4 days after injury) and 
local injection (6 x 106 cells) 
Systemic and local delivery improved 
wound breaking strength; this was 
associated with an increase in collagen.  
Wounds improved with respect to 
inflammatory cell infiltration, + evidence 
of neovascularisation 
Increased the expression of growth 
factors critical to proper repair at wound 
(TGF-E, KGF, (EGF, VEGF, PDGF-BB) 
(Kwon et al, 
2009) 
 
Full-thickness excisional 
wound  
New Zealand White Rabbit. 
Rabbit BMA  
(Autologous) 
Intradermal injection at wound 
margins 
Granulation tissue appeared significantly 
faster. At 21 days better epithelisation 
more wound contraction. Healing tissue 
showed early disappearance of 
inflammatory reaction, significantly more 
neovascularisation, and more fibroplasias 
and early lay down and histological 
maturation of collagen (via histological 
analysis/ scoring). 
(Borena et al, 
2010) 
FTDW (20 mm)  
Sprague-Dawley Rat 
 
Rat BM MSC 
(Autologous) 
Type I collagen Matrix (2 x 106 cells) Accelerated early phase healing. 
Earlier expression of MMP-9 which 
correlated with maximal VEGF 
expression and enhanced 
neovascularisation 
(Kim et al, 
2011a) 
FTDW (10x10 mm)  
Sprague-Dawley Rat 
Human BM MNCs 
(Allogeneic) 
Nanofibrous scaffold (elecrospun 
collagen PLGA surface 
functionalised with CD29 to improve 
cell attachment (produced in 
mouse) 
(3 x 106 cells) 
Accelerated wound healing/closure. 
Faster re-epithelialisation and healed skin 
contained differentiated epithelium  
Increased Collagen production.  
 
(Ma et al, 2011) 
FTDW (Rabbit model) Rabbit BM MNC  
(Autologous) 
Intradermal injection at wound 
margins (2 x 106 cells) 
Increased neovasularisation; thicker 
granulation tissue; thicker and better 
arranged collagen I fibres, increased 
reticulin and elastin fibres. 
(Akela et al, 
2012; Argolo 
Neto et al, 2012)  
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Key: BALB/c mice= Defective T-cell immunity; C57BL/6 mice= Immunocompetent; Db/db mice= diabetic- healing incompetent; FTDW= Full-thickness dermal 
wound (excisional); IV= intravenous administration. Note- All results reported are statistically significant unless otherwise stated.
FTDW (Streptozotocin-
induced diabetic mice) 
Murine BM MSCs  
(Autologous) 
Saline (3.3 x 107 cells), and covered 
with a polyeurothatne 
semipermeable membrane 
Increase rate of wound closure. 
Increased collagen I 
Decreased scarring. 
(Argolo Neto et 
al, 2012) 
FTDW  
Geneticaly diabetic mice 
(Lepr db/db) 
Murine BM MNCs  
(Allogeneic) 
Subcutaneous injection 
 
Promoted wound healing, 
neovascularization, and EPC recruitment 
(Castilla et al, 
2012) 
FTDW (5x6 cm). 
Streptozotocin-induced 
diabetic Wistar Rat  
Rat BM MSCs 
(Allogenic) 
Intradermal injection (1 x 107 cells), 
8 sites around wound margin 
Accelerated wound healing time, rats that 
received a second dose of MSCs healed 
faster compared to rats treated once  
Enhanced wound epithelialization and 
neovascularization, increased expression 
EGF and VEGF. Reduced CD45 
inflammatory cells 
(Kuo et al, 2011) 
FTDW (10x10 mm) 
(C57BL/6 mice) 
Murine BM MSCs 
(Autologous) 
8 % Methlycelulose containing cells 
(1 x 104) overlyn with dermal 
substitute. 
 Increased vascular density (CD31+ cells) 
with in the dermal substitute. 
(Leonardi et al, 
2012) 
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Clinical Studies  
 
 However, despite promising findings in animal studies, few clinical trials have taken 
place. There have been but a handful of case studies examining the effects of autologous 
BM-derived cells on chronic wounds involving fewer than 20 patients (Mulder et al, 2012). 
Although many authors refer to the cells investigated in WKHVHVWXGLHVDVµ06&V¶WKH\ZHUH
applying BMA or bone marrow mononuclear cells (BM MNC) to chronic wounds. Few 
authors have actually extracted and characterised the population of MSCs from the bone 
marrow and used them therapeutically (Falanga et al, 2007; Dash et al, 2009; Lu et al, 
2011; Xu et al, 2012) 7KHUHIRUH WKH WHUP µ06&¶ LV LPSOLHG LQ WKH ORRVHVWVHQVH LQVWXGLHV
involving BMA, since BM is a heterogeneous mix of cell types that contains a small sub-
population of MSCs.  
 
 Ichioka et el demonstrated that after administering autologous BMA to a patient with a 
wound which was unresponsive to conventional wound therapies, healing was achieved. 
Two weeks following treatment vascularised granulation tissue was apparent which 
facilitated the successful take of a split thickness skin graft, and the patient remained free of 
complications thereafter (Ichioka et al, 2005). Other reports presented similar findings and 
are summarised in Table 1.4. In common with all reports, authors admit that a case study 
alone is not a basis for sound conclusions, and they recommend a wider number of patients 
to be recruited for future trails, however they demonstrate the success of BMA cell-therapy 
where conventional treatments have failed and provide insight into the effects of BM-derived 
cells. Recently Yoshikawa and associates treated 20 patients with various untraceable 
dermatopathies, (including burns, skin ulcers and DFUs), using artificial dermis implanted 
with autologous bone marrow-derived cells. The authors reported this treatment to be 
successful because 18 out of the 20 wounds had mostly healed (13 completely and 5 
partially), and even in the wounds that showed the least improvement, the outcomes were 
still improved (Yoshikawa et al, 2008). 
 
 One critique of the use of BMA lies in the inability to quantify the number of viable 
MSCs applied to the wound in these studies. This is important because a correlation exists 
between the number of MSCs per surface area and reduction in ulcer size (Falanga et al, 
2007), and the cellular faction obtained from BMA varies between individuals (Sarasua et al, 
2011). Therefore purifying the MSCs population from BMA in accordance with good 
manufacturing practice (GMP) may enhance the clinical efficacy cell therapies.  
 
 Lu et al recently compared the use of BMA vs. MSCs isolated from BMA, in a double 
bind randomised controlled trial, to treat patients with bilateral chronic wounds arising from 
diabetic critical limb ischemia. The ulcer-healing rate from the MSC group was significantly 
higher than that of the BMA group 6 weeks after intramuscular injection, and complete 
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healing was achieved 4 weeks earlier than with the BMA group. Furthermore, both 
treatments provided a better outcome than treating the wound with saline (control). Upon 
follow-up at 24 weeks, the MSC group presented with improvements in limb perfusion over 
the BMA group (assessed by painless walking time, ankle brachial index, transcutaneous 
oxygen pressure and magnetic resonance angiography analysis). Additionally, cell 
treatments lowered the incidence of amputation over the follow-up period, however there 
was no difference in limb salvage between the treatment groups (BMA vs. MSCs). The 
authors recommended that larger sample-sizes and longer-term follow-ups are necessary to 
determine statistically significant differences. In summary they demonstrated MSCs to be 
more effective than BM (Lu et al, 2011). 
 
 Falanga et al (2007) applied autologous culture-expanded BM-MSCs to both acute 
wounds, secondary to excision of skin lesions, and DFUs using a topical fibrin spray. They 
reported that MSCs did not significantly help acute wounds heal. Of the four patients 
assessed, only two presented control sites with wounds of similar size, and no difference 
was observed between the control and treatment sites on these individuals. However one 
patient who presented with an initial wound area of 20 cm2, which was more than twice the 
average area of the other participants, showed accelerated healing. Of the six patients that 
presented with DFUs, one incidence of complete healing was reported, one did not respond, 
while the remaining four exhibited a mean wound area reduction of 40 % over 20 weeks 
(Falanga et al, 2007). 
 
 To date there is only one published report where a randomised controlled clinical trial 
has been conducted. Dash et al (2009) used culture-expanded BM-MSCs to treat a total of 
24 patients with chronic non-healing lower extremity ulcers resulting from either diabetes or 
Buergers disease. The treatment group received autologous BM-derived MSCs via 
intramuscular injection around the wound margins, whereas the control group only received 
standard wound dressings. After a 12 week follow-up the authors reported a significant 
reduction in ulcer sizes of both treatment groups. With respect to the DFU MSC-treated 
group, the mean ulcer size decreased by 72 %, while those who received the standard 
treatment had ulcers which only decreased by 23 %. In addition, MSC injections showed no 
adverse effects as assessed by hepatic and renal functional tests, and the MSCs injections 
LQFUHDVHG WKH SDWLHQW¶V SDLQ IUHHZDONLQJ GLVWDQFH)XUWKHUPRUHZRXQGELRSVLHV UHYHDOHG
an increased number of mature immune cells and fibroblasts in the dermis of MSC-treated 
wounds, suggesting an augmented immune response (Dash et al, 2009). 
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Table 1.4. The use of BM cells for the treatment of non-healing wounds in the clinic. 
 
Wound type Therapy type Delivery Method Controls Summary of Findings Reference 
Chronic wounds (n = 3) BMA 
(Autologous) 
Subcutaneous 
injection and 1-3 
topical applications 
None Complete closure of wounds. Increased 
inflammatory response and angiogenesis 
(Badiavas and 
Falanga 2003) 
Chronic leg ulcer 
(unknown aetiology) (n=1) 
BMA 
(Autologous) 
Collagen matrix 
impregnated with cells 
None Improved vascularization and granulation 
tissue developed (2 weeks), which facilitated 
split-thickness skin grafted to completely 
close the wound.  
Patient remained complication free (18 month 
follow-up). 
(Ichioka et al, 
2005) 
1) Acute wounds (n=4) 
2) DFUs (n=6) 
 
 
BM MSCs  
(Autologous) 
Topical fibrin spray Acute: 2 patients 
had untreated 
wounds 
DFU: None 
Acute wounds: No difference in healing rate. 
Noted pain relief. 
DFUs: 1 completely healed, 1 no difference, 
and 4 mean wound area reduction 40 %. 
Dose dependent effect.  
(Falanga et al, 
2007) 
 
DFU (n=1) 
(CLI-induced) 
BM-MNC 
(Autologous) 
Intramuscular injection 
multiple sites 
None Compete wound healing (20 weeks) 
Improved angiogenesis and perfusion in foot 
stump 
(Kirana et al, 
2007) 
Chronic wounds 
(HIV-neuropathic, n=1) 
(Venus insufficiency, n=1) 
(DFU- neuropathic, n=1) 
BMA 
(Autologous) 
Injected directly into 
wound. 
None Improved granulation tissue production in all 3 
patients, which facilitated the take of STGSs 
leading to complete healing. Reduced scaring 
also observed. 
(Rogers et al, 
2008) 
20 patients with 
irretraceable 
dermatopathies (serve 
burns, (n=2); skin ulcers, 
(n=7); traumatic skin 
necrosis, (n=1) and 
decubitus ulcers, (n=10)). 
 
BMA  
(Autologous) 
Artificial dermis 
soaked with BMA 
 
None Wounds mostly healed in 18 of the 20 
patients. In all patience autologous cell 
transplantation was shown to be effective. 
(Yoshikawa et 
al, 2008) 
 
Chronic wounds  
(DFUs and Buergers 
Disease) (n = 24) 
BM-MSC 
(Autologous)   
Intramuscular and 
subcutaneous 
injection of > 1 × 106 
cells/cm2 ulcer. 
Standard wound 
care 
Decreased wound sizes.  
Increased pain-free walking distance 
(Dash et al, 
2009) 
DFU (n=41) BM MNC Intramuscular injection Bilateral ulcers (n Ulcer healing rate of the BM-MSC group was (Lu et al, 
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(CLI- induced) (n=21), 
BM MSC 
(n=20) 
(Autologous) 
multiple sites wound 
margins 
=41), saline 
injection 
faster than BM-MNCs group, healing 4 weeks 
earlier (week 6).  
Controls failed to heal after 24 weeks. 
BM-MSCs improved limb perfusion over 
controls.  
2011) 
DFUs (n=8) 
(Neuropathic) 
 
 
 
 
 
BM MNC  
(Autologous)   
 
 
Direct  
Injection into wound 
bed various sites, 
followed by platelets 
and fibrin glue mixed 
with BM-MNCs, and 
covered by collagen 
matrix seeded with 
BM-MNC  
None Wounds completely healed in 3 patients, and 
were significantly reduced in the remaining 5 
after 4 weeks. 
(Ravari et al, 
2011) 
Pressure ulcers (Type IV) 
 > 4 months in duration 
(n=22) 
BM MNC 
(Autologous) 
Injection in wound site None Pressure ulcers fully healed in 19 patients, 
after a mean time of 21 days.  
None of the resolved ulcers recurred after 19 
months. 
The number of MNCs isolated was patient 
dependent, although similar clinical outcomes 
were observed in each case.  
Compared to conventional surgical treatment, 
mean intra-hospital stay was reduced from 
85.16 to 43.06 days.  
(Sarasua et al, 
2011) 
 
Key 
BMA= Bone marrow aspirate; BM-MNC= Bone marrow mononuclear cells; BM-MSC= Bone marrow mesenchymal stem cells; CLI= Critical limb ischemia; DFU= 
Diabetic foot ulcer. Where indicated in the source literature, the number of cells administer is given. 
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06&¶s Mechanisms of Action in Wound Healing 
Differentiation  
 
 There is evidence to suggest that MSCs can mobilise from the bone marrow stroma, 
DQGWUDQVORFDWHRUµKRPH¶ to sites of ischemic tissue in a cytokine-dependent manner (Chen 
et al, 2011). It is also hypothesised that mechanical stresses in the skin triggers the release 
of various cytokines, which recruit blood-circulating MSCs (Rochefort et al, 2006).  
 
 Once at the site of injury, MSCs may contribute to wound healing via differentiation 
into dermal and epidermal cell types. In vitro MSCs have been shown to transdifferentiate 
into keratinocytes and endothelial cells both in vitro and in vivo (Oswald et al, 2004; 
Paunescu et al, 2007; Wu et al, 2007). For example, Sasaki et al demonstrated that MSCs 
in vitro, in the presence of bone morphogenetic protein-4, could induce the expression of 
Keratin 14 (Sasaki et al, 2008), which is considered a biochemical marker of stratified 
squamous epithelia (Coulombe et al, 1989). In addition, Sasaki et al provided evidence that 
MSCs may transdifferentiate to vascular-type cells in vivo. The authors showed GFP-
labeled BM-MSCs, in wounded murine tissue, to be co-localised with the expression of 
markers for endothelial cells (CD31) and pericytes (smooth muscle actin). Cell-fusion was 
ruled out as a possibility by in-situ hybridisation for X-Y chromosomes, since sex 
mismatched MSCs were donated to the recipient mouse, thus suggesting that these cells 
may directly contribute to angiogenesis through differentiation (Sasaki et al, 2008). 
However, the extent to which MSCs contribute to wound healing via differentiation is a 
subject of debate, especially concerning their contribution to skin cells (Prockop 2007). For 
example, there are studies that report MSCs can engraft to the epidermis (Badiavas and 
Falanga 2003; Fathke et al, 2004), however engraftment has not been shown to be a long-
term phenomena (Wu et al, 2007). 
Paracrine Mechanisms 
1) Angiogenic and Trophic Factors 
 
 There is growing evidence to suggest paracrine signaling is the predominant 
mechanism by which MSCs mediate their therapeutic benefits, and a wide range of 
cytokines produced by MSCs are thought to be involved in acceleration of wound healing. 
So-called 'conditioned medium' (CM) (culture medium collected after cells have been 
sustained by it for a defined period of time under hypoxic conditions), from BM-MSCs has 
been shown to be rich in mitogens secreted by the cells. Furthermore, MSC-CM has been 
shown in vitro to enhance the migration and proliferation of numerous cell types important to 
wound healing and it has also been shown to accelerate wound healing (Kinnaird et al, 
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2004; Volk et al, 2007; Chen et al, 2008; Kwon et al, 2008; Walter et al, 2010). In 2008, 
Chen and associates published a seminal work in which they extensively characterised the 
effects and composition of MSC-CM upon wound healing (Chen et al, 2008); a summary of 
their key findings will be presented.  
 
 Compared to human dermal fibroblasts, the authors found CM originating from human 
BM-MSCs to contain a distinctly different profile of cytokines. Enzyme-linked 
immunosorbent assay (ELISA) and protein array analysis revealed MSC-CM to contain 
much greater amounts factors such as: VEGF-Į, IGF-1, EGF, KGF, angiopoietin-1, HGF, 
macrophage inflammatory protein-1 alpha and beta, stromal derived factor-1 and 
erythropoietin, compared to dermal fibroblast CM; all of which are essential to productive 
wound healing (Chen et al, 2008). 
 
 The authors subsequently demonstrated the ability of MSC-CM to enhance the 
migration of CD24+ monocytes, keratinocytes and HUVECs (human umbilical vein 
endothelial cells) across a transwell in a concentration-dependent manner (i.e. with serial 
dilutions of CM diminished the cells migratory capacity). Additionally, MSC-CM was found to 
support the proliferation of both keratinocytes and HUVECs in a similar fashion compared to 
their standard growth media, and in both instances MSC-CM was more effective than 
fibroblast-CM at stimulating cell proliferation (Chen et al, 2008). Accordingly other authors 
have shown paracrine factors in MSC-CM to: accelerate fibroblast and keratinocyte 
migration in scratch assays (Walter et al, 2010); promote tubule formation from endothelial 
cells (Wu et al, 2007); and enhance endothelial cell and smooth muscle cell migration and 
proliferation in vitro in a concentration dependent manner (Kinniard et al, 2004). Thus, MSC-
released cytokines positively affect cell types involved in wound healing in vitro.  
 
 Furthermore, Chen et al proved MSC-CM could accelerate wound healing in a full-
thickness excisional mouse model. Compared to vehicle medium or fibroblast-CM, MSC-CM 
exerted potent chemoattractive and mitogenic effects in vivo. Wounds treated with MSC-BM 
showed higher proportions of cells positive for endothelial-lineage cell markers (CD34, C-kit 
and Flk-1), and also an increased presence of macrophages. These results were consistent 
with the cytokine profile from MSC-BM whereby chemoattractants for the aforementioned 
cells types were found to be in abundance; their results were also consistent with those of 
others (Kinnarid et al, 2004; Wu et al, 2007; Volk et al, 2008).  
 
 In addition an association has recently been made between MSC-derived pro-
angiogenic factors and improved healing outcomes for DFU-patients in the clinic. Lu et al 
showed that culture medium collected from autologous BM-MSCs under hypoxic conditions 
contained high levels of angiogenic factors (VEGF, FGF-2 and Angiopoietin-1). CWs are by 
their very nature hypoxic environments therefore, the authors attributed, in part, the 
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improvement in limb perfusion experienced by patients following treatment with MSCs to 
their ability to create an angiogenic drive  (Lu et al, 2011). Together these findings provide 
strong evidence to support the hypothesis that MSCs mediate their wound healing benefits 
in a paracrine fashion, since MSC-produced paracrine factors alone can accelerate wound 
healing. For WKLV UHDVRQ &DSODQ  KDV VXJJHVWHG UHQDPLQJ 06&V DV ³PHGLcinal 
VLJQDOLQJFHOOV´)LJXUH1.8, summarises MSC paracrine action (Caplan 2007).   
 
 
 
Figure 1.8. Paracrine mechanisms of MSCs. (Figure reproduced from (Meirelles et al, 
2009).  
 
2) Immunomodulatory properties 
 
 As previously described, chronic wounds fail to progress through the normal phases 
of wound healing and enter a state of pathological inflammation. Therefore, reducing 
inflammation may improve wound healing (Ishida et al, 2004). An important property of 
MSCs, which has been demonstrated both in vitro and in vivo, is their immunosuppressive 
effect. MSCs are able to influence the activities of macrophages, dendritic cells and T-cells 
(Djouad et al, 2007; Selmani et al, 2008; Nemeth et al, 2009; Cutler et al, 2010) by the 
release of bioactive molecules which are produced either constitutively, or as a result of 
cross-talk with target cells (Tu et al, 2010). One such constitutively expressed molecule is 
hepatocyte growth factor (HGF), which has been shown to suppress CD4 and CD8 positive 
T-cells (Di Nicola et al, 2002). MSCs also alter the cytokine profiles of dendritic cells, 
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effector T-cells, and natural killer cells to more anti-inflammatory phenotypes (Aggarwal and 
Pittenger 2005), and this phenomenon is thought to be the basis for the use of MSCs to 
treat graft rejection and graft versus host disease (Bartholomew et al, 2002; Le Blanc et al, 
2004). Indeed, some authors have hypothesised that the resolution of chronic wounds after 
treatment with MSCs may be partly attributed to their immunosuppressive effect, however 
this has yet to be fully investigated (Chen et al, 2012).	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1.5. Optical Coherence Tomography (OCT) 
 
 OCT is an interferometric imaging technique that maps depth-wise reflections of near-
infrared (NIR) light from tissue in real-time to form cross-sectional images of morphological 
features at the micrometer scale (Zysk et al, 2007). Therefore, OCT is often described as 
WKHµRSWLFDODQDORJXH¶RIXOWUasound (Marschall et al, 2011). However unlike ultrasound, it is 
able to resolve features laterally LQWKHRUGHURIȝPDQGZLWKDGHSWK (axial) resolution of 
ȝPRUJUHDWHU (Povazay et al, 2002; Drexler 2004). Thus, OCT fills the gap, in terms of 
resolution and depth penetration, between that of ultrasound and confocal microscopy 
(Figure 1.9). In addition, unlike ultrasound, OCT holds the advantage of being a non-contact 
technique because no inductively coupling gel is required, and direct contact of the 
transducer with the sample is not necessary.  
 
 
 
Figure1.9. Comparison of depth/axial resolution vs. depth penetration of OCT compared to 
other imaging modalities (OCM= optical coherence microscopy). (Figure reproduced from 
Marshcall et al, 2011). 
 
 Figure 1.10. is a cross sectional image of human skin and illustrates the unique 
FDSDELOLWLHV RI 2&7 :LWKLQ D GHSWK RI  ȝP EDFN-scattering structures, such as the 
stratum corneum and epidermis, are clearly resolved and displayed. OCT therefore can 
provide information regarding the structure and morphology of tissue that would otherwise 
RQO\ EH REWDLQDEOH YLD KLVWRORJ\ ,QGHHG 2&7 LV RIWHQ UHIHUUHG WR DV DQ µRSWLFDO ELRSV\¶
method because OCT images of skin tissue correlate to the tissues histology (Brezinski et 
al, 1997). 
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Figure 1.10. OCT image from palmar skin. Scale bar= 1 mm.  
 
 The principles of various OCT systems are discussed below, however a detailed 
discussion of the theoretical aspects and physics related to OCT is beyond the scope of the 
thesis. For a more comprehensive overview I refer the reader to articles written by Fretcher, 
Ponoleanu,Smidt and Tomlins and Wang (Schmitt 1999; Podoleanu 2005; Tomlins and 
Wang 2005; Fercher 2010) . 
 
 Optical interference is at the core of OCT methods. In its most basic form, an OCT 
instrument consists of a Michelson-type interferometer with a focused sample arm and a 
lateral-scanning mechanism. Using a Michelson interferometer, a beam of light from the 
optical source is simultaneously split into two beams of nearly equal intensity using a half-
transparent mirror oriented at a 45-degree angle (plate beam-splitter). One beam, the 
internal or reference beam is directed on to a flat fixed 'reference mirror', and the second 
beam is directed onto the sample. Reflected light from both optical paths is then recombined 
at the beam-splitter and a pattern of optical interference is produced and detected. The 
resulting one-dimensional depth scan produced from a single plane through the sample is 
called an A-scan (1D depth resolved point scans). Many adjacent A-scans can be made in 
succession by lateral scanning to produce a B scan (2D slices through a volume) (see 
Figure 1.11.), and C scans can also be made to produce 3D volume images.  
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Figure 1.11. Imaging planes. (Figure reproduced from Podolenau et al, 2005). 
 
Types of OCT System 
 
 A-scans can be generated by two methods: time domain (TD) or frequency domain 
(FD). TD-OCT systems were the first to be implemented (Huang et al, 1991) and composed 
the majority of systems between 1991 and 2003, but since then most of systems that have 
arisen have been FD OCT. This is because the SNR (signal: noise ratio) has been shown to 
be 100 times better than TD systems (Leitgeb et al, 2003), thus paving the way for real-time 
B-mode imaging.  
Time Domain OCT 
 
 OCT uses low coherence light. All light has a finite coherence length, which is defined 
as the distance over which trains of light remain in phase or synchrony. Coherence is 
inversely proportional to the bandwidth of a light-source; therefore light sources 
simultaneously producing a wide range of wavelengths provide light with lesser coherence 
than light which is produced from a single wavelength source (Figure 1.12.) (Chen and Lee 
2007). By using light with a broad spectral bandwidth, and thus a short coherence length, 
only backscattered light from the sample that has a path-length difference that is within one 
coherence length of the light-source, can interfere with the reference beam to create 
interference fringes. This condition creates a spatial and temporal gate whereby light can 
only be interrogated from a certain depth within the tissue; signal detected from shallower 
and deeper structures are rejected. This so-called 'coherence gate' can be shifted along the 
SURELQJ EHDP¶V D[LV WKURXJK FKDQJLQJ WKH OHQJWK RI WKH UHIHUHQFHSDWK E\ WUDQVODWLQJ WKH
reference mirror along the axial direction (Figure 1.13.). Analysis of the detected optical 
interference pattern provides information regarding the echo time of the sample that 
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corresponds to a depth within the sample. Together with the magnitude of the interference, 
this information is used to create a grey-scale cross-sectional image of the tissue. 
 
	  	  	  	  
 
 
Figure 1.12. Coherent and non-coherent light. A) Broad band light consisting of spectrum of 
colours (wavelengths). The light is incoherent. B) Monochromatic light such as LED light. 
Waves are not in phase (non-coherent). C) Laser light where waves are in phase 
(coherent). D) Light with a long coherence length. E) Light with a short coherence length.  
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Figure 1.13. A typical TD-OCT system set-up (Figure reproduced from Marshcall et al 
2011).  
 
Frequency/ Fourier Domain OCT (FD-OCT) 
 
 In TD-OCT, the speed at which the path length can be changed is the rate-limiting 
factor in image acquisition speed, i.e. the faster the reference mirror can move the faster 
imaging can proceed (Tomlins and Wang 2005). Frequency domain (FD) systems hold the 
advantage of being able to acquire A-scan images much more rapidly because they do not 
require a moving reference arm that limits the image acquisition rate. FD systems acquire A-
scans using a fixed reference path, and the sum of all the reflections from the tissue are 
detected, and the phase of the reflected light at certain frequencies is compared to the 
signal source, hence the name frequency domain (Fercher et al, 1995). Information 
regarding signal depth can be extracted using Fourier transform algorithms to reveal the 
sample¶V reflectivity profile; the term Fourier domain OCT therefore can be used 
interchangeably with frequency domain.  
 
 There are two ways in which FD-OCT image acquisition can be achieved. One can 
illuminate the interferometer with a broadband light source and then separate the reflected 
light originating from the sample into desecrate spectral components by placing a 
spectrometer at the output. This method is called 'spectral domain OCT (SD-OCT) (Bail et 
al, 1998) (Figure 1.14 a). Alternatively, 'swept source OCT' (SS-OCT) can be performed by 
probing a sample sequentially with different optical frequencies using a tunable narrowband 
light source that is able to sweep across a broad range of optical frequencies (Figure 1.14 
b). The strength of the reflected signals at each wavelength is recorded using a single 
balanced detector which subtracts the reference and sample signals, and the remaining 
signal emanating from a location within the sample is then amplified; this method is quoted 
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more economical than using an array detectors as found in SD-OCT systems (Tomlins and 
Wang, 2005). SS-OCT systems contain spectrometers comprised from very fast read-out 
1D linesman cameras that can offer up to several 100,000 readouts per second, and SS-
OCT lasers are capable of rapidly sweeping through their spectrum (Matcher, 2010).   
 
 
 
Figure 14. FD-OCT systems. A) Spectral Domain OCT. B) Swept-Source OCT. In both 
cases the reference mirror remains in a fixed position, and sampling the interference pattern 
by optical frequency provides a depth scan. If a broad band light source is used as in A), a 
spectrometer is used to separate the reflected light into discreet bands for analysis. 
Alternatively a tunable narrowband light source that can rapidly sweep through a range of 
optical frequencies can be used (b). (Figure reproduced from Marshcall et al, 2011).   
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Fundamentals 
OCT Vs. Confocal Microscopy 
 
 Confocal microscopes (CM) can achieve high axial and lateral resolutions because 
they use objective lenses with high numerical apertures (NA). However, because OCT 
achieves axial resolution using coherence gating, low NA lenses are selected because they 
provide a depth of focus that is able to cover the entire imaging depth range. This is one of 
the ways in which OCT can image deeper structures than CM, however it comes at the 
expense of losing some lateral resolution, leading it to EHVHYHUDO WHQVRIȝP rather than 
several microns (Marschall et al, 2011). This problem can be in part alleviated by using TD-
OCT because dynamic focusing can be performed, i.e. the focus can be shifted through the 
sample in synchrony with the coherence gate. Thus higher NA lens can be used whilst 
maintaining a good imaging depth (Holmes et al, 2008); this allows TD-OCT WRFROOHFW µHQ-
IDFH¶parallel to the surface). This technique is often termed optical coherence microscopy 
(Yang et al, 2006), and it is often performed when the most relevant information is contained 
within the en-face plane and where high-speed image acquisition is not a priority (Matcher 
2010).   
 
 In addition, due to the low NA of OCT lenses, working distances can be over several 
cm compared to less than 1 mm for high-NA objectives used for confocal. Several more 
points for comparison are listed below: 
 
x By its very nature OCT is insensitive to fluorescence emission, therefore 
fluorescence labeling is of little value. OCT can however be made indirectly 
sensitive to fluorophores using a functional method called 'pump probe' OCT 
(Jacob et al, 2010). 
 
x OCT images contain an inherent form of noise called 'speckle' which is absent 
in confocal images. 
 
 OCT produces 2D depth-resolved slices, whereas confocal microscopy 
produces 2D 'en-face' transverse slices. In both instances, software can be 
used to convert between these formats. 
Light Source/ Wavelength Selection 
 
 The light source is the most important component of an OCT device because it is the 
primary determinant of imaging depth and resolution. Only broadband light sources that are 
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of short coherence length make it possible to accurately measure the depth of the 
backscattered signal from tissue. Such light can be generated from femtosecond mode 
locked pulsed lasers, super-luminescent diodes of fiber amplifiers. NIR light is most 
commonly used, because as a general rule, the longer the wavelength the less scattering 
the light experiences, leading to deeper penetration of the tissue, and such wavelengths are 
not absorbed by haemoglobin (Matcher, 2010).  
 
 Original OCT systems operated in the region of 800 nm, and this remains the most 
widely used wavelength in ophthalmology because it has excellent penetration through 
water, however 1060 nm is emerging as the new preferred wave length because of its 
increased depth penetration and higher resolution due to a reduced sensitivity to blurring 
from water dispersion (Sharma et al, 2008). Light with a wavelength of 1300 nm has proven 
to be the most popular non-ophthalmic application because it has the advantage of 
achieving greater depth penetration into biological tissues than 800 and 1060 nm sources. 
There are a wide choice of sources available that operate in this range, however they are 
not suitable for imaging though aqueous environments due to high adsorption in water 
(Matcher, 2010). 
Resolution 
 
 Resolution is a measure of the ability of an optical system to distinguish detail. It can 
be defined as the minimum distance over which two distinct points can be separated for 
them to be identified or 'resolved' as two single points. For example, if two points have a 
proximity to each other that is within the resolution limit of the imaging system, they will be 
resolved as two desecrate points/pixels. If however they are closer to each other than the 
resolution limit, they will not be resolved and the two points will appear as a single point. 
The greater the resolving power of the system, the finer the detail that can be differentiated 
in an image. One of the advantages of OCT is that the axial resolution (the depth) and 
lateral resolution (transverse) are independent of each other (Mason et al, 2004). The axial 
resolution is inversely proportional to the bandwidth (Fujimoto 2001), therefore low coherent 
light sources provide greater axial resolutions compared to sources with a smaller 
EDQGZLGWK7\SLFDO2&7V\VWHPVSURYLGHD[LDOUHVROXWLRQVRIDSSUR[LPDWHO\ȝPZKLFKLV
up to 100 times that of ultrasound, thus making it suited to imaging morphological changes 
in smaller biological structures such as epithelia (Gambichler et al, 2006). In addition, novel 
ultra high-resolution OCT systems with laser light sources have achieved resolutions as 
high as ȝP (Morgner et al, 2000). The transverse/lateral resolution is dependent on the 
optical properties of the system, such as NA and focal spot size on the lens. The lateral 
resolution typically achieved in OCT is between 10- ȝP *DPELFKOHU DW DO, 2006). The 
lateral resolution can be improved upon by imaging with a high NA lens and focusing the 
beam to a smaller spot size, however a compromise must be made because imaging with a 
high NA lens sacrifices the depth of field (Fujimoto, 2001). 
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Optical Properties of Skin 
 
 The optical properties of the tissue greatly influence the performance of OCT in terms 
of depth penetration and SNR. The extent to which light is able to penetrate into tissue is 
determined by several factors, which include the absorption and scattering coefficient (the 
sum of which constitutes the attenuation coefficient); all of which are dependent on the 
make-up of the tissue. Understanding the structure of skin aids in understanding the factors 
governing its optical properties, which will be described below.  
1) Absorption 
 
 Absorption describes a reduction in light energy. Within skin, haemoglobin and 
melanin dominate the absorption of visible light. The dermis is the primary absorber of 
visible light due to the presence of haemoglobin contained within the erythrocyte-laden 
dermal vasculature (Bashkatov et al, 2005). In the IR range, light absorption is dominated 
by its interactions with water, which is estimated to comprise between 65.1 and 75.8 % of 
the volume fraction in the dermis (Reinoso et al, 1997)+RZHYHUGHVSLWHZDWHUV¶DEXQGDQFH
in tissue it is not a substantial absorber of light in the visible region (Meglinski and Matcher 
2002).  Melanins contained within the epidermis absorb light most strongly in the UV region, 
with the degree of absorption curtailing toward the IR end of the spectrum. Further 
absorption can be attributed to lipids (Prahl and Jacques, 2009), cell nuclei and filamentous 
proteins (Dawson et al, 1980).  
2) Scattering 
 
 When light changes direction, polarisation or phase, it is said to have been 
µVFDWWHUHG¶ /LJKW FDQEH VFDWWHUHG IURPVXUIDFHV E\ZD\ RI UHIOHFWLRQ RUPRVW commonly 
refraction, or as a of result interactions with regions of a material whose optical properties 
differ from its surroundings (particulate scatter) (Lister et al, 2012). Between 4 and 7 % of all 
visible light is estimated to be reflected from the surface of skin irrespective of skin colour; 
remaining light is refracted into the skin as it passes from air to tissue (refractive indices of 1 
and 1.36 respectively) (Anderson and Parrish 1981; Takiwaki 1998). Filamentous proteins 
present the principle source of scattering within skin. In the epidermis, keratins are the 
greatest filamentous protein constituent, whereas collagens are the most abundant 
filamentous component of the dermis, comprising 18-30 % of its volume (McGrath and Uitto, 
2004). 
 
 Using a Mie solution to Maxwell's equations, it has been shown, using data from in 
vitro skin, that the scattering probability increases with the diameter of fibrous proteins and 
decreasing wavelengths (Graaff et al, 1992) Taken together, the dependence of scattering 
upon fiber diameter, and the fact that protein structures in the dermis may be up to 10 times 
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as large as those of the epidermis (McGrath and Uitto, 2004), suggests the dermis produces 
a greater scattering cross-section despite the dermis containing a lesser density of 
filamentous proteins compared to the epidermis. In relation to collagen, scattering has been 
shown to occur at both the level of individual fibers and bundles (Bashkatov et al, 2011), 
and the reticular and papillary dermis, which differ principally in collagen fiber diameter have 
been shown to have a differential effect on the backscattering of light. For instance, the 
papillary dermis is highly backscattering because the collagen fibres are an order of 
magnitude lower than that of visible light, whilst the larger diameter collagen fibers of the 
reticular dermis cause a high degree of forward scattering (Claridge et al, 2003).  
 
 OCT is only able to detect light that is backscattered since it is only the backscattered 
light that escapes the tissue and reaches the detector. By considering skin a composite 
material composed of layers of different materials, one can understand how the grey-scale 
cross-sectional image is produced. The areas of the material which scatter light to the 
greatest degree have their pixels assigned a high white colour-intensity. Equally, pixels that 
originate from depths whereby there is a lesser degree scattering are represented in a 
relatively lesser intensity when the image is composed. Absorption of light does not directly 
contribute to image production. In order to maximise the optical inhomogeneity of the tissue, 
OCT systems must be optimised to reduce absorption (Welzel 2001). As discussed above, 
long wavelengths of light (between 750 and 1400 nm) are used because they experience 
less scattering than shorter wavelengths, thus allowing greater depth of penetration. 
Transparent tissues such as the eye allow the greatest depth of imaging, and depths of 
tissue-engineered structures (Georgakoudi et al, 2008) can be seen up to 2-3 mm, which is 
the limit for many tissues (Fujimoto 2003). 
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Applications of OCT 
Ophthalmology 
 
 OCT has made its most significant contribution to the field of ophthalmology, and it 
has been adopted as a standard diagnostic tool in the study of many retinal and vitroretinal 
diseases such as glaucoma (Medeiros et al, 2005), vitreous separation (Uchino et al, 2001), 
macular edema (Antcliff et al, 2000) and macular degeneration (Jumper et al, 2000). OCT 
has also been used to evaluate disease treatment protocols because it can capture 
treatment-LQGXFHGUHWLQDOFKDQJHVRQWKHȝPVFDOH(Costa et al, 2006).	  
 
 Compared to other imaging methods such as fluorescein angiography and ophthalmic 
ultrasound, retinal OCT is able to provide high resolution images of subsurface retinal 
features that were previously undetectable. Because of the different structure and reflectivity 
of the layers comprising the retina, each layer (retinal nerve fibber, nuclear layers, plexiform 
layers, external limiting membrane, retinal pigment layers and choriocapilliaris can be 
identified by this modality. Areas of the retina that contain cells which are aligned 
horizontally for example are correlated with high reflectivity, while layers that contain vertical 
structures and nuclei exhibit low reflectivity; and it is the differences in the optical properties 
of the retinal layers that allow each layer to be delineated (Zysk et al, 2007).  
Cardiology 
 
 Key to OCTs advancement in cardiology has been the miniaturization and the 
accommodation of the technology into rotational catheter-based probes (Zysk et al, 2007). 
OCT therefore has been used to examine the structure and integrity of the coronary artery. 
Compared with intravascular ultrasound (IVS), which is the current standard for imaging, 
OCT provides a greater resolution by approximately an order of magnitude, and is able to 
image 1-3 mm into the tissue with good correlation to IVS (Brezinski et al, 1997; Jang et al, 
2002). Applied to atherosclerosis, OCT can monitor the development of vulnerable 
atherosclerotic plaques in the coronary or carotid arteries to evaluate their potential for 
progression or rapture. When it comes to treating chronic total occlusions via stenting, OCT 
can be used to navigate the guide wire (Yabushita et al, 2002; Tearney et al, 2003; Chau et 
al, 2004); an inability to do so is the most common cause of procedural failure. It is also 
being evaluated as a tool to decrease the chances of guide wire perforation and dissection 
of the intima (Tanigawa et al, 2007). Also in relation to stenting, OCT imaging can be 
performed before and after balloon inflation (angioplasty), thus giving surgeons real-time 
information regarding stent apposition and re-expansion of the vascular walls (MacNeill et 
al, 2004), stent overexpansion (Bouma et al, 2003), and vessel injuries acquired post-
stenting (Surmely 2007),QDGGLWLRQGXHWR2&7¶VVXSHULRUUHVROXWLRQRYHU,96LWKDVDOVR
enabled the visualisation of stent integrity, neointimal proliferation, and neovascularization 
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(Kume et al, 2005a; Kume et al, 2005b; Regar et al, 2005). Recent efforts to develop 
functional modalities of OCT have allowed cardiovascular imaging to progress beyond 
morphological sensitivity alone, and thus has helped bridge the gap between structural and 
the underlying physiological information (Zysk, 2007). For example, fibrous calcified plaques 
have unique birefringence properties that can be visualised with polarization sensitive OCT 
(PS-OCT), and changes in these properties are thought to indicate changes in tissue 
structure. For instance, since the concentration of collagen dominates the birefringent signal 
in the image, it has been hypothesised that decreases in collagen, associated with 
vulnerable plaques, can be detected by PS-OCT (Giattina et al, 2006). Other functional 
techniques like optical coherence elastography are also being used to evaluate the 
mechanical properties of arterial walls (Rogowska et al, 2006). 
OCT in Dermatology 
 
 From the outset, OCT has been investigated as a tool for dermatology because skin 
presents the most readily accessible part of the human body. Over the past decade OCT 
has proven to provide optical biopsies with good homology to the histopathologies of a 
number of different skin diseases (Gambichler et al, 2011). Therefore, OCT is proving a 
useful tool in examining skin abnormalities that are difficult to assess by visual inspection 
alone. In particular, its use in assessing non-melanoma skin cancers has been the subject 
of much research, however OCT has also been used to study photo damage, burns and 
inflammatory diseases such as psoriasis and contact dermatitis and skin infections such as 
onychomycosis and scabies (Steiner et al, 2003; Mogensen et al, 2009b). 
 
 In spite of the many applications of OCT, it has yet to be adopted into the mainstay of 
clinical dermatology. OCT images are able to clearly differentiate layers of the skin's 
structure such as the stratum corneum, proliferative epidermis and dermis because each 
layer backscatters light to different extents, underpinned by their compositional make-up 
(Mogensen et al, 2008b). However, OCT cannot resolve individual cells; therefore it can 
only determine the presence of a skin disease if it causes the scattering properties the 
tissue to become significantly altered from the norm due to disease-related gross tissue 
morphological abnormalities. For example, OCT can detect the presence or absence of 
types of skin lesions, however it lacks the resolution to distinguish between cancer subtypes 
(Marschall et al, 2011); thus making it a tool most useful for screening but not for 
determining a differential diagnosis. 
1) Psoriasis 
 
 OCT is able to detect psoriatic patches by observing a strong entrance signal 
comprised from several parallel layers; with the layers resulting from the poorly 
backscattering region of poorly differentiated cells amongst mature highly backscattering 
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keratinocytes (Welzel et al, 2004). In hyperkeratotic conditions, due to the increased 
production of keratins, backscattering is increased from the superficial layers of the 
epidermis. Psoriatic pustules can also be identified; these appear as intraepithelial holes 
that are strong in signal intensity due to their backscatter (Welzel et al, 2004). Acanthotic 
epidermis (diffuse hyperplasia) can also be evaluated by tacking thickness measurements 
of the epidermis by means of A-scans averaging from B-scan images. A study by Morsely et 
al showed that OCT measurements of epidermal thickness from psoriatic skin correlates 
with other parameters of disease severity; thus OCT assessment of psoriatic plaques may 
prove a non-invasive method for following the development of psoriatic lesions in vivo 
(Morsy et al, 2010). However, OCT is not yet sensitive enough to differentiate between 
inflammatory skin conditions (Gambichler et al, 2007a). Additionally, OCT has also been 
applied in our lab to image inflammation in a model of psoriasis using cytokine-induced 
chronic inflammation in tissue engineered skin. Here, OCT was able to detect a 
hyperkeratotic thickening in the keratinised epidermis, and the images have also shown a 
good comparison to their histology (Bullock et al, 2011- shortly to be prepared for 
submission).   
2) Blistering Diseases 
 
 Both intradermal and subdermal blistering can be seen by OCT (Gambichler et al, 
2007), and it presents as large gaps between the dermis and the epidermis. In addition to 
the position of the blister, the nature of its content can also be deciphered via OCT in vivo. 
For example, serous infilling of the blister can be noted if the blister appears to be highly 
transparent, due to the area containing few scattering cellular components, whereas those 
that contain pus are perceived as brighter (more highly scattering) blisters because they 
contain a much greater volume of cells (Mogensen et al, 2008a) Again, however, due to the 
limits of OCT's sensitivity, it cannot distinguish between blistering diseases because the 
variations are too subtle; an enhanced resolution of OCT may overcome this shortcoming 
(Mogensen et al, 2008b)  
3) Skin Cancers 
 
 Actinic keratosis is an intraepitheilal neoplasm, of which 10 % progress to squamous 
cell carcinomas (Glogau 2000), and it can be identified by OCT, with an 83 % specificity 
(Korde et al, 2007) versus non-diseased skin, as white dots and streaks corresponding to 
hyperkeratosis. It has been suggested therefore that OCT can characterise and monitor the 
response of such neoplasms to chemotherapeutic agents (Jorgensen et al, 2008). 
Additionally, features of basal cell carcinomas (BCC) can be identified by OCT with 
excellent correlation with histology (Olmedo et al, 2006). Solid tumors for example can be 
discriminated by their homogeneous signal distribution (Forsea et al, 2010), whereas 
tumour cell nests present as sub-dermal hypereflective zones with a similar size and locality 
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to that which is observed via histology  (Olmedo et al, 2006). Multiple smaller tumour cell 
nests may also be observed deeper in to the dermis as poorly backscattering spots 
(Bechara et al, 2004). In malignant melanomas, large vertical, oval-shaped structures are 
the most striking OCT feature, which are absent from benign naevi, and these distinct 
features correlate to histopathological findings (Gambichler et al, 2007b). Signal intensity 
profiles can also be used to evaluate if a melanoma has become invasive. There is usually 
a second intensity peak from the backscattered light that represents the boundary between 
the epidermis and the dermis, however this peak may disappear, signifying that epidermal 
cells have invaded the dermis, although the extent of invasion can only be determined up to 
1 mm into the tissue due to the limitation of depth of light penetration into the tissue (Welzel 
et al, 2004).  
 
 Additionally, through the use of functional OCT methods extra information can be 
gained regarding the nature of the tumour, allowing it to be characterised more thoroughly 
than by visualisation alone. Using polarisation sensitive OCT (PS-OCT, the birefringent 
signal, originating from the highly organised collagen fibers, can be measured from the 
tissue; this signal becomes much attenuated when skin lesions are present. Therefore, it 
may be possible to use PS-OCT in addition to SS-OCT to identify basal cell carcinomas 
(Bredfeldt et al, 2005).    
 
 Interestingly, OCT has also proven to be less biased and more precise than 20-MHz 
high frequency ultrasound for measuring the thicknesses of BCC lesions (Mogensen et al, 
2009c). However one cannot differentiate between subtypes of BCC by OCT alone; 
histopathology is required (Gambichler et al, 2011). Despite OCT's inadequacy to diagnose 
BCC type, it has a relatively high accuracy when it comes to determining the presence of 
tumorous lesions from normal skin and identifying their boarders (Mogensen et al, 2009a) . 
Therefore, because of its non-invasive nature and ability to quickly acquire images over 
large areas of skin, it is a valuable tool for BCC tumor detection and screening. OCT can 
also be applied in surgery where cancer removal is concerned. Following the excision of 
diseased skin, the surgical wound margins can be examined to determine if any lesions that 
are not visible upon gross examination remain. The advantage over typical procedures for 
pathological assessment of excised tissue for cancerous remnants, such as light 
microscopy of paraffin embedded or frozen sections, is that it is far less time consuming and 
labor intensive and it does not suffer from limited spatial sampling over the mass, or artifacts 
produced from radiographic protocols (Vo-Dinh 2003). Therefore due to its ability to non-
invasively image to a depth of 1-2 mm, an entire tissue area can be immediately scanned in 
a timely manner to determine if tissue resection is required by the surgeon. For example, 
Hamdoon et al, demonstrated that OCT can be used to guide photodynamic therapy; by 
discriminating between healthy and tumor-involved tissue, the therapy could be better 
targeted to tumor sites thus reducing necrosis of healthy tissue (Hamdoon et al, 2011).  
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4) Evaluation of Therapeutics  
 
 The effects of a variety of therapeutics, including moisturisers, ointments, and 
biochemical agents such as glucocorticoids can be studied via OCT  (Pagnoni et al, 1999; 
Welzel, 2001). Skin hydration for example can be monitored by determining changes in the 
WLVVXH¶V UHIUDFWLYH LQGH[5,DQGVFDWWHULQJ LQGLFHVDQG LWKDVEHHQGHPRQVWUDWHG WKDWDQ
inverse relationship exists between the hydration state of the skin and its refractive index 
(i.e. the more hydrated skin, the lower the RI (Knuttel et al, 2004). Interestingly, it has been 
shown that the application of topical agents such as glycerol can transiently change the 
optical properties of skin tissue, by either decreasing reflectivity of the surface (Welzel et al, 
2004) or increasing transmittance (Vargas et al, 1999); thus allowing light to penetrate 
deeper into the tissue enabling greater depth of visibility form the tissue.  
 
 Because OCT can be used to quantify epidermal thickness, it has proven useful in 
the early detection and monitoring of the side effects of topical creams. Pagnoni et al 
studied glucocorticoid steroid (GCS) induced skin atrophy by OCT and reported a 21 % 
reduction in epidermal thickness over a 3 week period following the application of 0.05 % 
clobetasol propionate cream (Pagnoni et al, 1999). The authors additionally investigated 
experimentally induced acute inflammation via stimulating the skin with Dimethyl Sulfoxide 
(DMSO), and revealed morphological changes in the epidermis and a small attenuation of 
light in the dermis. Similar findings were reported by inducing inflammation with histamine 
and nicotinic acid (Welzel et al, 2004). Recently, Ashcoff investigated the effects of 1 % 
hydrocortisone cream on uninvolved skin in patients with atopic dermatitis, and found that 
after 2 weeks of application of the cream a 6 % reduction in epidermal thickness resulted  
(Aschoff et al, 2011). 
5) Wound Healing 
 
 OCT can be applied to study the mechanical properties of wounds. Using a novel 
TD-OCT based air-jet indentation system, which probes the wound by subjecting it to 
temporal waves of pressure leading to deformations at the level of microns (Huang et al, 
2009), Chao et al were able to characterise the mechanical properties of diabetic wounds in 
a non-invasive manner (Chao et al, 2011). After gathering data from eight subjects with 
diabetic foot ulcers (10 in total), the authors reported the average stiffness coefficients from 
the peri-wound area were significantly higher than that of the central wound bed (0.47 N/mm 
vs. 0.35 N/mm respectively), with high test/retest reliability (Chao et al, 2012). Since the 
biomechanical properties of connective tissues are dependent on the arrangement of their 
collagen and elastic fibers (Culav et al, 1999), it is thought that knowing the mechanical 
properties may provide insight into the extent to which the collagens are cross-linked and 
the degree of degradation of the elastic fiber network (Culav et al, 1999). Therefore this 
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technique offers a novel method to objectively monitor wound healing of diabetic wounds 
which may help shed more light on wound pathogenesis. However a limitation of the system 
is that it cannot measure tissue thickness, therefore it may be used in conjunction with other 
OCT methods to more comprehensively characterise the wounds. 
 
 Ferraq et al used OCT to evaluate the use of lasers to create area and depth-
defined skin wounds in vivo for the purpose of creating local environments in which wound 
healing could be studied. OCT was able to provide information regarding the depth and size 
of the wounds created via Er:YAG laser tissue ablation, and they found that laser created 
wounds were much more even in depth and size in comparison to those achieved via the 
established blister suction method (Ferraq et al, 2012). Therefore OCT has found use in 
developing protocols for creating experimental wound sites in vivo.  
 
 In addition, because OCT can perform optical biopsies, it can also be used to 
monitor wound healing both in vivo using animal models (Oh et al, 2006; Singer et al, 2007; 
Todorovic et al, 2008; Sahu et al, 2010) and in vitro using tissue-engineered skin (Yeh et al, 
2004; Smith et al, 2010). It has also been used to evaluate novel wound dressings (Yeh et 
al, 2004; Wang et al, 2008). Recently Barui et al (2011) conducted a clinical pilot study 
using SS-OCT to monitor wound healing under honey dressing in patients with traumatic leg 
wounds and found that the OCT image could be correlated with the immunohistochemistry 
findings. The authors observed a characteristic transition from a uniform hypolucid (poorly 
backscattering) region, which was present below the early reformed stratum corneum, to a 
highly lucid region in the OCT image, which corresponded to the maturation of the 
epidermis as confirmed by histology. They also reported that the aforementioned change in 
optical properties of the tissue in the epidermal region corresponded to the time point when 
E-cadherin, a key cell-cell epidermal adhesion protein involved in wound healing (Jakob et 
al, 1999) was maximally expressed. Therefore Barui et al propose that OCT can indirectly 
provide information as to the extent of maturation and integrity of the reformed epidermis 
during wound healing (Barui et al, 2011).   
 
 There is particular interest in using OCT to elevate the severity of burns because 
early determination of wound depth is vital to informing clinicians as to how to treat the 
wound, which in turn is a key determinant of the prognosis (Monstrey et al, 2009). While the 
standard for burn assessment is visual, the accuracy of evaluation is largely dependent on 
WKH VXUJHRQ¶V H[SHULHQFH 2&7 KRZHYHU RIIHUV D PRUH REMHFWLYH ZD\ WR QRQ-invasively 
evaluate the wound (Kim et al, 2012). Collagen, in its native state, is capable of polarising 
light into two perpendicular rays; a phenomenon known as birefringence. Upon thermal 
injury however the collagens become denatured and their birefringencey (BF) is lost 
(Thomsen et al, 1989). PS-OCT is able to determine the state of polarisation of 
backscattered light from tissue, in terms of birefringence amplitude orientation and 
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attenuation, therefore PS-OCT can quantify tissue damage by monitoring differences in 
phase retardance between burn and healthy tissXH$UHGXFWLRQLQFROODJHQ¶V%)LVWKRXJKW
to be related to burn depth, as well as collagen unraveling during healing, and animal 
studies have shown that PS-OCT measurements hold good correlation to histology with 
regards to burn depth (Park et al, 2001; Srinivas et al, 2004). Although most studies on OCT 
and its application to burns have been conducted on animals or ex vivo skin (Pierce et al, 
2004), Kim et al recently reported the use of OCT to evaluate burns in the clinic. The 
authors examined two paediatric patients, both superficial and deep burns, by both 
conventional and PS-OCT, and observed that superficial burns presented with a similar 
layered structure to their contralateral control but with increased visibility of dermal 
vasculature and a reduced BF. In contrast, deeply burned skin presented a loss of its 
layered structure, almost absent vasculature, and a much reduced BF. In both instances the 
burned tissue had significantly reduced levels of BF throughout the depth of imaging 
compared to the controls (Kim et al, 2012).  
  
OCT can also be used to determine the state of scaring following burn injury. In 
more than 60 % of patients, scars often become hypertrophic, which may lead to 
complications such as skin contraction over joints (Li-Tsang et al, 2005; Engrav et al, 2007). 
Hypertrophic scars are characterised by a high degree of angiogenesis, which presents as 
redness and an over-production of collagen at the wound margin; the higher the degree of 
redness, the higher the risk of scar hypertrophy. Visual assessment of scars based on the 
Vancouver scar scale for example are open to subjectivity, therefore more objective 
assessments of scar characterisation are required. OCT can create vascular maps of 
tissues by speckle de-correlation techniques based on determining fluctuations in the 
intensity of reflected light due to PRYLQJEORRG¶VHQGRJHQRXVVFDWWHULQJSURSHUWLHV (Enfield 
et al, 2011). Liew et al (2013) recently demonstrated that OCT was capable of visualising 
ZRXQGYDVFXODWXUH WRDGHSWKRIȝP LQSDWLHQWVSUHVHQWLQJZLWKK\SHUWURSKLFVFDUVDW
various stages. They reported that hypertrophic scars contained much more vasculature 
compared to contralateral tissue as observed by the OCT images (Liew et al, 2013). In 
addition, they derived a methodology for the automatic quantification of vessel parameters 
such that median vessel diameter and total vessel area density data could be extracted 
from the OCT images. Accordingly, both parameters were found to be much increased in 
hypertrophic scars vs. healthy tissue (Liew et al, 2013). Therefore OCT can provide both 
qualitative and quantitative information regarding scar formation; this may aid the 
identification of wounds that are likely to become hypertrophic and assist in the evaluation of 
scar treatments though observing vessel reduction.««««««««««««««««« 
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Aims and Objectives  
Aims 
 
This project aimed to develop an MSC delivery method derived from synthetic materials, 
and evaluate the healing potential of MSCs in in vitro wound models, derived from TE skin, 
using OCT. 
Objectives 
 
1) To evaluate to ability of medical grade silicone modified with plasma polymerised 
acrylic acid to deliver MSCs to model wound beds. The suitability of the delivery 
method was assessed by determining the efficiency of MSC delivery along with 
viability, and effects on cell phenotype and function. 
 
2) To develop a reproducible 3D wound model based TE skin that could be used to 
study the effect of MSCs in an in in vitro wound environment.  
 
4) To adapt the use of OCT so that it was optimised for use in making non-invasive 
assessments of wounded TE skin. As part of this objective, the most appropriate 
way to sample wound volumes and extract quantitative information from the images 
was determined.  
 
5) To apply OCT to evaluate the wound healing of TE skin in the presence or absence 
of MSCs. As part of this evaluation, histology and immunohistochemistry was 
performed to complement the OCT images.  
 
6) To screen wound models, in the presence of absence of MSCs, for several key 
soluble factors (HGF, IL-8, bFGF), by ELISA to determine if an association could be 
made between wound healing outcomes and the relative levels of these factors.  
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Chapter Two:  
Materials and Methods 	  
2.1 Materials 
Cell Culture 	  
1) Dulbecco's Modified Eagle's Medium (DMEM), GlutaMAX- (Gibco/Invitrogen, UK)  
2) Nutrient Mixture F12 (Ham's F12)- (Biosera, UK) 
3) 06&*0- Mesenchymal Stem Cell Growth Medium- (Lonza Biologics, UK) 
4) Fungizone® Amphotericin B- (Invitrogen, UK) 
5) L-Glutamine- (Sigma Aldrich, UK) 
6) Fetal Calf Serum- (Biosera, UK)  
7) Penicillin/ Streptomycin- (Sigma Aldrich, UK) 
 
8) Adenine- (Sigma Aldrich, UK) 
0.5 g adenine powder was added to 70 ml distilled water (dH2O) and acidified by 
adding 1 M Hydrochloric acid (HCl) until the power dissolved. The solution was 
brought to a final volume of 80 ml by adding a further 10 ml dH2O to give a final 
concentration of 6.25 Pg/ml. After filter sterilisation the adenine solution was 
aliquoted and stored frozen at -20qC.  
 
9) Insulin from bovine pancreas- (Sigma Aldrich, UK) 
10 mg of insulin powder was dissolved in 1 ml 0.01 M HCl, to which 9 ml dH2O 
was added to give a final concentration of 1 mg/ml. The stock solution was 
stored at 4qC.  
 
10) Apo-Transferrin, Human minimum 98 % (3,3'5-Triiodo-L-thyronine Sodium salt) 
(T3)- (Sigma Aldrich, UK) 
 
11) T3/Transferrin Solution 
13.6 mg of T3 was dissolved in a minimum of 0.02 M Sodium Hydroxide (NaOH) 
and made up to a volume of 100 ml in dH2O. 250 mg of apo-transferin was 
dissolved in 30 ml phosphate buffered saline (PBS) to which 0.5 ml T3 solution 
was added. The volume was made up to 50 ml with PBS and the stock solution 
was aliquoted and stored at -20qC. The final concentrations were (1.36 Pg/ml 
T3) & (5 mg/ml apo-transferrin) respectively. The stock solutions were stored at -
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20qC.  
 
12) Hydrocortisone- (Sigma Aldrich, UK) 
25 mg of hydrocortisone power was dissolved in 1 ml dH2O, and the final volume 
was made up to 10 ml with PBS to produce a stock concentration of 2.5 mg/ml. 
The stock was stored at 4qC.  
 
13) Epidermal Growth Factor (Human Recombinant from E. Coli)- (Sigma Aldrich, UK) 
 
14) Cholera Toxin- (Sigma Aldrich, UK). 
1 mg of cholera toxin (extracted from Vibrio Cholera) was dissolved in 1.18 ml 
dH2O and stored at 4qC. 100 ȝl of this stock was diluted in 10 ml serum free 
medium to give a concentration of 8.47 Pg/ml.   
 
15) Phosphate buffered saline (PBS)- (Oxoid Ltd, UK). 
One PBS tablet (Dulbecco A) was added to every 100 ml of dH2O prepared in a 
glass bottle suitable for the autoclave. PBS was autoclaved for 10 min at 115qC 
and stored at room temperature. The final concentration was 100 mM.   
 
16) Trypsin EDTA -(Sigma Aldrich, UK). 
0.25 % (v/v) trypsin and 0.02 % (w/v) ethylenediaminete- traacetic acid (EDTA) 
solution in PBS (pH 7.4). 
 
17) Trypan Blue- (Sigma Aldrich ,UK). 
 
18) Difco-Trypsin- (DIFCO Laboratories, USA). 
Difco-Trypsin was prepared at a concentration of 0.1 % (w/v), with added D-
glucose 0.1 % (w/v). To 100 ml of PBS, 0.1 g of trypsin and 0.1 g of D-glucose 
were added, along with 100 Pl phenol red. The pH of the solution was adjusted 
to 7.45 by the addition of 2 M NaOH. Difco-trypsin was filter sterilised, divided 
into 10 ml aliquots, and stored at -20qC. Prior to use the Difco-Trypsin was 
supplemented with 100 IU/ml penicillin, 100 mg/ml streptomycin and 0.625 Pg/ml 
amphotericin B. 
 
19) Collagenase A (from Chlostridium Histolyticum)- (Roache Diagnositics, USA)  
A 0.05 % solution (w/v) of collagenase A was made by dissolving 0.05 g 
collagenase A in 10 ml DMEM supplemented with 10 % FCS. The volume was 
filter sterilised, divided into 10 ml aliquots and stored at -20qC.  
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Immunohistochemistry 
 
1) Rabbit Anti-Human RFP- (Abcam, UK) 
2) Mouse Anti-Human Pan-Cytokeratin- (GeneTex, USA) 
3) Biotinylated Goat Anti-Rabbit IgG- (Vector Labs, USA) 
4) Texas Red Goat Anti-Rabbit IgG- (Vetor Labs, USA). 
5) FITC Horse Anti-Mouse IgG- (Vetor Labs, USA). 
 
6) Sodium Citrate Buffer  
2.94 g of sodium citrate were dissolved in 1 L of dH2O to make a 10 mM solution. 
1 M HCl was added slowly to adjust the pH to 6.0, and 0.5 ml of Tween-20 was 
added (0.05 %, v/v). The buffer was stored at RT for 3 months or at 4qC for long-
term storage. 
 
7) Tris/EDTA 
A 1 M stock of Tris (mw 121.4) was made by adding 12.1 g Tris to 100 ml of 
dH2O. A 0.5 M EDTA (Mw 292.24) stock was madly adding 1.46 g EDTA in 7 ml 
dH2O and adding 5 M NaCl until the EDTA dissolved and the volume was then 
topped up to 10 ml by adding additional dH2O.  A 10/1mM working solution of 
Tris/EDTA was prepared by adding 10 ml of a 1 M Tris Base stock solution to 2 
ml of a 0.5 M EDTA stock and making the final volume up to 1 L by adding 988 
mL dH2O. 0.1 % Tween-20 (v/v) was then added, and the pH was adjusted to 9.0 
by adding 1 M NaCl. Once made, it was stored at RT and used within three 
months.  
 
8)   Trypsin- for enzymatic antigen retrieval.  
A 0.5 % solution of trypsin (Sigma Aldrich, UK) was made by adding 1 ml of a 
0.5 % trypsin (w/v) stock solution (50 mg in 10 ml dH20), to 1ml of 1 % calcium 
chloride (w/v) stock solution (0.1 g CaCl2 in 10 ml dH2O), and adding 8 ml dH2O 
to make the final volume 10 ml. The solution was mixed well and pH adjusted to 
7.8 through the addition of 1M NaOH. The working solution was stored at 4qC for 
one month of at -20qC for long-term storage. 
 
9)  DAPI 4', 6-diamidino-2-phenylindole- (Invitrogen, UK) 
A 5 mg/ml stock solution was prepared my dissolving 10 mg in 2 mL of dH20 or 
dimethylformamide (DMF). For long-term storage the stock solution was 
aliquoted and stored at -20qC and protected from light. For use, aliquots were 
diluted 1:1000 by adding 10 Pl to 10 ml of PBS. The final concentration was 300 
nM. 
Nathan	  Walker	  (2013)	   	   Chapter	  Two	  
	   59	  
 
10) Vectastain Elite® ABC Reagent- Avidin and Biotinylated horseradish peroxidase 
macromolecular Complex (ABC), (Vector labs, USA) 
 
11) ¶-diaminobenzidine (DAB), (Vector Labs, USA) 
 
12) Hydrogen Peroxide (H2O2) (Invitrogen, UK) 
A 0.3 % (v/v) solution of H2O2 was prepared by diluting a 3 % stock solution 1:10 
in dH20 
 
ELISA 
 
1) Human IL-8 ELISA Development Kit- (PeproTech, Germany). 
2) Human bFGF ELISA Development Kit- (PeproTech, Germany). 
3) Human HGF Quantikine ELISA Kit- (R&D Systems, USA). 
 
Note- each kit came complete with capture and detection antibodies, cytokine standards 
and Avidin-HRP conjugate.  
 
4) ABTS Liquid Substrate (ƍ-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)- 
(Sigma Aldrich, UK). 
 
5) Substrate Reagent Pack (Stabilised hydrogen peroxide and stabilised 
tetramethylbenzidine)- (R&D Systems, USA). 
 
6) Stop Solution (2N Sulphuric Acid)- (R&D Systems, USA). 
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Others 
 
1) Mounting Medium DPX- (VWR International, UK) 
2) (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylltetrazolium bromide (MTT)- (Sigma 
Aldrich, UK) 
3) Stainless steel metal grids 
4) Stainless steel rings (8 mm diameter) 
5) All solvents were purchased from Fisher Scientific UK Ltd.  
6) Tween-20- (Sigma-Aldrich) 
7) Sodium Citrate- (Tri-sodium citrate (dehydrate) (Invitrogen, UK) 
8) Calcium Chloride- (Sigma-Aldrich, UK)  
9) Trizma- (Sigma-Aldrich, UK) 
10) Parafilm M- (Alcan Packing, UK) 
11) Cylindrical glass vessel- (QVF Process Systems, UK). 
12) Two-stage rotary vane pump- (Vacuum Research, USA) 
13) Pirani gauge -(Edwards Crawley, UK) 
14) Anhydrous Acrylic acid 99 %- (Sigma Aldrich, UK) 
15) RBS 35 Detergent Concentrate- (Thermo Fisher Scientific, UK) 
16) Medical Grade Silicone- (Polymer Systems Technology, UK) 
17) Paraffin Wax- (Sigma-Aldrich, UK) 
18) Fragrance free exfoliating facial sponge (Boots, UK) 
19) Ramer sponge- (Boots, UK) 
20) Ear plugs-  (Boots, UK) 
21) Washing up sponge- (Wilkinsons, UK) 	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2.2. Methods 
Cell Culture 	  
All cell culture was carried out in Class II laminar flow hoods (Walker Safety 
Cabinets, UK). Any equipment or materials used within the hoods were sterilised prior to 
use by 70 % (v/v) industrial methylated sprits (IMS) (Fisher Scientific, UK) or by autoclave. 
Sterile plastic wear used for cell culture was purchased from Costar, UK and Greiner Bio-
one, UK. Any liquids used for cell culture were purchased sterile from the supplier or 
sterilised prior to use by passing them through a 0.2 Pm filter (Millipore, USA). All cells were 
maintained in their appropriate growth medium and incubated at 37qC in a humidified 
environment containing 5 % CO2. Medium was changed every 2-3 days.  
Culture of Epidermal Keratinocytes 
 
Freshly isolated keratinocytes were cultured in Greens medium, composed 
according to Table 2.1. in the presence of a feeder layer of lethally irradiated 3T3 murine 
fibroblasts (i3T3) (XCELLentis, Belgium). Keratinocytes were not used after passage 3. 
 
Component Stock Concentration/Volume  Final Concentration 
DMEM GlutaMAX 330 ml 66 % 
Hams F12 108 ml 21.6 % 
FCS 50 ml 10 % 
Penicillin/ 
Streptomycin 
5 ml containing 10,000 IU/ml penicillin & 
10,000 Pg/ml streptomycin 
100 IU penicillin 
100 Pg streptomycin 
Amphotericin B 1.25 ml of 250 Pg/ml 0.625 Pg/ml 
Adenine 2 ml of 6.25 Pg/ml 0.025 Pg/ml 
Insulin 2.5 ml of 1 mg/ml 5 Pg/ml 
T3/transferrin 0.5 ml containing 1.36 Pg/ml T3 & 5 
mg/ml transferrin 
1.36 ng/ml T3 
5 Pg/ml transferrin 
Hydrocortisone 80 Pl of 2.5 mg/ml 4 Pg/ml 
EGF 25 Pl of 100 Pg/ml 5 ng/ml 
Cholera toxin 500 Pl of 8.47 Pg/ml 8.47 ng/ml 
 
Table 2.1&RPSRVLWLRQRI*UHHQ¶V0HGLXP 
 
 
 
 
 
 
 
 
 
Culture of Dermal Fibroblasts 
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Dermal fibroblasts were cultured in DMEM supplemented with additional 
components (Table 2.2.). Fibroblasts were used between passages 3 and 8. 
 
Component Stock Concentration/Volume  Final Concentration 
DMEM 438.75 ml 87.75 % 
FCS 50 ml 10 % 
Penicillin/ 
Streptomycin 
5 ml containing 10,000 IU/ml penicillin & 
10,000 Pg/ml streptomycin 
100 IU penicillin 
100 Pg streptomycin 
Amphotericin B 1.25 ml of 250 Pg/ml 0.625 Pg/ml 
L-Glutamine 5 ml of 200 mM 2 mM 
 
Table 2.2. Composition of fibroblast medium. 
 
Culture of Mesenchymal Stem Cells (MSCs) 
 
Human bone marrow MSCs (passage 2), were purchased from Lonza Biologics, 
England, and expanded in complete mesenchymal stem cell growth medium (MSCBM) 
supplemented with L-glutamine, gentamicin sulfate, amphotericin B, and mesenchymal cell 
growth supplement (Lonza Biologics). MSCs were used between passages 3 and 8. 
Passaging of cells 
  
 When cultured cells had reached 80 % confluence in their culture flasks, the medium 
was decanted from the flask. The surface of the flask was rinsed twice with 10 ml of PBS to 
remove any remaining medium; medium contains serum proteins that will hinder the action 
of the trypsin in the subsequent step. To detach the cells, 5 ml of trypsin/EDTA, pre-warmed 
to 37qC in a water bath, was added to the flask, and the flask was incubated at 37qC for a 
minimum of 5 min with the trypsin/EDTA. The incubation time varied depending on the cell 
type. Trypsin was neutralised by the addition of medium which contains aprotinin, the 
bovine equivalent of human basic pancreatic trypsin inhibitor (BPTI). Cells were centrifuged 
at 1200 revolutions per minute (rpm) for 5 min using a bench top centrifuge. The 
supernatant was discarded from the resulting cellular pellet, and the pellet was re-
suspended in a desired volume of medium. The cells were 'split' by seeding them at lower 
cell densities into additional culture flasks. 
Counting Cells 
 
 Cells were counted using a Neubauer hemocytometer (Weber Scientific International, 
UK). A glass coverslip was slid over the toS RI WKH KHPRF\WRPHWHU DQG  ȝO RI FHOO
suspension was pipetted under the coverslip on both sides of the glass, so that the counting 
grids of the hemocytometer were filled. The hemocytometer was placed under a light 
microscope and the number of cells was counted in each grid. Each 1 mm2 grid had a 
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volume of 1 x 10-4 ml. Therefore, by knowing the cell count and the volume they occupied, 
the cell concentration was calculated as follows: 
 
Average number of cells/1 mm2 grid x Dilution factor= Cells/ml 
Volume counted (1 x 10-4ml)  
 
e.g. An average cell count of 100 with no dilution = 1 million cells/ ml 
 
Trypan blue which permeates damaged membranes was used to identify dead cells so that 
they could be excluded from the cell count. Trypan blue was diluted 1:1 with cell suspension 
(usually 10 Pl of each) and then a small volume was introduced to the hemocytometer.     
Freezing cells for Cryo-preservation 
 
 For long-term cell storage; cells were kept frozen in liquid nitrogen; this required the 
use of a preserving agent. Cells were trypsinised as above and re-suspended in cryo-
preservation medium (90 % FCS, 10 % DMSO v/v). The cells were counted, and cell 
concentrations between 1 and 3 x 106 cells/ml, depending on cell type, were pipetted to fill a 
set of cryovials (Cellstar cryovials, Greiner Bio-one, UK). The cryovials were placed in a 
Nalgene Cryo 1qC freezing container (Nalgene Co, USA), which contained 250 ml 
isopropanol. This allowed the cryopreservation medium, and thus the cells, to cool at a rate 
of 1qC/ min in a -80qC freezer; thus avoiding cell lysis caused by rapid freezing. Cells were 
kept in a -80qC freezer for a minimum of 4 h before they were transferred to a liquid nitrogen 
Dewar (temperature of -196qC). The described method was performed quickly because at 
room temperature DMSO is toxic to cells. Cells were stored for no longer than 3 years.  
Thawing Cells 
 
 Cryovials containing the desired cell types were removed from storage in liquid 
nitrogen and immediately placed in a water bath (37qC) to thaw. Once thawed the cell 
suspension was added to 10 ml of the cell appropriate pre-warmed medium and centrifuged 
at 1200 rpm for 5 min. The supernatant was discarded form the cellular pellet, and the cells 
were re-suspended in culture medium and counted. Resulting cells were divided into T-75 
flasks and cultured until a passage was required. The medium was changed after 24 h of 
being put into culture, to remove any dead cells, and then replaced every 2-3 days 
thereafter. Cells were used for up 10 passages; stocks of low passage cells were kept in 
storage. Cells were periodically tested for mycoplasma infection and any infected cells were 
discarded. 
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Cell Isolation from Human Skin 
 
 Skin, from which fibroblasts and keratinocytes were extracted, was kindly donated for 
research purposes by patients undergoing plastic surgery (breast reductions and 
abdominoplasties) at the Royal Hallamshire Hospital (Sheffield). Informed consent from 
patients and full ethical approval was sought through the Sheffield Hospitals Ethical 
Committee. All research using this skin took place in the Kroto Research Institute under the 
Research Tissue Bank License No. 12179. 
Keratinocyte isolation 
 
 Skin was removed from its collection pot, placed into a petri dish containing a small 
volume of PBS, and the skin was unfolded so that it lay flat in the petri dish. Using a scalpel, 
the biopsy was cut into small pieces of approximately 0.75 - 1 cm2. The pieces were 
transferred to a sterile plastic tube containing 15 ml of 0.1 % w/v Difco-Trypsin (plus 0.1 % 
w/v D-glucose in PBS, pH 7.45), and incubated overnight at 4qC for a minimum of 12 h, but 
no more than 20 h. The following day, pieces of skin were removed from the Difco-Trypsin 
and placed dermal side down into a petri dish where they were washed with PBS. Using 
forceps, the epidermis was gently peeled from the dermis to expose the underside of the 
epidermis and the papillary dermis. Using a scalpel, the undersides of pieces of epidermis 
and the papillary dermis were gently scraped to remove cells into suspension. The cell 
suspension was removed from the petri dish and pipetted into a 30 ml universal tube 
containing 10-15 ml of Green's medium and spun at 200 x gravity for 10 min in a centrifuge. 
The supernatant was discarded and the resulting pellet was re-suspended in Green¶s 
medium and counted. Additional medium was added to the cell suspension to produce a 
keratinocyte concentration no less than 1.5 x 106 cells/ml, and cells were placed into a T-75 
flask containing a feeder layer of i3T3 cells. These primary cultures once established are 
termed P0. 
Fibroblast Isolation 
 
After removal of the epidermis from skin during the keratinocyte isolation procedure, 
the dermis was kept aside in PBS for fibroblast isolation. The pieces of dermis were cut 
even smaller with a scalpel and placed into a universal containing collagenase A for an 
overnight incubation at 37qC. The following day the collagenase appeared cloudy indicating 
the presence of cells in suspension, the pieces of dermis were removed and the 
collagenase was centrifuged for 10 min at 2000 rpm. The supernatant was discarded and 
the resulting cell pellet was resuspended in DMEM. The cells were counted and, if 
necessary, additional medium was added to make the final concentration 1 million cells/ml. 
Between 0.5 and 1x106 cells were seeded in each T-75 flask.  
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Preparation of de-epithelialised Dermal Substrates  
 
De-epithelialised dermal (DED) substrate was prepared from two sources. Firstly 
µIUHVK¶VNLQWKDWZDVQRWXVHGIRUWKHH[WUDFWLRQRINHUDWLQRF\WHVDQGILEUREODVWVSURYLGHGD
source of dermis, and secondly when this was not available, Euroskin (glycerol-preserved 
split thickness cadaveric skin) was used (Euro Tissue Bank, Beverwijk, The Netherlands). 
Prior to the use of Euroskin, the preserving glycerol was thoroughly removed by extensive 
washing with PBS. Both fresh skin and Euroskin, following glycerol removal, were then 
treated similarly. Skin was incubated in sterile 1 M Sodium Chloride (NaCl) for 18 h at 37°C. 
Subsequently, the epidermis was separated from the dermis to leave behind DED (bare 
dermis). µ)UHVK¶ VNLQ UHTXLUHV RQO\ D SDLU RI VWHULOH forceps to peel a continuous sheet of 
epidermis from the dermis, whereas for Euroskin, because of glycerol preservation, a 
scalpel blade had to be used to gently scrape the epidermis from the dermis. DED from 
either source was incubated at 37°C and 5 % CO2 LQ*UHHQ¶VPHGLXPIRUKDVDPHDQV
to test sterility of the preparation; the medium containing phenol red would rapidly change 
colour, from red to orange, in the presence of any contamination. The two skin sources 
were used interchangeably between experiments.  
Making Tissue Engineered Skin 
 
'(' SUHSDUHG IURP µIUHVK¶ VNLQ IURP surgery was cut into approximately 2 cm2 
pieces using a scalpel and placed into individual wells of a 6-well plate. Sterile stainless 
steel chamfered-edge rings (0.8 mm in diameter) were placed on top of each piece of DED 
and pressure was applied to the top of the ring using forceps, so that the edges of the ring 
impressed into the DED. To the center of the ring, 3x105 keratinocytes at passage 2 or 3, 
and 1 x 105 fibroblasts were added in suspension. These new so-FDOOHGµFRPSRVLWHV¶ZHUH
placed in an incubator (37ºC and 5 % CO2) for 24 h. The following day the rings were 
removed from the composite and medium was replaced so that the composite was 
submerged in medium. Composites were kept in submerged culture for two days before 
being lifted to an air liquid interface (ALI). ALI was achieved by placing the composites onto 
stainless steel grids, which raised the composites approximately 0.5 cm from the base of 
the weOOSODWH*UHHQ¶VPHGLXPZDVSLSHWWHGLQWRWKHZHOOVXSWRWKHSRLQWMXVWEHORZZKHUH
the medium would break over the surface of the composite. This allowed the composite to 
be perfused with medium from the underside of the tissue, whilst the top surface was kept 
as dry as possible. This differential in environment was essential to the development of a 
good stratum corneum by promoting differentiation by the basal keratinocytes. Once at ALI 
the medium was changed every 2-3 days, and the composites could be maintained at ALI 
for up to 14 days. 
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Plasma Polymerisation 
Plasma Polymerisation of Acrylic Acid  
 
Polymerisation was carried out in a 6.2 L cylindrical glass vessel which was sealed 
by stainless steel flanges with PTFE gaskets at both ends (Figure 2.1). A vacuum was 
obtained within the vessel using a two-stage rotary vane pump, and liquid nitrogen cold trap. 
A Pirani gauge, which was placed downstream from the vessel, measured the pressure in 
the rig. The base pressure in the reactor was less than 3x10-3 mbar. Monomeric anhydrous 
acrylic acid (AA) (CH2=CHCO2) was used for plasma polymerisation without any prior pre-
treatment, except for degassing by several freeze-thaw cycles. AA contained within a round-
bottomed glass flask was connected to the reactor through one of the flanges via the needle 
inlet valve. The needle valves were used to control the flow rate of the monomer through the 
UHDFWRUGXH WR$$¶VKLJKYDSRXUSUHVVXUHDW URRP WHPSHUDWXUHFlow rates of 4.8-5.2 cm3 
(STP) min - 1 (sccm, standard cubic centimeter per minute) were established and maintained 
using methods first described by Yasuda (Yasuda 1985). To measure flow rate, the stop-
valve was closed for 30 sec, while the monomer was allowed to continually flow into the 
reactor. The resulting increase in the pressure within the system was noted, and the flow 
rate was calculated using the following equation: 
 
Flow rate (sccm) = 'P (Pf - Pi) x V 
 
P= pressure, Pf= final pressure in the system (30 seconds after stop-valve closure), Pi= 
initial pressure of the system (before stop-valve closure), V= volume of the reactor (6.2 L).  
 
Typically, an initial pressure of 7.5 x10-2 mbar was sufficient to produce a flow rate 
between the desired ranges (4.8- 5.2 sccm). The flow rate was calculated several times to 
be certain the flow rate was stable. A plasma was initiated and sustained via a radio 
frequency (RF) source (13.56 MHz, 2 W), which was inductively coupled to the reactor by 
copper wiring which was coiled around the outer surface of the glass chamber. An 
impedance matching unit was then fine-tuned to minimise power loss from reflectance to < 
0.1 W. 
 
Sheets of medical-grade silicone were cut to fit neatly into Petri dishes and placed 
LQWKHµJORZ¶UHJLRQRIWKHUHDFWRUXSWRWKUHHSHWULGLVKHVFRXOGEHSODFHGLQWRWKHUHDFWRUDW
any one time. The plasma was sustained for 20 min to ensure it produced a polymer 
thickness sufficient to obscure the signal from the substrate in XPS analysis; a thickness 
was taken to be greater than 5-10 nm (Beamson and Briggs 1998). After the allotted 
deposition time, the power was switched off and the monomer flow rate was measured to 
ensure that there had been no change in the flow rate during the deposition cycle. Before 
opening the reactor, monomer was allowed to continue to flow through the reactor for a 
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further 10 min to terminate any reactive free radical species that remained on the surfaces 
of the samples, and to reduce the uptake of atmospheric oxygen by the surface. The flow of 
monomer into the reactor was finally terminated by fully closing the needle valve, and 
monomer that remained in the chamber was drawn out by the vacuum for a further 5 min 
before the reactor was opened. Once removed from the reactor, samples were stored at 
room temperature and wrapped in Parafilm (Alcan Packing, UK) to prevent them from 
accumulating moisture from the atmosphere. After the silicone had been plasma treated 
ZLWKDFU\OLFDFLG WKH\ZHUH WHUPHG µFDUULHUV¶ DQG WKH\ZHUHXVHG IRU WKH ODWHUFXOWXUHDQG
delivery of MSCs within 60 days of production. No sterilisation step was performed prior to 
the use of the materials in cell culture because it is assumed that the harsh environment, 
which is rich in free radicals and UV radiation, of the plasma kills bacteria thus sterilizing the 
surface (Moisan et al, 2002). 
 
 
 
Figure 2.1. A photograph of the plasma polymerisation rig.  
 
Degassing the Monomer 
 
 Under vacuum, vaporised acrylic acid may not be the only gas that enters the reactor 
from the monomer flask - atmospheric gases that became trapped in the aqueous acid 
during storage may also be released into the system. If not removed, additional gases will 
contribute to the pressure of the system and the flow rate of monomer will be overestimated. 
A process of degasification by cycles of freeze thawing, which achieves the removal of 
gases from liquids, was therefore performed prior to calculating the flow rate of the acid into 
the reactor.  The flask containing AA monomer was rapidly frozen by partially submerging it 
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in a container of liquid nitrogen. Once frozen, the monomer was thawed at RT under 
vacuum. The needle valve was opened allowing any bubbles of gas eluted from the acid to 
be released into the vacuum. Once the acid had thawed, the process was repeated a 
minimum of three times or until no more evolution of gas was observed during thawing. 
Cleaning the Monomer Flask 
 
The monomer flask was routinely cleaned after the monomer in the flask had 
expired, and before fresh monomer was added. To this end, a 10 % (v/v) solution of RBS 
detergent in acetone was poured into the flask and the flask was placed into a sonicator for 
5 min. This removed any impurities and contaminants from the flask. Monomer was 
replaced in the flask every 2 weeks, and the flask was stored at 4qC. The flask was wrapped 
in foil when it was used at the reactor to protect the acid from the light, and thus slow the 
rate of spontaneous polymerisation.  
Cleaning the Rig using an Oxygen Plasma 
 
Before any reaction took place, the reactor was exposed to a high-energy oxygen 
plasma. This buffeted any material that had previously been used in the reactor and had 
polymerised from the wall of the reactor, thus preventing contamination of samples when a 
new deposition cycle was run. The chamber was evacuated to a base pressure between 6-8 
x 10-2 mbar, and O2 was let into the reactor into the reactor until the pressure became 1.5-
1.7 x 10-1 mbar.  50 W of RF energy was put into the system and the reflected energy was 
minimised by fine-tuning the impedance matching unit. A blue plasma was ignited as 
cleaning began as a result of exciting the pre-deposited polymer from the reactor walls. 
Once the reactor was clean, the blue plasma disappeared indicating the residual polymer 
had been successfully removed. This took between 20-30 min depending on the amount of 
residual polymer that was coating the walls of the reactor.  
Contact Angles  
 
Samples were placed onto the stage of a RemeHeart goniometer (RameHart, USA) 
(Figure 2.2.a), and a 2 Pl drop of dH2O was dispensed onto the surface of interest using a 
Hamilton Syringe (Hamilton, Switzerland). The droplet formed was backlit using a lamp, and 
the sample was viewed through an eyepiece. The angle between the stage and the drop 
profile, with the origin at the three-phase line, was noted. Two points on each sample were 
measured from three replicate preparations. Surfaces that create droplets with contact 
angles exceeding 90q are described as hydrophobic with poor wetting, poor adhesiveness 
and a low solid surface free energy. Hydrophilic surfaces create contact angles lower than 
90q and have the opposite characteristics of hydrophobic surfaces (Figure 2.2.b). 
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Figure 2.2. Measurement of contact angles. A) RameHart Gioniometer. B) Hydrophilic vs. 
hydrophobic surfaces. (Images from RameHart.com).  
 
X-Ray Photoelectron Spectroscopy (XPS) 	  
XPS was carried out using a Kratos Axis Ultra X-ray photoelectron spectrometer 
(Kratos Analytical Ltd, Manchester, UK). All samples where maintained under a vacuum of 1 
x 10-8 mbar for 2 hours prior to XPS analysis, and all data were collected at 90° relative to 
the sample plane. A minimum of two survey scans and two narrow scans were performed 
on each sample, with pass energies of 160 eV and 20 eV respectively, to obtain O1s and 
C1s peaks. Charge neutralisation was applied to all samples. 
 
CasaXPS software (www.CasaXPS.com, UK) was used to determine the elemental 
composition of individual peak areas. C1s peaks where fitted using combinations of 
Gaussian (30 %) and Lorentzian (70 %) curves against a linear background. The full width 
half maximum of all components was constrained to be equal to that of the aliphatic carbon, 
but all other parameters where left to free to vary during fitting, optimizing parameters taken 
from spectra of similarly prepared surfaces in the literature (Alexander and Duc 1998; 
Haddow et al, 2003)	  
Seeding Cells onto Carrier Surfaces 
    
2 cm2 (2 x 2 cm) pieces of silicone treated with acrylic acid (carriers) were placed 
acid side up into wells of a six well plate. 8 mm diameter stainless steel rings were placed 
on top of each carrier, and 5 x 105 cells were seeded into the volume of the ring; thus 
providing a cell density of 38,000 cells/cm2. Rings were used to confine the cells to the 
FDUULHU¶V VXUIDFH 3ULRU WR WKH LQWURGXFWLRQ RI FHOOV WKH TXDOLW\ RI WKH VHDO SURYLGHG E\ WKH
rings on the surfaces was tested in two ways: firstly, each carrier was wetted with medium 
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and placed on top of the rings. Each ring was then inverted and held upside-down using 
forceps; the carrier should have remained stuck to the underside of the ring. If the carrier 
adhered to the underside of the ring it was placed into the well plate and gentle pressure 
was applied to the top of the ring with forceps. Secondly, a test volume of 800 Pl of medium 
was pipetted into the ring to completely fill it, and 10 min later the rings were observed to 
see if any leakage of medium had occurred. If leakage was evident the carrier was resealed 
to the ring and retested for further leakage. Once cells were seeded, additional medium was 
added to top-up the total volume of medium in the ring to 800 Pl, and the volume outside of 
the ring was filled with medium (Figure 2.3.). Well plates containing the carriers were placed 
into an incubator (37qC, 5 % CO2, humidified environment) for 24 h before the medium was 
discarded. The rings were carefully lifted from the carriers using forceps and the carriers 
were submerged in fresh medium and cultured on the carrier for up to 7 days, with medium 
changes every 2-3 days.   
 
 
Figure 2.3. Seeding cells onto the carrier. A) photograph of a well that contained a carrier 
seeded with cells. Dotted line indicates the carrier. B) a labeled diagram of A).  
Cell Transfer from Carriers to DED  
 
Cells were transferred from the carriers to 1.5 cm2 pieces of de-epithelialised dermis 
(DED), after being in culture for 24 or 72 h on the carriers. DED was placed papillary side up 
in a separate 6-well plate. Medium was removed from a well containing a carrier, and the 
carrier was plucked from the well by its corners using forceps. The carrier was then placed 
cell-side down onto the dermis (Figure 2.4.). To achieve this, one edge of the carrier was 
carefully aligned along one edge of DED, from this point of contact the rest of the carrier 
was brought down to meet the DED¶s surface by a rolling action (similar to the action of 
peeling but in reverse). Fresh medium, enough to submerge the carrier, was pipetted into 
the well. Stainless steel grids were placed on top of the carriers to provide a light weight to 
keep the carrier from sliding over the surface of the DED when medium was added. Carriers 
were left in contact with the DED for 24 h before the carriers were removed from the DED 
using forceps.  
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Figure 2.4. Cell transfer regime. A-D sequence of events in the method. A) Carrier during 
culture. B) Carrier placed on top of DED. C) Steel grid placed on top of the carrier. D) Well 
filled with medium. E) Schematic representation of C. 
  
 
 
Assaying Metabolic Activity Via MTT 
 
The metabolic activity of the cells was assayed by 3-[4,5-di- methylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT), and it was used as a crude indicator for cell viability 
(Mosmann 1983). MTT is a tetrazolium dye that when up taken by cells, becomes reduced 
by their mitochondria producing an insoluble formazan salt. The salt, which is dark 
blue/purple in colour, can be eluted from the cells using an inorganic solvent, and the optical 
absorbance/density of the solubilised salt can be measured to give a semi-quantitative 
measure of the metabolic activity of the cell population. The absorbance is directly related to 
the amount of formazan salt formed, which in turn is related to the metabolic activity of the 
cells. 
 
After 24 h of contact with the DED, carriers were separated from the dermis using 
forceps, and the metabolic activity of the cells that had been transferred to the dermis was 
assayed by MTT at 24 h, 72 h, or 7 days following transfer. The dermis and the carriers 
were washed twice with PBS to remove remaining medium. MTT (0.5 mg/ml in PBS) was 
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added to each well and the samples were incubated at 37qC with 5 % CO2 for 40 min. 
Formazan salt was eluted by adding 500 Pl of 2-hydroxy ethanol (Sigma-Aldrich, UK), or 
acidified isopropanol (125 Pl 10 M HCl in 100 ml isopropanol, final concentration 12.5 M). 
The elutant was mixed by pipetting, and 200 Pl were transferred twice from each sample to 
a 96-well plate to provide readings in duplicate. The optical density (OD) of the solution was 
read at 540 nm and a reference wavelength of 630 nm was used on a spectrophotometer. 
In addition, the MTT assay was also performed on blank DED (DED without any transferred 
cells); the average OD from the blank, served as a baseline that was subtracted from the 
experimental values. In this way, any contribution to the reduction of formazan from the 
DED alone was accounted for.  
Vascular Tubule Assay 
 
Endothelial colony forming cells (ECFCs) were derived from umbilical cord blood 
(sourced from the John Radcliffe Hospital, Oxford, England, with ethical approval from the 
Oxford and Berkshire Ethics Committees, and with fully informed and written consent), and 
cultured in complete endothelial growth medium-2 (EGM-2) (Lonza Biologics, UK), before 
being phenotyped or labeled with eGFP previously described (Zhang et al, 2009; Khoo et al, 
2011). Approximately 1 x 105 hBM-MSCs were seeded into the wells of six-well TCP plates 
(5000 cells/ cm2), that either contained or did not contain ppAAc carriers. hBM-MSCs were 
cultured for 24 or 72 h before 4 x 104 they were reseeded into collagen-coated 48-well 
plates (BD Biosciences, UK). Cells were allowed to adhere for 2 h, before 2-8 x 103 
(passage 4-5) eGFP-labeled ECFCs were added to the culture in EGM-2. Medium was 
changed every 2-3 days for 14 days and the cultures were periodically photographed. 
Image analysis was performed using the semi-automated AngioSys software program (TCS 
Cellworks, England), and the number of junctions and tubules, and total tubule lengths per 
field (8.4 mm2) were calculated similarly to Khoo et al (2011). 
Flow Cytometry 	  
Adherent cells were detached from tissue-culture flasks by treatment with accutase 
(PAA Laboratories, Austria) for 5 min at 37°C, and washed twice with PBS with 1% BSA. 
Cells were incubated with FcR blocking reagent (Miltenyi Biotec, Germany), followed by 
relevant conjugated Mabs or isotype-matched negative-controls at 4°C for 30 min. The 
following test antibodies were used: CD44-FITC, CD90-FITC, CD106-FITC, CD14-PE-Cy7, 
CD45-PE-Cy7, CD73-PE, CD117-PE (Becton Dickinson (BD) Biosciences, USA), CD146-
FITC (Millipore Ltd, UK), CD34-APC (Miltenyi Biotec, Germany), CD29-FITC (Immunotech, 
USA), and CD105-FITC (R&D Systems, USA). The corresponding isotype-matched 
antibodies used included: mIgG2a-FITC (Serotec, Germany), mIgG1-FITC, mIgG1-PE (R&D 
systems, USA), mIgG2a-APC (Miltenyi Biotec, Germany), mIgG2a-PECy7, mIgG1-PE-Cy7 
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(BD) Biosciences, USA). The final concentration was the same for the isotype control and 
test antibodies. Cells were resuspended in PBS with 1% BSA before running them through 
an LSR II flow cytometer (BD Biosciences, USA), A minimum of 20,000 events were 
collected, and analysis was performed using FACS DIVA software (BD Biosciences, USA). 
Cytotoxicity of Sponges 	  
Five different sponge materials (listed in materials) were placed in medium and 
placed in an incubator (37°C, 5 % CO2) for 24 h. The presence of leachates from the 
material into the medium was observed by eye after the incubation period. Of the materials 
that did not produce leachates, 1 cm2 blocks were cut form them using a scalpel and, they 
were sterilised with 70 % IMS for 24 h at RT. The foams were thoroughly washed with PBS 
to remove the IMS. The sponges were placed into a transwell insert (Gibco, UK), and each 
insert was placed into a single well of a TCP 12-well plate. Each well of the 12 well plate 
contained 3 x 105 (cell density= 7,893 cells/cm2) human dermal fibroblasts (passage 4-7) 
which had been seeded 24 h prior to the introduction of the transwell inserts. Immediately 
before the transwells were inserted the medium was changed and the sponges remained in 
contact with the culture medium for 24 h before the transwells were removed and an MTT 
assay performed on the cultures. Fibroblasts cultured in the absence of indirect contact with 
sponges served as positive controls. 
Histology  
Processing 
 
Samples were washed twice with PBS and then directly placed into 3.7 % 
formaldehyde (Sigma-Aldrich, UK) (diluted stock 1:10 in PBS), for 24 h at 4qC. Post fixation, 
the samples were infiltrated with wax to offer support to the tissue during microtomy. 
Paraffin is hydrophobic and immiscible with the formalin fixative, therefore dehydration of 
the tissue to dispel it of water was required before paraffin infiltration could occur. To 
achieve this, the samples were run through a graded series of alcohols of increasing 
concentration in order to remove the fixative. Following this, the alcohol was replaced by a 
µFOHDULQJ¶VROXWLRQVXFKDV[\OHQHWKDWZDVPLscible with the embedding medium (paraffin 
wax). The wax was then allowed to replace the clearing medium. The above sequence of 
tissue dehydration, clearing, and wax infiltration was automated by a bench-top tissue 
processor (Leica TP1020, Leica microsystems, UK). Samples were placed into the 
processor overnight, and the processor followed the regimen in Table 2.3. 
 
Solution Exposure Time (hours) 
10 % Formalin  1 h 
70 % Ethanol (1) 1 h 
70 % Ethanol (2) 1 h 
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80 % Ethanol 1h 30 min 
90 % Ethanol 1h 30 min 
95 % Ethanol (1) 1h 30 min 
100 % Ethanol (2)  1h 30 min 
Xylene (1) 1h 30 min 
Xylene (2)  1h 30 min 
Paraffin Wax (1) 2 h 
Paraffin Wax (2) 2h 
 
Table 2.3. Histological Processing Schedule. 
 
 
 Once the processing cycle had finished, the samples were promptly removed from 
the molten paraffin; too long a time in the paraffin can make the specimen hard and brittle, 
which becomes evident during tissue sectioning. Long exposure times to the high 
temperatures sufficient to melt the wax (50-60qC) can have deleterious effects on the 
staining of some antigens (Bancroft and Stevens, 1996). 
Embedding 
 
Samples were embedded in blocks of paraffin wax so that they could be mounted 
onto a microtome for sectioning. Embedding took place in a Leica EG1160 embedding 
center, dispenser and hot plate (Leica microsystems, UK). A small amount of molten 
paraffin was dispensed from the reservoir of the embedder into a metal mould, and the 
mould was placed on the hot plate to prevent the wax from setting. In turn, each sample of 
tissue was removed from its cassette and bisected (through the middle), using a scalpel. 
The partially wax-filled mould was then moved to a cold plate, and forceps were used to 
place the newly exposed edges of the tissue, revealed after bisection, into the center of the 
setting wax. The halves of the tissue were placed parallel to each other and perpendicular 
to the bottom surface of the mould, so that the samples could be cut in the required 
orientation. The wax-filled mould was left on the cold plate to complete setting, and as the 
wax cooled and solidified it held the tissue firmly in place. Once the wax set and hardened 
(about 30 min), the paraffin block was removed from the mound leaving a block of wax 
attached to a cassette base. Tissue blocks were stored at RT. 
Sectioning 
 
 Tissues were sectioned using a Leica RM2235 microtome (Leica microsystems) fitted 
with a S35 type blade (Feather, Japan). Wax blocks were initially 'trimmed', making serial 
FXWWLQJVȝPWKLFNXQWLO both halves of the tissue were fully exposed on the surface of the 
wax block. Slices 5-6 PPWKLFNZHUHWKHQFXWSURGXFLQJDVWULQJRUDµULEERQ¶RIVHULDOVOLFHV
joined together. Ribbons of tissue were transferred to a water bath (40°C), which allowed 
the wax sections to warm slightly. Glass slides were placed under the tissue sections and 
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they were lifted out of the water and onto the surface of the glass slide. Residual water was 
dried from the slides on a hot plate (37qC) overnight (Leica). 2-3 cuttings were mounted 
onto each standard glass slide, if H&E was to be performed, or to SuperFrost® Plus slides 
(VWR, International, UK), if immunohistochemistry was to be performed.  
Haematoxylin and Eosin Staining 
 
 Wax was removed from the slides using xylene, and then the tissue was gradually 
rehydrated by placing the slides through a graded series of alcohols, from high to low 
concentration: absolute ethanol (5 min); 95 % ethanol (5 min); 70 % ethanol (5 min), and 
then into distilled tap water for 5 min. Regressive H&E staining was then performed. Slides 
were transferred to Harris haematoxylin solution for 4 min to deliberately over-stain the 
samples, after which they were removed and placed under running tap water for 5 min to 
SHUIRUPµEOXHLQJ¶DSURFHVVWKDWUHPRYHVH[FHVVVWDLQIURPWKH tissue so that a blue color 
was differentiated. Slides were stained with eosin-Y solution of 5 min and subsequently 
washed briefly in water, cleared and mounted. Slides were quickly dehydrated by dipping 
them through a series of graded alcohols low to high concentration: 70 % alcohol (30 sec); 
95 % ethanol (30 sec); 100 % ethanol (1 min) and then into xylene for clearing for 1 min. It 
was important that dehydration was performed quickly because eosin is dissolved in 95 % 
ethanol; if it is left too long in ethanol the stain will be eluted from the slide leading to 
decolouration. 7-10 rinses in 95 % ethanol was sufficient to remove excess stain but 
minimise losses. The samples were then mounted in xylene-based DPX medium and dried 
at RT, before they were observed under a light microscope and photographed.  
Immunohistochemistry (IHC) 
Wax Removal and Rehydration 	  
 5-6 Pm thick sections were made from paraffin wax embedded samples, using a 
microtome, and mounted on to SuperFrost® slides. Wax was removed from the tissue by 
placing the slides in xylene for 5 min at RT. The tissues were rehydrated using a graded 
series of alcohols from high to low concentration: 100 % ethanol (5 min); 95 % ethanol (5 
min); 70 % ethanol (5 min); dH2O (15 min).  
Quenching Endogenous Peroxidase Activity 
 
Where antigen detection was performed using an avidin-biotin system that 
contained the enzyme Horseradish peroxidase (HRP) to develop a coloured precipitate, 
blocking of endogenous peroxidase activity in the tissue was required. Samples were 
incubated with 0.3 % H2O2 (15 min), followed by washing in PBS (5 min).  
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Antigen Retrieval 
 
Heat-mediated antigen retrieval was performed by placing the slides into a glass 
beaker filled with either TRIS/EDTA (pH 9) or sodium citrate buffer (pH 6), and heating the 
buffer close to its boiling point on a hot plate for 20 min. After which, the slides were cooled 
to RT in water. Enzymatic antigen retrieval (Typsin) was performed for 20 min at RT when 
detecting antigens in the presence of eGFP, since heat-mediated methods strongly 
GLPLQLVKHGH*)3¶VIOXRUHVFHQFH 
Blocking 
 
µNRUPDOVHUXP¶ IURPWKHVSHFLHV LQZKLFK WKHVHFRQGDU\DQWLERG\ZDVUDLVHGZDV
used in the blocking buffer. Blocking was performed using 10 % normal serum in PBS 
containing 0.1 % Tween-20. Enough volume of blocking buffer was dropped to cover the 
surface tissue from a pipette, and it was incubated with the samples for 2 h. The area 
containing tissue on each slide was ringed with a hydrophobic barrier pen (Dako pen) to 
confine the blocking buffer to the tissue; this greatly reduced the quantity of reagents that 
were in contact with the slides.  
 
Endogenous biotin was also blocked to prevent the Avidin in the ABC reagent from 
binding non-specifically. Blocking was performed using an Avidin/ Biotin blocking kit (Vector 
Labs) after blocking with normal serum; biotin blocker was dispensed from the drop-bottle 
onto the tissue and incubated for 15 min at RT. Following this it was washed off in PBS for 5 
min and Avidin blocking solution was added to the samples and incubated at RT for 15 min.   
Addition of Primary Antibodies 
 
Primary antibodies (1q Abs) were added to the tissue, in 1 % Goat serum with 0.1 % 
Tween-20 at the following dilutions: Collagen IV (1:500); RFP (1:1000); Pancytokeratin 
(1:50). The optimum dilution was determined by performing an antibody titer. 1q Abs were 
incubated with the tissue overnight at 4qC in a humidified chamber.  
Addition of Secondary Antibodies  
 
After incubation with the 1q Abs the slides were washed with PBST (x 3) for 10 min 
to remove residual antibodies. Biotinylated 2q Abs (Vector Labs, USA) were added to the 
tissue at a dilution of 1:500 in PBS containing 0.1 % Tween-20 and 1 % Goats serum, and 
incubated for 45 min at RT. The tissue was washed extensively in PBST (three 15 min 
washes) to remove unbound 2q Abs.     
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Detection  
 
Slides were incubated with Vectastain® Elite ABC reagent for 30 min and washed 
IRUPLQLQ3%67KHFKURPRJHQ¶-diaminobenzidine (DAB) was added to the samples 
(one at a time), and colour development was monitored under a light microscope. DAB 
produced dark brown staining at the site of the HRP, and sufficient staining intensity was 
produced between 3-5 min. The reaction was terminated by placing the slides in dH20 to 
elute the DAB from the tissue.   
Counterstaining and Mounting 
 
Slides were counter-stained with haematoxylin by placing them in contact with the 
solution until the desired staining intensity was produced, about 30 seconds provided a 
good balance between obtaining nuclear detail without masking the chromogen. The slides 
were then dehydrated, cleared and mounted by placing them through a graded series of 
alcohols (low to high concentration), and then into xylene for 1 min each. DPX mounting 
medium was used to seal the coverslips to the slides. The slides were left at RT for the 
mounting medium to harden, and the samples were viewed the following day.   
Immunofluorescence 
 
For immunoflourence protocols, the IHC procedure was performed up to the 
addition to the 2° Abs. The 2° Abs applied in step 6 were fluorophore-conjugated (FITC, 
Texas Red). They were applied at a dilution of 1:100 in 1 % goat serum, 0.1 % Tween-20 in 
PBS, and incubated for 45 min at RT. The sides were then washed in PBS for 15 min (x3) 
and counter stained by incubating the samples with DAPI for 30 min at RT. The slides were 
washed in PBS for 5 min before mounting coverslips on the slides using aqueous mounting 
medium.   
ELISA (Enzyme-linked immunosorbent assay) 
 
All capture antibodies were diluted with PBS to the concentration specified by the 
PDQXIDFWXUHU  ȝO RI WKH FDSWXUH $Es were added to each well of the ELISA plates 
(NUNC, Maxisrop), and incubated over night at RT; the plates were sealed with parafilm. 
300 ȝl blocking buffer (1 % BSA in PBS) was added to each well and incubated at RT for 2 
h. Cytokine standard solutions were prepared according to the manufactures instructions, 
and serially diluted eight-fold in PBS (+ 0.05 % Tween-   %6$  ȝO RI WKH
standards and samples were added to the ELISA plates in duplicate and the plates were 
LQFXEDWHGDW57 IRUKȝO RIELRWLQ\ODWHG DQWL-cytokine primary antibodies were then 
incubated for 2 h at RT with the samples and standards. Avidin-HRP conjugate was 
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prepared according to the PDQXIDFWXUHU¶V LQVWUXFWLRQVDQGȝOZDVDGGHGWRHDFKZHOOLQ
WKHSODWHVDQGLQFXEDWHGDW57IRUPLQȝORI$%76VXEVWUDWH was added to the IL-8 
and bFGF ELISA, and the colourimetric signal was detected on a plate reader at 405 nm 
with the wavelength correction set to 650 nm. The readings were used to construct a 
standard curve from which the concentrations of the samples could be calculated. For the 
+*)SODWHVȝORI70%VXEVWUDWHVROXWLRQZDVXVHGLQVWHDGRI$%76DQGLQFXEDWHGIRr 
PLQDW57EHIRUHȝOVWRSVROXWLRQZDVDGGHGWRHDFKZHOO7KHSODWHVZHUHWKHQUHDG
at 450 nm and referenced at 560 nm. Before new reagent/solution was added to each 
ELISA plate, the plate was aspirated and washed with wash buffer (0.05 % Tween-20 in 
PBS). 
Wound Healing Study 	  
 Full-thickness incisional wounds were made (10 mm in length) in TE skin, which had 
been raised to ALI for 5 days, using a 15A blade scalpel. Wounded TE skin samples were 
divided equally into two groups. Both groups of samples had 100 ȝl of fibrin glue inserted 
into their wound cavities. The concentrations of fibrinogen and thrombin were 6 mg/ml and 
25 IU respectively. One group however also contained 1x 105 RFP-labeled MSCs within the 
fibrin glue.  
 
 MSCs were pelleted via centrifugation (5 min, 1500 rpm), after being removed from 
culture, and the supernatant was discarded. Following this, PBS was added to the MSC 
pellet and they were resuspended by gentle pipetting and centrifuged for a second time; this 
was performed to remove residual culture medium, since it caused premature clotting when 
cells were added to the fibrinogen. MSCs (passage 5-8) were kindly donated by Prof. 
Suzanne Watt's Group.   
 
At days 1, 3, 7, 10 and 14 after wounds were created, medium was collected from 
the samples and frozen (-20°C) before an ELISAs for HGF, IL-6 and bFGF were performed 
(see ELISA methods for details). At each of the above time points, samples were imaged 
via OCT. At days 1 and 7 one sample form each experimental condition was removed and 
histology and IHC was performed. RFP-labeled MSCs and pan-cytokeratin were detected in 
IHC using I° Ab concentrations of 1:1000 (rabbit polyclonal) and 1:50 (mouse monoclonal) 
respectively. All IHC sections were counterstained with DAPI (see IHC section for details). 
At day 14, the final time point, histology and IHC were performed on all remaining samples. 
Figure 2.5 outlines the experimental plan for the above. 	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Figure	  2.5.	  Experimental	  overview.	  (IHC=	  Immunohistochemistry;	  ELISA=	  Enzyme-­‐linked	  
immunosorbent	  assay;	  D=	  day;	  n=	  number	  of	  samples/experimental	  condition)	  	  	  	  	  
Fluorescence Imaging 
Wide-Field Fluorescence Microscopy 
 
Fluorescence microscopy using an ImageExpress® imaging system (Molecular 
Devices, USA). DAPI was excited using a wavelength of 340 nm, and a 400 nm filter was 
used to detect its emission. TRIC/Texas Red was excited at 543 nm, and 560 nm long pass 
filter was used in fluorescence detection. GFP/FITC was visualised by exciting at 405 nm 
and filtering at 488 nm. All images were obtained from samples using the same exposure 
settings.    
Confocal Microscopy 
 
All images were collected using a Zeiss LSM 510 META Upright Laser Scanning 
Confocal Microscope using either a x 10 or x 40 objective lens (Carl Zeiss, England). eGFP-
labeled cells were excited with a 488 nm argon laser. Fluorescent light was collected 
through a 505 nm long-pass emission filter. Z-series compositions were acquired by 
SKRWRJUDSKLQJVHFWLRQVDWȝm intervals. All cells were imaged at RT in pre-warmed (37°C) 
phenol red free alpha minimum essential medium. Images were analysed using the 
corresponding LSM 510 META Software (Carl Zeiss, England). 	  
OCT Imaging of Tissue Engineered Skin 
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Imaging of TE skin was performed using a swept-source optical coherence 
tomography system (SS-OCT) (Figure 2.6). The system was comprised from a commercially 
available OCT apparatus (Michelson Diagnostics Ltd, EX1301), which contained a swept-
source laser, and an in-house fibre optic Michelson interferometer. The laser operated at a 
sweep rate of 10 KHz, and had a central wavelength of 1315 nm, a bandwidth of 128 nm, a 
wavelength range of 157 nm, and an output of 10 mW. The spectral characteristics of the 
VRXUFHSURYLGHGDQD[LDOUHVROXWLRQRIȝPLQDLUDQGWKHRSWLFVRIWKHV\VWHPSURYLGHGD
ODWHUDO UHVROXWLRQRI ȝP DFFRUGLQJ WR WKH IRFXVHG VSRW VL]H IUom the Thorlabs LSM03 
OCT telecentric scanning lens in the sample arm. The SS-OCT system employed balanced 
photodetection to improve signal to noise ratio (SNR). 
 
 
Figure 2.6. SS-OCT set-up. SS, swept-source; C, collimator; BD, balanced photodetection 
and signal conditioning; DAQ, data acquisition card; L, focusing lens; G, galvanometer; M, 
mirror. Figure reproduced from Smith et al, 2010. 
 
 
Statistical Analysis  
 
Statistical differences were determined using a two-WDLOHGXQSDLUHG6WXGHQW¶VW-test 
where two different experimental groups were compared. Paired t-tests where performed to 
determine differences between the same experimental group. One-way analysis of variance 
(ANOVA), in conMXQFWLRQZLWK7XNH\¶VWHVWSRVW-hoc, was performed where three data sets 
were compared. Test p-values < 0.05 were regarded as statistically significant. Origin 8 
software was used to conduct all statistical analysis.  
 
 
 
 
Nathan	  Walker	  (2013)	   	   Chapter	  Two	  
	   81	  
 
Nathan	  Walker	  (2013)	   	   Chapter	  Three	  
	   82	  
Chapter Three:  
Delivery of MSCs to Model Wound Beds 
3.1. Aim 
 
 The aim of this work was to evaluate the use of cell-carriers derived entirely from 
synthetic materials, by preparing surfaces of medical-grade silicone elastomers with acrylic 
acid via plasma polymerisation, to deliver human bone marrow-derived mesenchymal stem 
cells to model human skin wound beds. Parts of this chapter have been published in Tissue 
Engineering. Part C: Methods, 18 (2): 143-155, (2012). 
3.2. Introduction 
 
 Wounds arising as a result of age or diabetes-related vascular problems, pressure 
sores or chronic limb ischemia can lead to chronic non-healing wounds. Current methods 
for treating these wounds are often met with limited success, and as such they cause 
significant morbidity and disability (Calles-Escandon and Cipolla 2001). Therefore there is a 
need for more active therapies for the treatment of complicated wounds. Cell therapy may 
offer a feasible and beneficial alternative. In recent years, mesenchymal stem cells (MSCs) 
have been shown to positively affect wound healing outcomes in both the pre-clinical and 
clinical setting (Reviewed in Chapter 1). MSC can accelerate re-epithelialisation and 
epithelial differentiation, increase angiogenesis and collagen production, reduce scaring, 
and modulate the inflammatory response to injury.  
 
 Currently, the main procedure for administering MSCs to wounds in patients is via 
subcutaneous injection around the wound margins, or intramuscular injection; and these are 
favored because they are minimally invasive (Jiang et al, 2012). However, poor cell 
viabilities are often attained post injection (Zhang et al, 2001; Aguado et al, 2011), and this 
may limit their therapeutic potential, especially considering that chronic wounds present 
difficult microenvironments to cells, because they are sites that display high levels of 
enzymatic activity and inflammation (Lobmann et al, 2005; Brem and Tomic-Canic 2007). 
Therefore, increasing the percentage of live cells delivered to wounds may be key to the 
success of MSC therapies.  
 
 Alternatively, MSCs may be delivered to wounds in the clinic using natural materials 
such as, animal-derived collagen in the form of matrices (Vojtassak et al, 2006; Ravari et al, 
2011)  or as a component of artificial dermis (Yoshikawa et al, 2008). However, it is 
desirable to avoid the use of xenogeneic materials due to concerns surrounding the 
transmission of bovine spongiform encephalitis (BSE), and the risk that an immune 
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response could be mounted (Keenan et al, 2006) Additionally, fibrin glues can be used to 
entrap MSCs at the wound site (Falanga et al, 2007), however these delivery methods are 
disadvantaged by their complex preparation requirements and short working times and the 
potential to negatively affect cell proliferation (Ho et al, 2006). Therefore developing a cell 
delivery method derived from synthetic materials, which is a lower risk to patients and is 
convenient for the clinician to use, would be advantageous.   
 
 Silicone elastomers are synthetic materials that have many rarely-combined physical 
properties which include: thermal stability, flexibility, transparency, low chemical reactively 
and toxicity, excellent gas permeability (over 400 times that of a typical rubber at RT) and 
good electrical insulation (Owen 1990). Chiefly however, the material is considered 
'biocompatible'. Williams, as part of the European Society for Biomaterials in 1986, defined 
ELRFRPSDWLELOLW\DVµµWKHDELOLW\RIDPDWHULDOWRSHUIRUPZLWKDQDSSURSULDWHKRVWUHVSRQVHLQ
a specific appliFDWLRQ¶¶ (Ratner 2004). Therefore, silicone elastomers are well tolerated by 
tissues, and they do not provoke an inflammatory reaction upon contact with the body or its 
fluids. Because of these traits, silicone elastomers are biomaterials that have become 
widely used in the medical industry since their introduction in the 1960s. They can be found 
in devices such as: artificial limbs, breast implants, catheters (both urinary tract and 
intravenous), contact lenses, external feeding tubes, hearing aids heart valves, oxygenators 
and voice prostheses (Yoda 1998).  
 
 Therefore silicone elastomers possess many desirable characteristics that would 
make them a preferred material in the development of a cell-delivery vehicle. However, 
silicone elastomers are very hydrophobic, with surfaces energies equal to or below 23 nN/m 
(Jones, 1988), as such, cell attachment via protein adsorption to its surface, is more often 
than not, reported to be poor (Harris et al, 1980). To devise a cell-carrier therefore, it is 
important that the material possesses not only the desired bulk properties, but also 
favorable surface chemical properties that promote cell attachment. There are many 
methods that have been used to improve cell anchorage to silicone by altering its surface 
chemistry including non-covalent methods (physioabsorption of fibronectin) (Grey et al, 
2003), however the adsorption of matrix proteins to silicone elastomers has since been 
shown to be inefficient and often not reproducible (Cunningham et al, 2002). Additionally, 
surface oxidation via plasma treatment (Prichard et al, 2007), gelatine glutaraldehyde cross-
linking (Ai et al, 2002); layer-by-layer polyelectrolyte coatings (Ai et al, 2003); and plasma 
treatment of materials to create hydrophilic groups or radicals at the surface to which pre-
formed polymers can subsequently be grafted (Hsiue et al, 1994), have also been explored, 
although these surfaces have been shown to degrade when stored in air to their original 
chemistry  (Lee et al, 2004).  
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 Plasma polymerisation is a well-established, one-step technique that can be used to 
provide a defined surface chemistry to almost any substrate with little or no pretreatment, 
and without detriment to the bulk properties of the material (Desmet et al, 2009). Plasma 
polymerised deposits of acrylic acid (ppAAc) have been shown to support the attachment 
and spreading of a variety of cell types including keratinocytes (France et al, 1998; Higham 
et al, 2003), melanocytes (Eves et al, 2005), and corneal epithelial cells (Deshpande et al, 
2009), on surfaces previously unfavorable to cell-surface interactions. It has also been 
demonstrated that delivery of keratinocytes, in isolation or in co-culture with melanocytes, 
can be achieved from ppAAc-coated medical-grade silicone elastomers to model wound 
beds in vitro (Haddow et al, 2003; Bullock et al, 2006; Eves et al, 2008) These so-called 
'carriers' have been used successfully in the clinic to deliver autologous keratinocytes to 
challenging wound environments in patients presenting with extensive skin loss resulting 
from diabetic foot ulcers, or flowing trauma from burn injuries (Moustafa et al, 2004; Zhu et 
al, 2005; Hernon et al, 2006; Moustafa et al, 2007). Recently, ppAAc surfaces have been 
shown to enhance cell attachment and spreading of MSCs (Colley et al, 2009; Filova et al, 
2009). In this study, medical-grade silicone elastomers were surface-functionalised with 
acrylic acid, via plasma polymerisation, for the purpose of supporting cell attachment of 
MSCs to the substrate, and their potential as a cell-delivery vehicle for these cells, to model 
wound beds, was evaluated in vitro. 	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3.3 Results 
Surface Characterisation 
 
 Cell carriers were derived from silicone elastomers that were coated with a thin 
layer of ppAAc that was deposited from a low-power (2 W) radio frequency sustained 
plasma. After the surfaces had been prepared and removed from the reactor, their static 
water contact angles (WCA) were recorded, and further characterisation by X-ray 
photoelectron spectroscopy (XPS) was performed to analyse their surface elemental and 
functional composition. 
Hydrophobicity 
 
 To observe if the plasma deposition cycle had altered the hydrophobic character of 
the silicone elastomers, their WCAs were measured and compared with untreated silicone. 
8QWUHDWHG VXUIDFHV FUHDWHGDZDWHU GURSOHWZLWK D µEDOOHG¶ SURILOHZKHUHDV SS$$F FRDted 
surfaces allowed water to spread more freely over the surface. These observations were 
UHIOHFWHG E\ WKHLU UHVSHFWLYH :&$¶V ppAAc surfaces exhibited a much reduced WCA 
compared to un-functionalised silicon (25° ± 3° vs. 99° +/- 2°) (Figure 3.1).  
 
 
 
Figure 3.1. Hydrophobicity of ppAAc silicone surfaces. A and B, Silicone without and with 
plasma treatment respectively. C, A typical contact angle measurement for the samples 
depicted in B.  
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X-Ray Photoelectron Spectroscopy (XPS) 
 
 Wide scans revealed, in order of abundance, the presence of the following 
superficial elements: oxygen, silicone and carbon. The proportion of silicone that was 
detected indicated that the silicone substrate was covered with an acid layer with a 
thickness less than the depth of X-ray penetration (8 nm for Si 2p photoelectrons) (Figure 
3.2). Narrow scans (high-resolution scans) of the C1s region revealed the high binding 
HQHUJ\SHDNSHUWDLQLQJWR& 22;¶VDQGLWVDVVRFLDWHGEHWD-shifted carbon C-C(= O)OX. 
Where 'X' could represent a diversity of functional groups such as carboxyl groups (where 
; 5 DQGRU HVWHU ZKHUH ; 5 DQGRU DQK\GULGHV ZKHUH ; + &ROOHFWLYHO\ & 22;¶V
and C-C(= O)OX comprised 43.5 % of the C1s peak area (8.1 % and 35.4 % respectively). 
 
 
 
Figure 3.2. XPS. A) wide scan of the ppAAc coated silicone. B) narrow scan of the C1s 
peak present in A).. 
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MSC Phenotype 
 
 The cells used in this study were provided through collaboration with Prof Suzanne 
:DWW¶V*URXS7KH FHOOVZHUHSXUFKDVHG IURP/RQ]D%LRORJLFV8.DQG SKHQRW\SHGXVLQJ
flow cytometry by the Watt Group to confirm that the cell population possessed an antigen 
profile characteristic of MSCs. Figure 3.3 shows the cells to be negative for CD14, CD34, 
and CD45, and positive for CD73, CD90 and CD105; this expression profile meets the 
minimum requirements as specified by the International Society of Cellular Therapy 
(Dominici et al, 2006) for classifying MSCs, because there is no single-cell marker that 
uniquely identifies them. The cells were also tested by Prof Suzanne Watt's lab, at 
passages 4-5 for their tri-lineage potential to generate adipogenic, chondrogenic, and 
osteogenic cell-types. In addition, they also had the capacity to support neovascularization 
in vitro (Martin-Rendon et al, 2008). Taken together, the cells most certainly had the 
properties of MSCs. 
 
Figure 3.3. Immunophenotype of cultured MSCs. Representative flow cytometry histograms 
are shown displaying the median fluorescence intensity for three independent batches of 
MSCs. (Data courtesy of Gigorious Tsaknakis).	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Coated Vs. Uncoated Carrier (Cell Behaviour) 
Cell Attachment to ppAAc Surfaces 
 
 To assess cell attachment to the carriers, cells were seeded on to either ppAAc 
surfaces or untreated silicone for 24 h, before an MTT assay was performed to identify the 
presence of cells on their respective surfaces by their metabolism of the yellow MTT dye to 
a purple formazan salt.  Cells attached well to the ppAAc surfaces, whereas few cells 
adhered to uncoated silicone (Figure 3.4A). Cells could be seen as a circular and densely 
stained purple patch on the center of the ppAAc surfaces thus, indicating where the cells 
had been seeded at high density within the confines of the stainless steel rings. In contrast, 
only a faint amount of formazan could be seen by eye on untreated surfaces because the 
majority of cells failed to adhere to these surfaces. These observations were reflected by 
the optical density (OD) values from the cells following formazan salt elution as measured 
by spectrophotometry (Figure 3.4B.. The uncoated carriers recorded significantly lower OD 
values than that which was obtained from the ppAAc surfaces (0.02 vs. 0.15 a.u. 
respectively, p<0.001). 
 
 
Figure 3.4. Cell attachment to surfaces (ppAAc Coated Vs. Uncoated). A) Representative 
photograph displaying cells attached to uncoated (left wells) and ppAAc coated surfaces 
(right wells) after incubation with MTT, B) Mean optical density values of formazan salt 
eluted from cells on their respective surfaces following incubation with MTT (± SEM). (N=3, 
n-3). (***p < 0.001).	  	  	  	  
Cell Viability on ppAAc Surfaces 
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72 h after seeding MSCs onto tissue culture plastic (TCP) or ppAAc carriers, their 
viability was assessed by TO-PRO®-3 staining followed by flow cytometry. TO-PRO®-3 is a 
fluorescent live/dead stain, that is only permeable to cells that are dead or dying because of 
their lack membrane integrity. The dye cannot permeate live cells. MSCs cultured on the 
carriers showed no difference in cell viability vs. those cultured on TCP. The majority of the 
cell counts from both surfaces (TCP and ppAAc) were in the lowest region of fluorescence 
intensity (< 103 a.u.), thus showing that there was mass exclusion of TO-PRO 3 uptake by 
the cell population, and therefore indicated that the cells had high viability on both surfaces. 
Indeed, the fluorescence intensity histograms had similar profiles, with 85.3 % (TCP) vs. 
83.7 % (carrier) of the total cell counts from each surface lying to the left of an arbitrarily set 
gate (Figure 3.5), showing that the ppAAc surfaces did not significantly affect cell viability 
relative to TCP surfaces. If there were a large subset of dead cells within the population 
cultured on the ppAAc carriers, a secondary peak would be observed much higher in 
fluorescence intensity. 
 
 
 
Figure 3.5. Cell viability by TO-PRO®-3 staining. Viability of MSCs cultured on TCP or 
ppAAc carriers (left and right panel respectively) via TO-PRO-3 staining. Flow cytometry 
histograms are representative of three independent batches of MSCs. (Data courtesy of 
Anita R Mistry). 
 
Optimal Cell Seeding Density on Carrier 
 
To determine the optimal cell seeding density, cells were seeded onto carriers at a 
range of cell densities (1 x 104 - 6 x 104 cells/ carrier) and cultured for 7 days with 
AlamarBlue assays carried out on the first and last day of the experiment. The increase in 
percentage AlamarBlue reduction between the two time points served as an indicator for 
cell proliferation on the carrier. The results showed that the MSCs attached to the ppAAc 
surfaces and proliferated over the course of 7 days regardless of their initial seeding 
density, in a similar fashion to those cultured on TCP (Figure 3.6). However, successive 
doublings in cell densities above 4 x 104 cells/ carrier did not significantly increase viabilities 
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at day 7 as compared with those obtained, at the same time point, from 4 x 104 cells/ carrier; 
this is likely due to the phenomena of contact inhibition (Abercrombie 1967; Abercrom.M 
1970). Accordingly, for the subsequent cell transfer experiments, cells were seeded on to 
carriers at a density of 5  x 104 cells/ carrier. 
 
 
Figure 3.6. Cell seeding density. Cell viability over 7 days on either TCP or carriers as 
determined by AlamarBlue. The percentage reduction of AlamarBlue is shown normalised to 
1 x 104 cells on TCP. Error bars indicate the SEM for three independent experiments 
performed in triplicate. (* p < 0.05, ** p < 0.01, *** p < 0.001). (Data courtesy of Louise E 
Smith).  
 
MSC Phenotype After Contacting Carriers  
 
To evaluate if MSC culture on ppAAc surfaces affected their phenotype, cells were 
cultured on TCP or ppAAc surfaces for 72 h before they were detached and phenotyped by 
flow cytometry. Analysis revealed no significant changes in the cell surface expression for 
key markers including: CD90, CD105, CD73, CD34, CD14, CD45, HLA-ABC and HLA-DR 
(Figure 3.7). 
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Figure 3.7. Cell phenotype analysis following culture on ppAAc surfaces. 
Immunophenotyping for the antigens CD90-FITC, CD105-FITC, CD73-PE, CD34-APC, anti-
HLA-ABC-APC, CD14- PE-Cy7, CD45-PerCP, and anti-HLA-DR-PE antibodies or 
appropriate isotype controls.  Flow cytometry histograms are representative of three 
independent batches of MSCs. The mean % positive ± SEM above an arbitrary gate set for 
the isotype control is indicated for each histogram by two intersecting lines, one in the 
horizontal and the other in the vertical plane. (Data courtesy of Anita R Mistry). 
 
MSC Tubule Formation Capacity 
 
MSCs were cultured on both the carriers and TCP for 24 and 72 h, and their ability 
to support vascular tubule formation from umbilical cord blood derived endothelial cell 
colony forming cells (ECFCs) in vitro was assessed and quantified. The results showed that 
contact with ppAAc surfaces for up 72 h did not affect the functional capacity of the MSCs to 
form tubules from ECFCs (Figure 3.8 and 3.9). Qualitatively, MSCs cultured for 24 or 72 h 
on either TCP or ppAAc surfaces prior to ECFC co-culture were capable of stimulating 
tubule formation from the ECFCs, as evidenced by the similar density of vascular-like 
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structures that were derived (Figure 3.8 B). By contrast, in the absence of MSCs, ECFCs 
did not form tubules in culture regardless of their seeding density; neither a cell seeding 
density of 4x103 or 8x103 cells/ 48-well plate (4210 cells/cm2 or 8420 cells/cm2 respectively) 
could derive tubules (Figure 9 A). Following imaging, image analysis was performed to 
quantify tubule formation from the ECFCs in co-culture with the MSCs. The results 
demonstrated that there were no significant differences in the numbers of junctions, tubules, 
or the total tubule lengths that were formed from ECFCs cultured with MSCs that were 
cultured on either surface (TCP or ppAAc carriers) for 24 h (p= 0.77, p= 0.90, p= 0.80, 
respectively) or 72 h (p= 0.37, p= 0.88, p= 0.69, respectively) prior to commensuration of 
the co-culture (Figure 9 B). There were also no significant differences between the numbers 
of junctions, tubules, or the total tubule length that could be formed after MSCs were 
cultured for 24 h versus 72 h on their respective surfaces; TCP (p= 0.96, p= 0.99, p= 0.55) 
or on the ppAAc carriers (p= 0.14, p= 0.72, p= 0.14). 
 
 
 
Figure 3.8. Tubule formation. A) Umbilical cord derived ECFCs seeded at either 4 or 8 x 104 
cells/well in a collagen coated 48-well plate and cultured in the absence of MSCs. B) 
Representative photographs of MSC in co-culture with ECFCs after 14 days (magnification 
x 4, field area 8.4 mm2). MSCs were cultured on TCP or ppAAc surfaces for 24 or 72 h 
before co-culture began. Vascular tubule formation assays were carried out for three 
independent batches of MSCs. (Data courtesy of Anita R Mistry).  
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Figure 3.9. Quantitation of tubule formation. The numbers of tubules and junctions formed, 
and total tubule lengths per field area (8.4 mm2) at day 14 of MSC-ECFC co-culture are 
tabulated. MSCs were cultured on TCP or ppAAc surfaces for 24 h A) or 72 h B) before 
commencing co-culture. Vascular tubule formation assays were carried out on three 
independent batches of MSCs. Bar charts represent the mean ± SEM..(Data courtesy of 
Anita R Mistry). 	  
Assessment of Cell Transfer 
Verification that DED was Decellularised 
 
Before attempting to transfer cells to dermis from ppAAc carriers, it was important to 
ensure that the dermis was successfully decellularised by the NaCl protocol, so that it could 
be said WKDW WKHSUHVHQFHRIFHOOVRQ WKH'('¶VVXUIDFHZHUHH[WHUQDOO\GHULYHG Iollowing 
cell transfer. Histological analysis verified that the dense layer of keratinocytes comprising 
the epidermis was completely removed and the dermal fibroblasts contained within the 
dermis were also removed (Figure 3.10 A and B). Collagen IV staining revealed that the 
decellularisation protocol did not remove the basement membrane (Figure 3.10 C). 
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Figure 3.10. Decellularisation of dermis. A) and B) Cellular composition of skin before and 
after NaCl decellularisation, (arrows indicate cells). C) Basement membrane indicated via 
collagen IV detection. All photos were taken at x 10  magnification, and x 40  inset, with 
sFDOHEDUVUHSUHVHQWLQJDQGȝPUHVSHFWLYHO\.   
 
Uncoated Vs. ppAAc Coated Silicone 
 
 Cell delivery from the ppAAc surfaces to model wound beds, composed from DED, 
was assessed by culturing MSCs for 24 h on either unmodified silicone substrates or ppAAc 
surfaces, and placing them in contact cell-side down with the DED. After 24 h in contact with 
the DED the substrates were separated from the DED, and both the substrates and the 
DED were incubated with MTT to visualise and describe semi-quantitatively the extent of 
cell delivery to the DED from the substrates. ppAAc-functionalised surfaces were capable of 
delivering far more cells than un-functionalised silicone. Initially, a large number of cells 
were attached to the ppAAc carrier, and after contact with DED, few cells remained present 
on the carrier because the cells had transferred to the DEDs' surface (Figure 3.11 A and B). 
In contrast, far fewer cells could be transferred from the unmodified surfaces to DED, 
however far fewer cells attached to these surfaces in the first instance. These observations 
were confirmed by their respective MTT OD values (Figure 3.11 C). After contacting ppAAc 
surfaces, the OD vales obtained from the DED were significantly higher (p < 0.001) than 
those obtained from DED following contact with unmodified surfaces (OD values of 0.075 
and 0.015 respectively). The OD values from the carriers or unmodified surfaces after 
transfer were very similar (0.005 and 0.007 respectively) and bordered on the threshold of 
detection by the spectrophotometer. 
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Figure 3.11. Assessment of cell transfer (ppAAc-coated vs. uncoated carriers). A) 
Photographs of MTT-stained MSCs before and after transfer from uncoated silicone, A1 and 
A2 respectively. B) Photographs of MTT-stained MSCs before and after transfer from ppAAc 
carriers. B1) MSCs on carrier prior to contact with DED, B2) MSCs present on DED after 
contact with the carriers, B3) MTT stained ppAAc carrier after transfer. C) Elution of the stain 
from the DED. Mean ± SEM, (N=3, n=3), (*** p < 0.001). 
 
 
 
Cell Viability Post Transfer 
 
 The viability of the cells following their transfer to DED was assessed over a period of 
7 days. An MTT assay was performed on the DED 24 h, 72 h and 7 days after cell transfer. 
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Figure 12 shows that the cells remained viable post-transfer to the DED for at least 7 days, 
and by day 7 the metabolic activity of the cell population had significantly increased (p < 
0.05), suggesting that the cells had begun to proliferate on the DED after transfer. 
 
 
 
Figure 3.12. Cell viability 7 days following transfer. A) Representative photographs of MTT-
stained cells 24 h, 72 h, and 7 days after transfer. B) MTT O.D. values following stain 
elution. Mean ± SEM from three independent experiments performed in triplicate. (** p < 
0.01, *** p < 0.001). 
 
Cell Transfer After 72 h on Carrier 
 
 MSCs were cultured on ppAAc carriers for 72 h before they were placed in contact 
with DED, and cell viability of cells on the DED was measured by MTT at the following time 
points: 24 h, 72 h and 7 days. Similarly to 24 h pre-culture prior to transfer, the cells 
remained viable post-transfer to DED (Figure 3.13). However, there was a slight difference 
in the degree of cell transfer to the DED after an extended period of culture on the carrier 
prior to transfer. After 24 h of pre-culture on the carrier, few cells remained after transfer 
(OD values from the carrier were just above the threshold of detection by the plate reader). 
In contrast, following 72 h of pre-culture more cells remained on the carrier after transfer to 
the DED; the OD values from the carriers were 0.006 vs. 0.012 for 24 h and 72 h pre-culture 
respectively (p < 0.05). The differences obtained were perhaps due to an increased amount 
of extracellular matrix produced from the MSCs during a longer residence on the carrier 
prior to transfer, which may have enhanced cell adhesion to the carriers making them more 
µUHOXFWDQW¶ WR WUDQVIHU 'HVSLWH WKLV DSSUR[LPDWHO\ ±90% of the cells transferred to the 
DED. While there is a significant difference (p < 0.05) between the MTT values obtained for 
cell viabilities on the DED between the experiments performed in Figure 3.12 and 3.13, at 
72 h and 7 days, this may be due to a difference in the metabolic activity of cells from 
different donors (Sittichokechaiwut et al, 2012).  
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Figure 3.13. Cell viability post transfer (72 h Pre-culture). Mean ± SEM (N=3, n=3), (* p < 
0.05, ** p < 0.01, *** p < 0.001). All experiments were conducted on split thickness skin. 
 Cell Transfer to Gelatin Coated Surfaces 
 
To investigate if the presence of basement membrane collagen on the surface of 
DED (as earlier identified, Figure 3.10) was a factor facilitating cell transfer, the cell transfer 
regime was performed on gelatin-coated surfaces. Gelatin surfaces were prepared at 
concentrations of 5 %, 1 % and 0.1 % (w/v) in dH2O and dispensed to cover the surface of 
wells in TCP 6-well plates. Cells were then seeded on the carriers as previously described, 
and after 24 h culture on the carriers they were placed cell-side down on to the gelatin 
surfaces for 24 h, before an MTT assay was performed on both the gelatin-coated surfaces 
and the carriers to determine the extent of cell transfer. Sirius red staining, which associates 
with collagen, was performed to determine if the gelatin had successfully coated the well 
plates. Staining clearly confirmed the presence of a thin layer of gelatin from the 5 % gelatin 
preparation, however staining was much weaker for the 1 % and 0.1 % gelatin 
concentrations (Figure 3.14 A). Following the removal of excess Sirius red, by washing with 
PBS, much gelatin was removed from the wells coated with the 1 % and 0.1 % gelatin 
concentrations. As a result much lower levels of Sirius red staining was visible after the 
samples had dried (Figure 3.14 B). Nonetheless gelatin was present on the surfaces of 
wells from each of the gelatin concentrations tested.  MTT staining showed that cell transfer 
was possible from the carriers to the gelatin surfaces. Cells could be seen (by retention of 
the formazan salt from MTT) on the surfaces for each of the gelatin preparations, with the 
greatest extent of transfer achieved to the 0.1 % gelatin surfaces, although in all instances a 
considerable number of cells remained on the carriers (Figure 3.14). Cell transfer was most 
consistent to the 0.1 % gelatin surfaces, and as a result it was the only gelatin concentration 
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for which there was a statistically significant difference between the number of cells on the 
gelatin compared to the number on the carrier (p < 0.01). 
 
 
 
Figure 3.14. Cell transfer to gelatin surfaces. A and B) Sirius red staining before and after 
washing of excess stain (5%, 1% and 0.1% from left to right). B) Representative 
photographs of MTT stained cells on the carriers (left) and the gelatin surfaces (right). C) 
Optical density of the stain eluted from the cells. Error bars represent the SEM of three 
independent experiments performed in triplicate. (**p < 0.01).  
MSCs Post-Delivery to DED 
 
Enhanced green fluorescent protein (eGFP) labeled MSCS were used to visualise 
the cells post transfer to the DED by confocal microscopy, chosen for its ability to conduct 
optical slicing, to investigate if cells were able to migrate into the dermis. Firstly however, 
cell transfer experiments were conducted, using the regime described earlier, to determine 
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that the eGFP-labeled cells could behave similarly to the untransfected cells (i.e. transfer 
was possible and the cells remained viable). Figure 3.15 shows that the eGFP-labeled cells 
were able to successfully transfer to the DED from the carriers, and proliferate over the 
course of 7 days. Transfer of non-transfected cells to DED was efficient because very few 
cells remained on the carriers as indicated by the very low OD value (0.013) (data not 
shown) and the higher OD reading from the DED (0.072) (p < 0.05). At each successive 
time point, the cells on the DED showed significant increases in their metabolic activity, as 
indicated by the OD values. 
 
 
Figure 15. eGFP-MSC viability post-transfer to DED via MTT. (*p < 0.05) Mean ± SEM for 
three independent experiments performed in triplicate.o 
oooooooooooooooooooooooooooooooooooooooooooooooooooo
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Confocal microscopy was conducted to image cells cultured on the ppAAc carriers for 7 
days or 7 days following cell transfer to DED, and showed that cells could be clearly 
identified on their respective surfaces (Figure 3.16). Cells cultured on the ppAAc carriers 
had a flattened morphology, similar to that found in culture on TCP surfaces, whereas those 
that were transferred to the DED possessed a more spindle-like appearance. Z-stack 
images of the DED acquired 7 days after transfer showed cells to be present to a depth of 
up to 80 Pm (Figure 3.17). 
 
 
 
Figure 3.16. MSC morphology on ppAAc surface and DED after extended culture. 
Representative confocal images of MSCs either cultured on the carrier for 7 days A), or on 
the DED 7 days after transfer to DED from the carrier B). (Scale bars= 200 Pm). 
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Figure 3.17. Confocal microscopy of eGFP-MSCs. A) an y/z composition derived from serial 
sections (2 Pm/ slice, 50 slices) through the DED 7 days after cell transfer from the carrier. 
TB)-D) are x/y images that correspond to the red, green, and blue transects in the z-plane in 
A). (Scale bar B- D)= 40 Pm). 
 
Histology Post Cell Transfer to DED 	  
 Histology was performed on the DED as an additional means to determine if the cells 
were able to migrate into the dermis following transfer. Histology confirmed the presence of 
cells on the surface of the DED as a superficial layer (Figure 18). Previous testing of DED 
SUHSDUDWLRQVVKRZHGWKHHIIHFWLYHUHPRYDORILQWULQVLFFHOOVWKHUHIRUHWKHFHOOVRQWKH'('¶V
surface came from the carriers and were transferred MSCs and not cell remnants from 
insufficient cell removal during DED preparation. 
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Figure 3.18. Histology post cell transfer to DED from ppAAc carriers. A) Representative 
image of H & E stained DED 7 days after MSCs delivery from the ppAAc carrier. B) An 
enlarged image from the stared region in A). C) an enlarged image of the region PDUNHGµ[¶ 
in B). The arrowheads indicate the presence of MSCs, which can be identified as a 
superficial layer even at the lowest magnification (x 4). Scale bars: 1 mm, 250 ȝm and 50 
ȝm in A-C respectively.  
 
Transfer Vs. Direct Seeding 
 
 To investigate if the cells were prohibited from migrating into the dermis because the 
carrier had affected them in some way, cells that were transferred from the ppAAc carriers 
were compared to cells that were seeded directly onto the DED and evaluated histologically 
after 7 days (Figure 3.19). Upon comparison of results, no difference between the two 
PHWKRGV FRXOG EH REVHUYHG DQG LQ ERWK FDVHV WKH06&V FRXOG EH VHHQ RQ WKH '('¶V
surface as a superficial layer and migrated into the dermis.  
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Figure 3.19. Transfer Vs. direct seeding. H&E stained DED 7 days after direct seeding or 7 
days after transfer form carriers (A and B respectively). Representative photographs are 
show from three independent experiments performed in triplicate. Images are shown at x 10  
and x 40  magnification inset with scale bars UHSUHVHQWLQJȝPDQGȝPLQVHW.  
 
eGFP-MSC and Keratinocyte Co-cultures on DED 
 
 Keratinocytes were co-cultured with eGFP MSCs on the DED to determine if the 
presence of keratinocytes could encourage the MSCs to migrate into the dermis. After 7 
days of co-culture on the DED, fluorescent microscopy was performed to identify the MSCs, 
via their GFP label. The basement membrane (BM), which was stained by 
immunofluorescence using a TRIC-labeled secondary antibody raised to the anti-collagen 
IV primary antibodies. Cell nuclei were stained by DAPI, and this stain predominantly 
indicated the presence of keratinocytes. In the presence of keratinocytes, MSCs were 
capable of migrating across the BM and they could be identified in the dermis to a depth of 
XSWRȝm, and very few MSCs remained above the BM, which was heavily populated by 
keratinocytes. %\FRQWUDVW06&VFXOWXUHGRQ'('¶VVXUIDFHLQLVRODWLRQZHUHQRWFDSDEOHRI
entering the dermis and they remained as a layer above the BM (Figure 3.20). Following 
counting of the MSCs, it was revealed that their migration across the BM and into the 
dermis  increased 2.06 fold (p < 0.001) in the presence of keratinocytes; 30.31 % of MSCs 
penetrated the BM vs. 62.51 % (MSCs alone vs. co-culture with keratinocytes) (Figure 
3.21). 
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Figure 3.20.  MSC and keratinocyte co-culture on DED. A) and B) fluorescent micrographs 
of DED seeded with 5 x 105 MSCs after 7 days of culture on DED. C) and D) fluorescent 
micrographs of DED seeded with 5 x 105 MSCs and 1 x 106 keratinocytes (K) after 7 days 
co-culture on DED. Images in A) and C) were taken at x 10 magnification, the scale bars 
UHSUHVHQWȝP ,PDJHV LQ%DQG'ZHUH WDNHQDW[PDJQLILFDWLRQZLWKVFDOHEDUV
UHSUHVHQWLQJ  ȝP Blue= DAPI, Green= eGFP-MSCs, Red= Collagen IV. A & B) 
Representative images from three independent experiments performed in triplicate are 
shown.  
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Figure 3.21. Percentage of MSCs present below the basement membrane (BM) of DED in 
the presence (Co-culture) or absence of keratinocytes (MSCs Only). MSCs that were 
situated above or below the BM, identified by their eGFP-label, were manually counted 
XVLQJ WKH µFHOO FRXQW¶ SOXJLQ LQ LPDJH-$SSUR[LPDWHO\FHOOVZHUHFRXQWHGILHOGRIYLHZ
obtained with using x 10 objective and approximately 200 cells were counted/ sample. The 
bar chart represents the mean percentage of MSCs that were found below the BM, +/- the 
SEM from three independent experiments performed in triplicate. (***p < 0.001). 
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3.4. Discussion 
 
The aim of this work was to evaluate the use of a synthetic cell carrier dressing, 
prepared from ppAAc-coated medical-grade silicone, for the delivery of MSCs to a skin 
wound model. 
Surface Characterisation 
 
 It is known that significant fragmentation of the monomer occurs in glow discharges, 
and as a result, a wide range of functional groups appear in the coating (Kelly et al, 2003). 
As can be seen from the C1s trace, a range of surface functionalities are produced 
including: carboxylic acid/ester (COOH/R), carbonyl, alcohol/ester, and hydroxyl, resulting 
from the break down of the acrylic acid as it is induced into a plasma.  A limitation of XPS is 
that it cannot distinguish between carboxylic acid and ester groups, which collectively 
JHQHUDWH WKH FDUER[\ODWH &22+5 SHDN2¶Toole et al demonstrated, by grazing angle 
infrared (IR) spectroscopy, that the entire carboxylate peak in the XPS spectra from plasma 
deposits of acrylic acid generated under low energy conditions (5 W), related to the 
presence of carboxylic acid rather than to esters; whereas under higher power conditions 
(10 W), plasma deposits contained a greater proportion of ester vs. acid groups (Otoole et 
al, 1996) 2¶7RROHHWDO ,QDGGLWLRQ$OH[DQGHUDQG'XQFGHPRQVWUDWHG WKDWDW ORZ
power: flow ratios, approximately 30 % of the carboxylate peak can be assigned to acid 
groups (Alexander and Duc 1998). 
 
 In relation to the C-OH/R group, it is thought to consist predominantly of hydroxyl 
groups resulting from a reaction between the plasma deposit and water desorbed from the 
walls of the reactor during polymerisation, and atmospheric oxygen and water post 
polymerisation (Haddow et al, 2003). On the basis of these studies, it must be 
acknowledged that the entire COOH/R peak obtained in this work does not pertain wholly to 
acid, however because low power conditions (2 W) were employed in this study, it can 
reasonably be assumed that a significant proportion of the carboxylates are acids.  
 
 The degree of fragmentation can be minimized by carefully tuning parameters such 
as power, input and duty cycle to obtain a high degree of monomer structural retention in 
the deposited film. Alexander and Dunc demonstrated under an µHQHUJ\-GHILFLHQW¶ regime 
(where incident power into the reactor is very low), films of acrylic acid could be produced 
with an elemental and functional composition similar to that of conventional acrylic acid. 
Using similar conditions used in the experimental set-up herein (flow rate of 5 sccm and 
lowest power used of 2 W), they showed that both the functional and elemental composition 
of the surfaces changed as a function of power. By incrementally increasing the power 
above 2 W to 20 W, a successive decrease in the surface oxygen content, and an increase 
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in the C-C content were noted, as well as a decrease in (COOH/R) content. In addition, the 
authors indicated, by secondary ion mass spectrometry (SIMS), the presence of linear 
structures containing up to five acrylic acid units, which bared close resemblance to the 
spectrum from pure polyacrylic acid (Alexander and Dunc, 1998). Therefore in light of this 
study, it can be said with confidence that the deposits of acrylic acid on our silicone 
substrates possess good functional retention of acid groups.  
 
 The presence of surface acid groups increases the number of oxygen-containing 
species available on the surface, and surface oxygen content has been shown to positively 
correlate with surface wettability, and in most cases cell adhesion (Parhi et al, 2010). ppAAc 
was capable of producing surfaces that could convert the properties of the silicone from 
hydrophobic to hydrophilic. Water that was dispensed to the surface of the uncoated 
VLOLFRQH SUHVHQWHG D µEDOOHG-XS¶ DSSHDUDQFH SUHVXPDEO\ EHFDXVH RQ VXFK K\GURSKRELF
materials water interacting with itself proved more energetically favorable than interacting 
with the surface, thus limiting the spreading of water. By contrast, water spread rapidly over 
the ppAAc surfaces. These observations were reflected by their respective contact angles. 
The presence of ppAAc reduced the contact angle from over 100 degrees to 25.03 +/- 3 
degrees; this finding is in agreement with other studies (Colley at al, 2009; Flivova et al, 
2009).  
Cell Attachment to ppAAc and Un-functionalised Surfaces 
 
 Protein adsorption plays a vital role in affecting how cells respond to a material. When 
a material is placed in contact with cell culture medium containing serum, adsorption of 
proteins to its surface from the serum happens almost instantaneously (Baier and Dutton 
1969). Cells, which later come into close proximity to the substrate's surface recognise the 
adsorbed proteins because they act as ligands for cell surface receptors such as integrins; a 
family of heterodimeric transmembrane receptors that connect the extra cellular matrix 
(ECM) to the cytoskeleton (Roskelley et al, 1995). Integrins are not only involved in 
anchoring cells to the ECM; they also support cell spreading (Reddy et al, 2001), motility 
(Vicente-Manzanares et al, 2009) and trigger intracellular signals that regulate survival, 
proliferation and differentiation (Chastain et al, 2006; Tan et al, 2010; Du et al, 2011) 
Therefore, cellular responses on substrates are affected by the biological activity and 
composition of adsorbed protein layer, which is underpinned by the surface chemical 
properties of the material. Thus, cells do not interact directly with the surface chemistry, 
rather they interact indirectly with the surface via an adsorbed protein layer; the composition 
of which is governed by the surface chemistry. Although the exact mechanisms are poorly 
understood, parameters such as surface free energy, roughness, and chemical composition 
have a significant influence (Wilson et al, 2005). 
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 The surface chemistry of a material is reflected, in part, by its wettability, and it is 
widely accepted, although there are exceptions, that hydrophilic polymers generally 
enhance cell adhesion and spreading (Guo et al, 2008; Dowling et al, 2011) (Dowling et al, 
2011). The general observation that wettable surfaces display enhanced cell adhesion to 
polymeric surfaces, was reflected by the fact that cell attachment to ppAAc coated surfaces 
was considerably greater than to un-functionalised surfaces, which were hydrophilic and 
hydrophobic respectively. In relation to MSCs, both conventional acrylic acid, and plasma-
polymerised acrylic acid containing surfaces have been shown to support cell attachment, 
spreading and differentiation (Guo et al, 2008; Colley et al, 2009; Filova et al, 2009). With 
respect to ppAAc, Filova et al prepared micro-patterned surfaces by coating silicone wafers 
with ppAAc followed by the deposition of a 1,7 Octadiene (OD) through a mask to 
investigate the spatial distribution of various cell types. Their results showed that a range of 
cell types including rat vascular smooth muscle cells, bovine endothelial cells, porcine 
mesenchymal stem cells (MSCs) and human skeletal muscle cells, grew preferentially on 
the ppAAc strip domains; with 90 % of the MSCs favoring the ppAAc surface. This was 
expected because OD is a hydrocarbon containing polymer that is known to be inhibitory to 
the adhesion of a numerous cell types (Daw et al, 1998; France et al, 1998), and it has been 
used as both a negative control to investigate plasma polymers, and as a diluent in acrylic 
acid plasmas to control the percentage of COOH functional groups on a surface. However 
they showed for the first time that MSCs cultured on ppAAc possessed more organised 
actin cytoskeletons and more pronounced tallin staining, indicating the presence of better 
developed focal adhesion plaques, as compared to the small proportion of MSCs found on 
the OD surfaces (Filova et al, 2009). Colley et al (2009) studied cell attachment and 
morphology of MSCs on ppAAc coated polydimethylsiloxane (PDMS) substrates of varying 
stiffness to determine the effect on differentiation. They found that cell attachment to ppAAc 
PDMS was markedly improved over untreated PDMS, and provided a similar level of 
attachment to tissue culture plastic (TCP). In addition they showed ppAAc did not affect 
MSC proliferation over 7 days and showed, similar to Filova, that cells on ppAAc surfaces 
contained a more defined actin cytoskeleton. Interestingly, they also demonstrated MSCs 
had reduced capacity for osteogenic differentiation on ppAAc surfaces, the cells retained 
WKHLU µVWHPQHVV¶$OWKRXJKDGLIIHUHQWLDWLRQVWXG\RQSS$$FVXUIDFHVZDVQRWFRQGucted as 
part of my own study, the results demonstrated that brief contact (up to 72 h) with the 
SS$$FVXUIDFHGLGQRWDIIHFWWKH06&V¶IXQFWLRQDOFDSDFLW\DVVKRZQE\WKHLUDELOLW\Wo form 
tubules from ECFs. The physical properties of the material as opposed to the surface 
chemistry may have contributed to Colley HW DO¶V results, because MSCs only showed a 
reduced oesteogenic FDSDFLW\RQ3'06VXEVWUDWHVZLWKORZ<RXQJ¶VPRGXOLORZVWLIIQHVV
and  substrate stiffness  can alter cell phenotype (Engler et al, 2006). 
 
 However, none of the studies highlighted above investigated the proteins adsorbed to 
the ppAAc surfaces, and how they influenced MSC attachment. One candidate protein for 
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MSC attachment is fibronectin. Serum contains numerous proteins including albumin, 
immunoglobulins, fibrinogen, fibronectin (FN) and vitronectin (VN), all of which have been 
studied with relation to adsorption to substrates and subsequent cell responses (Yun et al, 
1995; Tsai et al, 2002; Higuchi et al, 2003; Keselowsky et al, 2003). Of particular interest 
are the ECM proteins FN and VN; they have been shown to control cell adhesion and 
spreading (Steele et al, 1995; Garcia et al, 1999) cell survival, proliferation and expression 
of differentiated phenotypes (Menko and Boettiger 1987; Werb et al, 1989; Streuli et al, 
1991). Albumin is the most abundant of all serum proteins and accounts for nearly one half 
of all plasma proteins (Blomback 1976), however it is not considered to be cell adhesive due 
to its lack of cell binding domains (Carter and Ho 1994), as such Allen et al hypothesised 
that the initial attachment of osteoblasts was most likely influenced by albumin adsorption. 
They found more albumin than FN was adsorbed from serum to pNIPAM surfaces 
compared to their more hydrophobic counterparts, and accordingly fewer cells were 
observed to attach to the hydrophilic surfaces (Allen et al, 2006) In contrast, Zelzer et al 
demonstrated that from a binary mixture of FN and albumin, hydrophilic surfaces of plasma 
polymerised allyamine (ppAAm) adsorbed more FN and provided significantly better cell 
adhesion than their more hydrophobic hydrocarbon containing counter parts (Zelzer et al, 
2012). These two studies, where contradictory results are reported, highlight the scientific 
FRPPXQLW\¶V LQFRPSOHWH XQGHUVWDQGLQJ RI WKH QDWXUH VXUIDFH FKHPLVWU\ SOD\V RQ SURWHLQ
absorption and cell attachment to substrates. However both studies agreed that enhanced 
FN adsorption to surfaces is critical for achieving good cell adhesion. Therefore, in my 
study, since ppAAc greatly enhanced MSC attachment to silicone elastomers, it would be 
reasonable to assume that the surface selectively absorbed FN from serum thus mediating 
better attachment.  
 
 To my knowledge there are no studies on protein adsorption to plasma polymer 
deposits and their effect on MSCs attachment however, Danmark et al recently investigated 
human bone morrow MSC attachment to a variety of polymers (Danmark et al, 2012). They 
screened the MSCs for an array of integrins and showed the presence of a wide variety of 
integrin subunits, indicating that the MSCs expressed receptors for FN, VN, COL1, laminin 
ĮȕȖ /0- DQG ODPLQLQĮȕȖ /0-511), all of which are common ECM proteins  
(Plow et al, 2000). Danmark also found that VN from 10 % serum (same concentration used 
in this study) adsorbed 4-fold more than FN to polystyrene (the most hydrophilic material 
they tested compared to aliphatic polyesters). However, although VN was the most 
abundant surface protein, functional-blocking studies, where antibodies where targeted to 
either the subunits of the integrins to VN or the VN protein itself, revealed that preventing 
VN recognition had no effect on reducing MSC attachment, whereas preventing FN 
recognition halved MSC attachment (Danmark et al, 2012). Thus, their data showed that the 
main protein responsible for mediating MSC attachment was FN despite its low surface 
abundance. In addition, they identified the integrin subunits alpha 5 and beta 1 as 
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responsible for FN recognition by MSCs, and very recently other authors also identified 
these subunits as forming the key integrins of MSCs (Weeks et al, 2012). In light of the 
above, further investigation is clearly required to determine which proteins are available at 
the surface of ppAAc after adsorption from serum, and importantly, which of the proteins 
present are essential for MSC attachment by performing functional blocking studies.   
 
 In light of the above, I speculate that FN mediates the improved MSC attachment to 
ppAAc surfaces vs. un-functionalised. It is likely that albumin adsorbs first to the surface 
from serum, being the most abundant, smaller and more mobile protein than FN; and it is 
subsequently displaced from the surface by FN. It has been previously reported that FN's 
capacity to displace non-cell-adhesive albumin from hydrophobic surfaces is much reduced 
compared to hydrophilic surfaces (Koenig et al, 2003; Zelzer et al, 2008). Therefore, due to 
VLOLFRQH¶V K\GURSKRELF QDWXUH VLOLFRQH surfaces may absorb lesser amounts of FN 
compared ppAAc surfaces; thus non-acid-functionalised surfaces may present fewer ligands 
for MSC attachment. In addition, FN adsorbed to un-functionalised silicone may be 
structurally altered such that integrin recognition is perturbed (Steele et al, 1995). Figure 
3.22 summarises the mechanism by which MSCs may attach to plasma-polymerised 
deposits of acrylic acid.  
 
 
 
Figure 3.22. Diagram illustrating a proposed mechanism for MSC attachment to ppAAc 
surfaces. 1) Albumin (Alb) absorbs first to the surface being the most abundant protein in 
serum. 2) Fibronectin (FN) and Vitronectin (VN) displace Albumin from the surface. 3) MSCs 
ELQGWR)1YLDLQWHJULQĮȕ1.  
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 The results presented in this chapter also demonstrated that a very limited amount of 
cell attachment was attained on the non-functionalised surfaces. This could be attributed to 
the fact that even though the surfaces are hydrophobic, proteins for cell attachment are still 
adsorbed to the surface from the serum. Hydrophobic surfaces have been reported to 
adsorb more protein than hydrophilic surfaces (Absolom et al, 1987; MacDonald et al, 2002) 
, although this is not universal observation (Elwing et al, 1995; Keselowsky et al, 2002). 
Keselowky found that self-assembled monolayers (SAMs), which functionalised with either 
CH3 or COOH, producing surfaces with contact angles of 107 and 28 degrees respectively, 
adsorbed similar amounts of FN from serum. Therefore it is possible that the non-
functionalised surfaces adsorbed much protein from serum, however those that adsorbed 
could have adopted a conformation that was not favorable for cell attachment. It has been 
shown that proteins that adsorb to hydrophobic surfaces are more susceptible to structural 
unfolding (Haynes et al, 1994; Keselowsky et al, 2003; Wilson et al, 2005), and this may 
alter their RGD sequences by which integrins recognise cell-anchorage proteins. In addition 
to the chemical surface properties, the physical properties of the material such as surface 
roughness may go part way in explaining why cells were adherent to the un-functionalised 
surfaces. Devesh et al recently attributed the attachment of MSCs to hydrophobic silicone 
substrates to surface roughness. They found that untreated silicone elastomers had rough 
surfaces, with 1.8 +/- 0.3PM ridges as determined by atomic force microscopy, and they 
proposed that surface roughness was able to overcome, to a limited extent, the hydrophobic 
nature of the silicone (Misra et al, 2012).   
Mechanism of Transfer 
 
 With regard to the mechanism of transfer, one could speculate that the DED presents 
a surface more favorable to the MSCs than the ppAAc functionalised and un-functionalised 
surfaces. The basement membrane (BM) is a protein-rich site that provides the site of 
anchorage of epithelial cells and one of its chief constituents is collagen. The DED that was 
prepared had their BM preserved as noted by the presence of a thick band of collagen IV on 
the D('¶V DSLFDO VXUIDFH Integrins may be directed towards the collagen-containing BM 
where they become concentrated and produce more focal adhesions than are present on 
the opposing side of the cell, which is in contact with the carriers, so that the strength of cell 
adhesion to the DED is greater than to the carriers such that when the carriers are removed 
they remain in contact with the DED.  
 
 To test whether collagen mediated the transfer of cells, the transfer regimen was 
repeated onto wells coated with varying concentrations of gelatin (5 %, 1 %, 0.1 %). Only 
the lowest gelatin concentration (0.1 %) was capable of affecting significant cell transfer 
from the carriers (p< 0.01), however transfer was not as complete as compared to DED with 
Nathan	  Walker	  (2013)	   	   Chapter	  Three	  
	   112	  
visibly more cells remaining on the carriers after transfer was attempted to gelatin surfaces. 
This could be due to gelatin being denatured collagen whereby its fibrilar structure is no 
longer present. It would be interesting to use BM extract such as Cultrex®, which is a soluble 
IRUP RI %0 SXULILHG IURP KXPDQ SODFHQWD WR LQYHVWLJDWH LI FROODJHQ¶V ILEULODU VWUXFWXUH LV
necessary for effective cell transfer.  
 
 Using eGFP-labeled cells, MSCs could be identified 7 days post-transfer to DED by 
fluorescence microscopy to determine if the MSCs had penetrated and migrated into the 
DED. Confocal microscopy revealed that the MSCs could only be observed at depths up to 
80 Pm; this depth corresponded to that of the contours SUHVHQW LQ WKH'('¶s surface as 
confirmed by histology. Thus, it is possible that the cells, while well attached to the DED, did 
not migrate into the dermis. A comparison of cell transfer, from ppAAc carriers to direct 
seeding of cells to the surface of DED, revealed that the ppAAc chemistry did not influence 
the MSCs entry into the dermis. Therefore, it is likely that migratory/invasive cues are 
missing from this simple wound bed model.  
 
 A key requirement for cells to migrate into tissue is their ability to traverse the protein 
fibers of the ECM (Westermarck and Kahari 1999). BMs are a highly specialised, dense 
ECM layer that separates epithelium from the stroma, thus it may act as a barrier to MSC 
migration. Metalloproteinases (MMPs) are a family of zinc and calcium dependent 
endopeptidases that are capable of degrading most proteins of the ECM (Nagase and 
Woessner 1999). Of particular interest are the gelatinases MMP-2 and MMP-9, due to their 
ability to cleave collagen IV, laminin, aggrecan, and elastin, all of which are major BM 
components (Van den Steen et al, 2002). Cell-types of mesodermal origin, such as 
fibroblasts, endothelial cells, and MSCs, constitutively express MMP-2, however they only 
express MMP-9 upon stimulation (Nguyen et al, 2001; Ries et al, 2007; Sasaki et al, 2008; 
Ries et al, 2009). Dermal fibroblasts have been shown to heavily up-regulate MMP-9 upon 
interaction with keratinocytes, as demonstrated in both transwell systems and direct co-
culture (Sawicki et al, 2005; Ries et al, 2009), thus providing evidence that communication 
between these two cell types are essential for modulating MMP-9 production. In addition, 
Gosh et al reported, whilst comparing methodologies for preparing human epidermal-dermal 
composites, human dermal fibroblasts could only enter the papillary dermis in the presence 
of keratinocytes (Ghosh et al, 1997); a phenomenon which Lee et al later attributed to the 
partial loss of the lamina densa in the presence of keratinocytes (Lee et al, 2004). 
 
 In light of this, and taking into account their shared embryonic lineage with fibroblasts, 
MSCs may behave similarly to fibroblasts with respect to their dermal migratory potential i.e. 
keratinocytes are required to create a permissive environment for cell migration. To 
investigate if the presence of keratinocytes could affect the capacity for MSCs migrate into 
the dermis, keratinocytes were co-seeded onto the DED with MSCs (eGFP-labeled). The 
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results clearly demonstrated that in the presence of keratinocytes, the majority of MSCs 
could traverse the BM, whereas in the absence of keratinocytes, the MSCs were restricted 
to the region superficial to the BM. In light of the discussion relating to MMPs, I speculate 
that the keratinocytes provide a permissive environment for MSC migration by way of 
enhancing MMP-9 production from the MSCs to a level that is sufficient to degrade the BM 
enough to allow their passage through it. Further investigation would be required to 
determine if changes in MMP-9 production were associated with the observation that MSCs 
could pass the BM in the vicinity of keratinocytes. Such an assessment could be made by 
comparing the MMP-9 content of the culture media from co-cultures on DED with the media 
from each cell type cultured in isolation on the DED via ELISA. If levels of MMP-9 were 
found to be elevated in the medium from the co-cultures, a causal link could be determined 
by blocking the function of MMP-9 by using specific inhibitors (Gu et al, 2005) to establish if 
MMP-9 functionality is essential to MSC migration. 
 
On Route to the Clinic 
 
 Collagen I has been used to effectively deliver cells for skin repair in the clinic, and 
there are several commercially available products licensed by the food and drug 
administration (FDA) which include OrCellTM- (Bilayered cellular matrix and composite 
cultured skin- 2001) and Integrea® (dermal replacement template- 2002). However, 
collagen is commonly bovine in origin and carries a low but inherent risk of disease 
transmission such as bovine spongiform encephalitis (BSE). Therefore, it is advantageous 
to avoid as far as possible the use of xenobiotic materials. Achieving effective cell delivery 
of MSCs from ppAAc carriers goes part way in achieving this goal because the materials 
are entirely synthetic i.e. medical grade silicone and acrylic acid. However it is also 
important to address the medium formulation on route to the clinic.  
 
 Fetal bovine serum (FBS) is usually added to culture medium because it provides a 
complex mixture of supportive agents for cell growth, including: growth factors, hormones, 
mitogens, transport proteins, detoxifying agents, attachment factors, protease inhibitors and 
vital nutrients (Freshney 2000). However, as MSCs are becoming more established in 
clinical settings, FBS's high content of xenogeneic proteins are a cause for concern 
surrounding immune reactions. In some cases, immunological reactions and anti-FBS 
antibodies have been observed and were considered to have affected the therapeutic 
outcome (Horwitz et al, 2002; Sundin et al, 2007). Despite this, most clinical data have been 
obtained with MSCs, expanded with FBS supplemented media, without major side effects 
(Bieback et al, 2009). In addition, FBS exhibits a high degree of batch to batch variation and 
carries the associated risk of transmitting infectious adventitious agents (Jung et al, 2012); 
although FBS can be obtained from clinically approved sources, originating from herds in 
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Australia or New Zealand where there have been no reported outbreaks of BSE, as was the 
case in this study. Considered together, regulators aim to minimise the use of FBS (Halme 
and Kessler 2006), thus creating a driving force to find alternatives. 
 
 In order to address the safety and regulatory concerns surrounding the use of FBS, 
human blood derived materials including human serum, platelet derivatives and cord blood 
serum are currently under investigation for their clinical benefit as a substitute for FBS. 
Autologous human serum has been reported to support MSC expansion (Stute et al, 2004; 
Kobayashi et al, 2005; Shahdadfar et al, 2005; Mizuno et al, 2006), although acquiring 
sufficient amounts to generate clinically relevant numbers of MSCs is deemed to be 
problematic due to the volume of blood that would be required (Sotiropoulou et al, 2006). 
Alternatively allogeneic type AB serum, which is a universal donor serum, could be pooled 
to provide sufficiently large quantities for large scale MSC expansion, however it has been 
met with mixed results. Some authors report that allogenic serum-containing medium is able 
to support MSC expansion over long-term culture in a similar fashion to FBS; including not 
altering their immunophenotype (Le Blanc et al, 2004) or differentiation capacity (Poloni et 
al, 2009), whilst others report growth arrest (Kuznetsov et al, 2000) and even cell death 
after the first passage (Shahdadfar et al, 2009). Other sources of allogeneic serum such as 
umbilical cord blood (Jung et al, 2009; Phadnis et al, 2006) and placental (Shafaei et al, 
2011) have also been proposed as alternatives to FBS because, these primitive tissues are 
rich in growth factors that support the proliferation and differentiation of the resident stem 
cell population in fetal blood (Phadnis et al, 2006).  
 
 Human platelet lysate (hPL), which is prepared from the mechanical of chemical lysis 
of their membranes (Tekkatte et al, 2011), provides another growth factor-rich source that 
has been shown to have considerable growth promoting properties and maintenance of 
'stemness' (Doucet et al, 2005; Capelli et al, 2007), however some report that hPL reduced 
the capacity of MSCs to differentiate down the oestoblastic and adipogenic lineage (Gruber 
et al, 2004; Lange et al, 2007), and also reduced their immunosuppressive capacity in vitro 
(Hartmann et al, 2010). Although these alternatives are promising, concerns surrounding 
the safety of the use of human sourced supplements still remain. There is the risk of 
contamination of allogeneic human growth supplements with pathogens that might pass 
undetected via the conventional blood screening of donors (Reinhardt et al, 2011) 
(Reinhardt et al, 2011). Also, these methods do not circumvent batch-to-batch variability 
similar to FBS. 
 
 Serum-free media may offer another alternative to FBS and reduce the problems 
associated with crude materials. By relying exclusively on the use of recombinant proteins, in 
replacement of those supplied by serum, serum-free media allows the precise make-up of 
the medium to be governed. As such, clearly defined medium formulations may be modified 
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in a way to enhance the expression of specific genes to promote an optimal cytokine profile 
for wound healing (Jung et al, 2012). StemPro MSC SFM from Invitrogen is so far the first 
and only commercial serum-free media that has been met with approval by the FDA (2011) 
as a medical device for use in clinical trials in the United States. It is therefore feasible that 
this media could be used in conjunction with the ppAAc carrier to provide a culture and 
delivery system for wound treatments that is safe for the clinic and entirely devoid of animal 
materials. With any change in cell culture medium formulation however, it will be important to 
evaluate how the MSCs respond to ppAAc surfaces under new conditions, because it has 
been shown that media composition can affect a cells' 'preference' for a given surface 
chemistry. For example, Eves et al demonstrated that under standard culture conditions 
melanocytes preferentially attached to ppAAc surfaces. However under serum-free 
conditions, this preference was reversed with the melanocytes favoring attachment to amine-
containing surfaces of plasma polymerised allyamine. In a similar fashion, the authors also 
demonstrated that cell attachment of fibroblasts to acid or amine chemistries was influenced 
by the medium composition. 
 
 Colley et al reported that MSCs can attach equally well to ppAAc coated PDMS 
substrates in the presence or absence of serum (Colley et al, 2009), however the cells used 
in this study had previously been exposed to serum during their initial isolation and 
expansion before being switched to serum-free conditions. Therefore, it is probable that 
serum derived contaminants were carried over into serum-free conditions given the sticky 
nature of serum proteins (Jung et al, 2012). To truly assess the effect serum-free medium 
has on MSCs attachment to ppAAc carriers, it would be necessary to compare cells that had 
been isolated and expanded in both standard vs. serum-free media. This will be the subject 
of future investigations en route to the clinic.      
 
 To adapt the methodology further and enhance its clinical appeal, trypsin, used to 
detach cells from culture for seeding them onto the carriers, may be replaced by 
commercially available alternatives such as Accutase; a mixture of proteyolic and 
collagenolytic enzymes derived from an invertebrate species. In fact, Accutase was favored 
over trypsin by one of the collaborators that contributed to the work in this chapter, because 
it is thought to be a more gentle method of cell detachment (Dr Anita Mistry-personal 
communication, 2010). Accutase was successfully used therefore to detach MSCs and 
prepare them for tubule assays. 
 
 In order for off-the-shelf MSC treatments to become widely available it is important 
that MSCs collected from multiple tissues and donors can be stored in an accredited stem 
cell bank (Cavallo et al, 2011; Sabatino et al, 2012),so that they can be utilised as and when 
treatments are required. For example, it may not always be appropriate to use autologous 
MSCs from elderly patients, whereby both the proportion of MSCs in bone marrow aspirate 
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(BMA) and their proliferative capacity are reduced (Stolzing et al, 2011; Li and Pei 2012). In 
addition it may not be feasible to acquire BMA from patients presenting with extensive burns 
because maintaining bodily fluids is critical; and to perform an invasive procedure upon a 
patient that has suffered extensive trauma is undesirable.   
 
 An important finding in this study was that MSCs could be cultured on the carriers for 
periods up to 72 h whist maintaining their phenotype, viability, and functional capacity to 
form vascular tubules from ECFCs. In addition, cell-transfer to DED following 72 h pre-
culture on the carrier was achieved to similar extents as transfer after 24 h pre-culture on 
the carriers. This was a key finding because this potentially provides a 3-day window, during 
which it may be possible for cells sourced from an accredited stem cell bank to be seeded 
onto the carriers and be transported anywhere in Europe. To this end, it would be useful to 
evaluate if the carriers could support the cells for greater durations so that MSC treatments 
could be provided to patients who live a considerable distance from a licensed cell therapy 
laboratory. In addition, performing vascular tubule assays could form part of the stem cell 
evaluation protocol held at a stem cell bank to assist batch screening, since stem cell quality 
is largely donor dependent (Pandey et al, 2011), and thus enhance their potential to 
promote wound re-vascularization and provide more effective wound healing. 
 
 Other important factors to consider, with the clinic in mind, are the cost of scaling-up 
of production to produce large quantities of ppAAc carriers, and evaluating the long-term 
VWDELOLW\ RU µVKHOI-OLIH¶ RI WKH PDWHULDO :KLWWOH HW DO SUHYLRXVO\ GHPRQVWUDWHG WKDW SS$$F
surfaces could be prepared to be stable for up to 300 days when stored at room 
temperature and protected from light (Whittle et al, 2000). With regards to scale-up, 
although vacuum pressure technology is now widely used in preparing coatings in industry, 
the use of low-pressure plasma polymerisation techniques it is not without its limitations. 
Disadvantages include the high running cost of maintaining vacuums that achieve low 
pressures and the difficulty in developing continuous processing systems (Heyse et al, 
2007). In light of this, there has been considerable interest in developing atmospheric 
pressure non-thermal plasma sources suitable for thin film deposition. Recently a new field 
of technology called atmospheric pressure dielectric barrier discharges (DBDs) has proven 
successful in producing polymer films of acrylic acid (Morent et al, 2009; Morent et al, 
2010); achieving glow discharges and plasma deposits at low pressures makes deposition 
regimes much more cost effective to run because it eliminates the need for expensive 
vacuum equipment. 
Comparison to Other Delivery Methods 	  
 The most common method for delivering of MSCs/ bone marrow mononuclear cells in 
the clinic for the treatment of wounds arising from chronic limb ishecmia, diabetic 
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ulclerations, pressure sores and acute wounds is cell injection sub-cutaneously around the 
wound site, or intramuscularly (for chronic limb ischemia); they are favored because they 
are minimally invasive (Rafii and Lyden 2003; Jiang et al, 2012). Table 3.1 presents a 
summary of the various means by which MSCs have been delivered to treat wounds. Cell 
injections pose several problems however; with the major obstacle being cell viabilities 
obtained are very poor. For example, it is reported that cell viability post injection can be as 
low as 1-32 % (Zhang et al, 2001) and it has recently been identified that it is the 
extensional flow that cells experience, due to the abrupt change in flow geometry which 
causes a dramatic change in velocity (i.e. from syringe to the needle), that is the major 
cause of acute cell death, although this can be much reduced by pre-encapsulating cells in 
alginate hydrogels to mechanically protect cells (Aguado et al, 2012). Therefore, increasing 
the percentage of live cells in the wound environment is critical to the success of cell 
therapies; this is especially important when considering cell delivery to chronic wounds 
because the microenvironments are harsh (hypoxic, inflammatory and display high levels of 
enzymatic activity) (Brem et al, 2007; Lobmann et al, 2005), and may further limit cell 
viability, and a positive correlation has been observed between the number of MSCs 
administered and the healing outcome (Flanga et al, 2007). Also, creating a suspension of 
cells for injection requires further cell manipulation and the use of trypsin, which can be 
potentially damaging to the cells.  
 
 Additionally cell-injection may not be best suited to treat large area skin defects 
because injection of cells around the wound margins will concentrate the cells, initially, at a 
single locality with the only the possibility that the cells will migrate throughout the wound. 
The use of carrier materials similar to those prepared in this study has previously been used 
clinically to deliver autologous keratinocytes to patients with chronic wounds (Moustafa et al, 
2004, 2007). In particular they have also been used to expedite wound healing in patients 
with extensive skin loss from burns injury (Zhu et al, 2005), thus demonstrating the 
materials ability to cover large defects this was achieved by placing several small patches of 
cell containing carriers to over the wound site. Carriers containing MSCs could therefore be 
used to deliver cells across large skin defects.  
 
 Very recently, collaborators in Scharffetter-Kochanek's group in Germany, took the 
delivery method used in this study one stage further and demonstrated that MSCs could be 
successfully delivered from ppAAc carriers in vivo. They demonstrated in a murine diabetic 
mouse model, where healing is impaired, that not only could the MSCs be delivered from 
ppAAc carrier, but that they participated and accelerated the healing of full-thickness 
excisional wounds through the suppression of TNF Į dependent inflammation, increasing 
anti-inflammatory Macrophage M2 numbers, myofibroblast differentiation and granulation 
tissue. In addition, the results on healing were found to be similar to those achieved via 
intradermal injection of MSCs, thus indicating that cell-delivery by ppAAc carriers offers a 
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non-invasive alternative to cell delivery to wound beds (Jiang et al, 2013). They also 
reported similar findings to this study by demonstrating that short-term culture on the ppAAc 
carriers did not affect MSCs functional behavior in vitro (as assessed by 
immunosuppressive assay). Although their experiments were conducted with MSCs derived 
from adipose tissue and not bone marrow, together it shows that the ppAAc carriers can 
support human MSCs from multiple tissue sources. This is advantageous because 
harvesting BM is an invasive procedure. 
 
 Alternatively, MSCs can be delivered from natural materials such as collagen-derived 
matrices (Vojtassak et al, 2006; Ravari et al, 2011), or artificial dermis (Yoshikawa et al, 
2008) for the treatment of non-healing wounds in the clinic, however, for the reasons 
outlined above, it is desirable to avoid the use of xenogenic materials. There are many 
commercially available fibrin sealants (such as Tisseel ® Florseal ® Baxter healthcare; 
Evicel ®, Ethicon (FDA-approved homeostatic aids) that aid topical cell delivery to wounds. 
However these fibrin 'glues' require complex preparation; fibrinogen must be mixed with 
thrombin to produce a bio-polymeric hydrogel matrix that resembles a fibrin clot, and they 
have short working times before the clot sets (Flanga et al, 2007). In addition, the fibrinogen 
concentration can negatively affect cell proliferation both micro-structurally and 
biochemically (Ho et al, 2006), therefore the ratios of thrombin to fibrinogen must be 
carefully balanced so that the gel can be sufficiently cross-linked to entrap cells, whilst 
maintaining a window long enough to allow the glue to be manipulated and spread over the 
wound area before the clotting reaction is complete.  
 
To my knowledge, there are no other cell carriers derived completely from synthetic 
materials used for the delivery of cells to skin. One method that may be promising though is 
cell-sheet technology. For example, Miyahara et al delivered sheets of MSCs to hearts 
following myocardial infraction using poly(N-isopropyl)acryamide (pNIPAM). This 
thermoresponsive polymer is able to undergo a temperature dependent hydrophilic to 
hydrophobic transition to release cells. However, following cell release form the pNIPAM, 
the authors found it necessary to transfer the cells to an elastic-plastic sheet so that the 
sheets could be handled, presumably because they were too difficult to handle due to their 
thin and fragile nature (Miyahara et al, 2006) (Miyahara et al, 2006). The thermoresponsive 
polymer therefore requires more handling on behalf of the cell culture technician than if cells 
are cultured directly on a carrier and then put in place.  Therefore the synthetic ppAAc 
carriers provide a simple, efficient and non-invasive delivery method of MSCs to wounds 
that may be well suited to clinical applications.   
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Table 3.1. Summary of delivery methods for MSCs. 
 
Cell Delivery Method Cell-type Study 
Cell Injection   
Intradermal injection at wound margins BM-MNC (McFarlin et al, 2006; Volk et al, 2007; 
Wu et al, 2007; Kwon et al, 2008; Stoff 
et al, 2009; Borena et al, 2010; Kuo et 
al, 2011; Ravari et al, 2011; Akela et al, 
2012; Castilla et al, 2012)  
 ADSC (Kim et al, 2011b) 
Injection directly into wound bed BM-MNC (Javazon et al, 2007; Sarasua et al, 
2011; Xu et al, 2012) 
 ADCS (Maharlooei et al, 2011) 
Intravenous injection  BM (Fathke et al, 2004; Higashiyama et al, 
2011) 
 BM-MNC (Mansilla et al, 2005) 
 BM-MSC (Li et al, 2006; McFarlin et al, 2006; 
Kwon et al, 2008; Sasaki et al, 2008; 
Wang et al, 2012) 
Intramuscular injection BM-MSC (Lu et al, 2011) 
   
Electrospun Materials   
Chitosan/ Poly(vinyl alcohol) UCB-MSC (Gholipour-Kanani et al, 2012) 
Collagen/ PLGA functionalised with 
CD29 
BM-MSC (Ma et al, 2011) 
   
Collagen-Based Materials   
Collagen gels ADSC (Kim et al, 2007; Lee et al, 2011) 
 BM-MSC (Kim et al, 2011b; Ravari et al, 2011) 
 BM (Ravari et al, 2011) 
Collagen-GAG scaffolds BM-MSC (Liu et al, 2008) 
bFGF-soaked Pelnac ® (dermal 
substitute) 
BM-MSC (Nakagawa et al, 2005) 
Pelnac ® BM-MSC (Yoshikawa et al, 2008) 
 ADSC (Nambu et al, 2007; Nambu et al, 2009) 
Acelluar dermal matrix ADSC (Orbay et al, 2011) 
Gelatin microspheres BM-MSC (Huang et al, 2012) 
Collagen-chitosan scaffold ADSC (Shokrgozar et al, 2012) 
   
Miscellaneous Natural Materials   
Amniotic membrane BM-MSC (Kim et al, 2009) 
Fibrin spray BM-MSC (Falanga et al,  2007) 
Fibrin gel BM-MNC (Mansilla et al, 2005) 
 ADSC (Steinberg et al, 2012) 
Matigel (reduced growth factor)  (Wu et al, 2007) 
Methylcellulose  BM-MSC (Leonardi et al, 2012) 
   
Synthetic Materials   
Polyurethane semi-permeable 
membrane 
BM-MSC  (Argolo Neto et al, 2012) 
Silicone elastomers functionalised with 
plasma polymerised acrylic acid  
ADSC (Jiang et al, 2013) 
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Key 
ADSC= Adipose tissue derived stem cells; BM=- Whole bone marrow aspirate; BM-MNC= 
Bone marrow mononuclear cells; BM-MSCs= Bone marrow mesenchymal stem cells; UCB-
MSCs= Umbilical cord blood derived mesenchymal stem cells¶ 
 
 
3.5. Summary 
 
x Plasma deposited films of acrylic acid (ppAAc) supported the culture of MSCs, and 
facilitated the delivery of MSCs to model wound beds composed from human de-
epithelialised dermis (DED).   
 
x MSCs cultured on the ppAAc carriers for up to 72 h retained their viability, 
phenotype, ability to support vascular tubule formation from endothelial colony 
forming cells. 
 
x MSCs remained viable and proliferated on DED for at least 7 days after delivery 
from ppAAc carriers. However, the basement membrane acted as a barrier to their 
migration. MSCs migration was observed in the presence of keratinocytes.  
 	  
   
Other   
Cells in suspension  BM-MNC (Rasulov et al, 2005) 
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Chapter Four:  
Developing a Wound-Healing Model Based on Human 
Tissue Engineered Skin 
 
4.1. Aim  
 
 The aim of this work was to develop an in vitro wound model, based on tissue-
engineered skin, which could be used to evaluate the healing properties of MSCs in vitro.  
 
4.2. Introduction 
 
 The scratch assay is a widely used method to study factors that affect wound healing 
in vitro. The method involves creating a 'scratch' in a monolayer of keratinocytes and 
capturing images at regular intervals to monitor the rate of scratch closure (Liang et al, 
2007). The scratch created is often referred to as a 'wound', hence the scratch assay in 
sometimes referred to as a wound-healing assay. However the scratch assay is essentially 
a cell migration and proliferation assay rather than a wound-healing assay, since these 
simple models lack epidermis-like structures, 3D cell communications and additional cell 
types.   
 
 So-called 'organotypic' cultures are a better alternative for studying wound healing in 
vitro. They are typically derived from collagen gels, which have been seeded with 
keratinocytes on the superficial side and have fibroblasts embedded within the collagen 
matrix. Cells in these 3-dimensional constructs form a differentiated epidermis, and thus 
they are a more representational model for wound healing (Maas-Szabowski et al, 2000) 
 
Tissue-engineered (TE) skin, on the other hand, can be derived from ex-vivo 
decellularised human skin and isolated primary fibroblast and keratinocytes. These 
constructs hold the advantage of being more physiologically relevant than amorphous 
collagen gels. TE skin closely resembles ex-vivo skin and has been used extensively by our 
laboratory to study, melanoma invasion and bacterial invasion, skin contraction and skin 
pigmentation (Eves et al, 2000; Chakrabarty et al, 2001; Hedley et al, 2002; Harrison et al, 
2006; Thornton et al, 2008; Shepherd et al, 2009; Shepherd et al, 2011).This chapter 
describes how a wound model was developed from TE skin, and details the problems that 
were faced during its development and how they were overcome. 
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4.3. Results 
Attaining Consistent Wound Sizes 
 
Composites, after 5 days at air liquid interface, were initially wounded using a 22-
blade scalpel (Figure 4.1 A). This blade was selected because it is a good general-purpose 
blade that is used in the lab for a variety of applications. Chiefly, it is the blade of choice for 
making smaller cuttings from skin that was obtained from surgery for the purpose of making 
DED. However using this blade proved problematic as far as achieving consistent wound 
lengths were concerned. The 22-blade possessed a curved profile; it is pointed at the tip 
becoming rounded towards the handle. To make an incisional wound in the skin a rocking/ 
seesaw motion was performed by pressing the tip of the blade into the tissue and rolling the 
remainder of the blade across the tissue. However using this method, it was hard to create 
straight wounds with consistent lengths between samples (Figure 4.1 B). 
 
After consulting a surgeon, I was informed that the 22-blade is designed for making 
an initial incision in tissue from which the blade could be dragged to open up a wound. 
Performing a dragging motion of the composite was not practical because the composites 
were too small. Upon surveying the full selection of blades available from Swan-Morton an 
alternative blade was tested. Blade 15A was chosen because it has a flat cutting surface 
(Figure 4.1 C). This blade could be pressed directly into the skin to create a full-thickness 
puncture-type wound through the skin, which resulted in making wounds with a length 
equivalent to that of the blade (9 mm). Upon comparing the wounds produced by each 
blade type, it is clear that those produced from the 15A blade are straighter and their 
lengths are more consistent than that which can be achieved using the 22-blade (Figure 4.1 
B and D). 
 
 
 
Figure 4.1. Producing consistent wounds.	   A) 22-blade. B) Wounds produced in TE skin by 
the 22-blade. C) 15A blade. D) Wounds produced in DED by the 15A blade. Scale bar: 1 mm.	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Optimising Fibrin Clotting 
 
Following wounding, and in accordance with the aim of the work, a suitable delivery 
method was sought to introduce cells into the wound. Injection of cells into the wound was 
not feasible, due to the small area of the tissue pieces and their thinness (< 2 mm), 
additionally cell injection would prove too fiddly because the tissue was difficult to handle. 
The carrier developed in Chapter 3 was not a suitable delivery vehicle in this application 
where incisional wounds are concerned. Cell delivery from ppAAc carriers is suitable for 
larger wounds but not for the small wounds produced in this incisional wound model.     
 
As a result of the coagulation cascade in vivo, fibrin quickly forms a plug at the 
wound site to achieve heamostasis. As such, this naturally occurring material is frequently 
used as a delivery vehicle for cells for the treatment of chronic wounds (Laurens et al, 
2006). Combining a mixture of thrombin with fibrinogen could make an artificial fibrin clot. 
Fibrinogen is a peptide that can be cleaved via the enzyme thrombin so that the fibrinogen 
fragments can become cross-linked to form a mesh/network structure to entrap cells. Firstly, 
it was important to establish the amount of thrombin to add to the fibrinogen that allowed the 
clots to form over a reasonable window of time. The concentrations of fibrinogen and 
thrombin were fixed at 6 mg/ml and 25 IU respectively and a range of volumes of thrombin 
was added to bijous containing 1 ml of fibrinogen. Secondly, following mixing of the two 
components together, the clotting time was monitored to identify the volume of thrombin that 
was sufficieQWWRSURGXFHDVROLGFORWZLWKLQDµZRUNDEOH¶WLPHLHLWZDVQRWGHVLUDEOHIRUWKH
clot to set so rapidly that the solution could not be pipetted from the bijou to the tissue, and 
equally it was important that the clot was able to set after a few minutes so that cells 
contained within the fibrin were fixed promptly to the wound site. The optimal volume of 
WKURPELQWRDGGWRWKHILEULQRJHQZDVIRXQGWREHȝO (final concentration = 10 IU) and this 
produced a solidified clot in less than 5 min (Figure 4.2).  
 
 
 
Figure 4.2. Fibrin clot. A) 1 ml of fibrinogen (6 mg/ml) was added to 20 ȝl of thrombin (25 
IU). Fibrin part way through the clotting reaction. B) Fibrin clot once set. The bijou has been 
inverted to demonstrate that the fibrin has a glue-like quality. 
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Minimisng Wound Leakage 
 
After optimising the fibrinogen and thrombin concentration and volume that 
produced a fibrin clot over an appropriate time, a fibrin clot was introduced into the wound 
site. Wounds were made in DED initially using the 15A blade as previously described. 
Thrombin was added to fibrinogen and mixed, and the mixture was dispensed from a pipette 
in to the center of the wound cavity. Leakage of fibrin, before it set, from the base of the 
wound was problematic. Leakages of this sort had to be prevented if cells were to be 
introduced in fibrin to the wound site, because leakages would substantially reduce the 
number of cells that could be retained in the wound. Additionally if leakage rates, or 
amounts from the composites differed between samples, it would likely lead to differing 
results in wound-healing outcomes due to differences in the number of cells that remained 
in the wound cavities. 
 
Because fibrin glue is a sealant, its usefulness in preventing leakages from wounds 
was tested. DED was wounded through the papillary surface and then was turned over to 
reveal the reticular dermis. Fibrin glue was then pipetted over the reticular surface of the 
dermis and once it had set the DED was flipped back over. Forceps were used to push the 
margins of the wound wider apart than would be used in an experiment, for the purpose of 
creating an over-sized cavity to test fluid retention. Cell culture medium was then pipetted 
into the wound cavity. No medium was found to have leaked from the tissue after 30 min 
(Figure 4.3). Therefore this method was successful at preventing leakages.   
 
  
 
Figure 4.3. Containing liquid to the wound site. A) Underside of a piece of DED that has 
been sealed with fibrin after making an incisional wound. B) Same piece flipped back over. 
C) Wound cavity 30 min after filling with cell culture medium. 
 
Consistency in Wound Diameter 
 
The second issue to address in creating consistently sized wounds was wound 
diameter. After wounding either composites or DED, due to the elastic nature of skin, the 
wound edges would naturally lie in close proximity to each other. As such if they were left 
untouched, the wounds would heal too fast to measure after the introduction of fibrin; this 
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observation was previously reported by a former PhD student within the group (C.M.D. 
Marques, 2011). Therefore the wound edges needed to be prised apart slightly to create a 
more difficult wound to heal. 
 
0\ RULJLQDO LGHD ZDV WR DGG VRPH VRUW RI µGLYLGHU¶ WR WKH ZRXQG WKDW D VKRUW
fragment of inert material might be placed in the wound to make it wider, so that when the 
fibrin is introduced the gap is maintained. This was decided against because the shard 
would remain in the wound after the fibrin had set and might prevent the course of healing 
at its point of introduction. 
 
The second idea that was tried was to use a compass. As a compass contains two 
pins that could be set a defined distance apart, it could be used to separate the edges of the 
wound a set amount whilst the fibrin glue is introduced into the wound. To start with the 
compass was set to its narrowest position i.e. the two pins were as close together as the 
instrument would allow, and the pins were inserted into the wound with each pin touching 
opposing sides to widen the wound a fixed amount (Figure 4.4). However this approach was 
discarded because the narrowest distance the compass could be set (3 mm) created 
wounds that were too wide. 
 
 
 
Figure 4.4. Attempt to create a defined wound diameter. A) and B) Compass gross and 
close-up view. C) and D) Representative images of the wound cavities created in DED.  
  
 
A third option was to try and bend a strip of dental wire into a two-pronged fork, and 
use the two edges of the fork to separate the wound edges a defined distance from each 
other. However manipulating the wire so finely proved too difficult to reproduce. 
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In the end a different approach was opted for. By compressing the tips of forceps 
together and placing each fork of the forceps on opposite sides of the wound, the pressure 
from the forceps could be released just enough to reopen the wound gap (this distance was 
approximately 0.6-7 mm in diameter- as seen by OCT in Chapter 5). Fibrin could then be 
added. This method was sufficient to provide consistency in wound diameter as 
demonstrated by Figure 4.5.   
 
 
 
Figure 4.5. Consistently-sized wounds. A)-C) series of wounds by the above method. 
Briefly, Full thickness wounds were created in TE skin, after 5 days at ALI, using a 15A 
scalpel blade and 100 ȝm of fibrin glue was inserted into the wound cavity.   
 
Introducing Cells to the Wound 
 
To test whether cells could be encapsulated into a fibrin clot and delivered into the 
wound cavity, human dermal fibroblasts (HDFs) were tested before delivery of MSCs was 
attempted. This was done because the former cells are plentiful and inexpensive compared 
to MSCs. Cells were trypsinised, and the cell volume containing 1 x 105 cells were extracted 
and placed into a tube containing PBS. The cells were centrifuged for a second time and the 
cells were resuspended in fibrinogen after discarding the supernatant. The additional step of 
adding the cells to PBS before adding them to fibrinogen was performed to wash the cells of 
medium, because clotting factors within the medium, if not removed by adequate washing, 
caused the fibrinogen to gelate prematurely. Wounds were then made in composites that 
had been at ALI (for 5 days, and thrombin was added to the fibrinogen containing the 
desired quantity of cells and mixed by gentle pipetting. This caused the clotting reaction to 
begin and the solution was added to the wound site. Histology revealed that both HDFs and 
MSCs could be successfully delivered to the wound site in fibrin; cells could be clearly seen 
at the wound site contained within the fibrin clot (Figure 4.6). Furthermore, evaluation of 
wounds after 14 days demonstrated that fibrin was necessary for wound healing to occur; in 
the absence of fibrin, the wounds failed to heal (Figure 4.7). 
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Figure 4.6. Introducing cells at the wound site. A) - C) light micrographs showing MSCs 
which have been introduced into the wound via a fibrin clot, at x 4, x 10, x 40 magnification 
respectivelyZLWKVFDOHEDUVRIȝPȝPDQGȝPUHVSHFWLYHO\. 
 
 
 
 
 
Figure 4.7. Histology of wounded composites after 14 days. A) TE skin without an incisional 
wound. B) Wounded TE skin without a fibrin clot. C) Wounded TE skin plus a fibrin clot. D) 
Wounded TE skin plus fibrin containing fibroblasts. (x 10 magnification, scale bars: ȝP 
).   
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MSC Compatibility with Greens Medium 
 
*UHHQ¶VPHGLum is used to support the growth and maturation of TE skin. However 
if MSCs are to be introduced into the wound model, it is essential to test if this medium is 
capable of supporting these cells because this medium is not their standard growth medium. 
MSCs ZHUH FXOWXUHG LQ HLWKHU WKHLU VWDQGDUGPHGLXP 06&%0 RU*UHHQ¶VPHGLXP IRU 
days, and photographs of the cultures were taken every few days to record if there were any 
visible proliferative or morphological changes between the MSCs cultured under each 
condition. At day 7 an MTT assay was performed to determine if there were differences in 
cell viabilities between culture conditions.  
 
MSCs cultured in MSCBM appeared to have a more spindle-like appearance 
FRPSDUHG WR*UHHQ¶VPHGLXPZKHUH WKHFHOOVSUHVHQWHGDPRUHVSUHDGPRUSKRORJ\ WKLV
difference was more pronounced at day 7 (Figure 4.8 A). There also appeared to be more 
cells per field of view in the MSCBM medium suggesting that this medium was more 
supportive of MSC proliferation, however the MTT data did not confirm this (Figure 4.8 B). 
The results of the MTT assay showed that there was no statistically significant difference in 
cell viability between the cells in the two different media (p= 0.248). Therefore MSCs can 
VXUYLYHZHOOLQ*UHHQ¶VPHGLXP 
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Figure 4.8. 06&FRPSDWLELOLW\ZLWK*UHHQ¶VPHGLXP$0RUSKRORJ\RI%0-MSCs over the 
course of 7 days cultured in either Greens Medium or MSCBM Medium (scale bars: 100 
ȝP. B) Cell viability via MTT expressed as % cell viability normalised to the control medium 
(MSCBM). Error bars represent SEM +/- (N=3, n=3).  	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4.4. Discussion 
  
The aim of this work was to devise a wound-healing model based on tissue-
engineered skin, for the purpose of evaluating the effect MSCs might have on the healing of 
in vitro wounds. The validity of the model developed in this chapter will be discussed.  
The Importance of Fibrin 
 
In the wound environment, fibrinogen is converted to fibrin, as a result of the 
coagulation cascade, to form an important provisional extracellular matrix for wound 
healing. Cells that contribute to wound healing (dermal fibroblasts, endothelial cells) are 
able to migrate into and degrade/remodel the fibrin and deposit neo-collagen to restore 
structural integrity to the skin (Laurens et al, 2006). TE skin has no blood supply therefore 
upon wounding of the TE composites there is no clotting cascade. Thus, to create a more 
realistic model of wound healing in TE skin, it was necessary to introduce a fibrin clot to the 
wound to better represent the wound environment.  
 
An artificial fibrin clot was made by combining thrombin with fibrinogen; fibrinogen is 
a soluble peptide that can be cleaved by the enzyme thrombin into fibrin monomers which 
then cross-link with one another forming a network of insoluble fibrin polymers (Weisel et al, 
1993). Additionally, fibrin served as a way to introduce cells into the wound site. Fibrin for 
H[DPSOHKDVSUHYLRXVO\EHHQUHSRUWHGDVDQµLGHDO¶GHOivery vehicle for cells to treat chronic 
wounds (Ravari et al, 2011). Other delivery methods such as injection of cells into the 
wound was not feasible, due to the small area of the tissue cuttings and their thinness (< 2 
mm), and cell injection would be too fiddly (the tissue would prove too difficult to handle). 
The carrier developed in Chapter 3 was not a suitable delivery vehicle in this application 
where incisional wounds were made. The carrier is suitable for the much larger wounds 
found in the clinic.  
 
It is also important to mention that fibrin provides more than a provisional matrix; it 
mediates cell responses such as cell adhesion, migration, proliferation and tubule formation 
from the participating cells in wound healing (Koolwijk et al, 1996; Staton et al, 2003; Becker 
et al, 2004; Cox et al, 2004). Therefore, when it comes to designing an experiment to test 
the efficacy of a wound healing intervention such as MSCs, using the model developed 
herein, it will be important to assess the effect fibrin alone may have on wound healing as a 
control. Fibrin for example was shown to be essential for wound healing in the TE skin 
model because wounds failed to heal within 14 days in the absence of fibrin.  
 
Wound Consistency 
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Achieving consistency in wound length and diameter was of obvious importance 
because, if there were differences in the sizes of the wounds between samples, it would 
firstly make evaluating the effect of MSCs within the wound difficult, and secondly it would 
hinder the reproducibility of the results. For example, MSCs introduced into the wound may 
have had a positive influence on the cells involved in wound healing, however an overall 
difference in the wound healing outcome may be masked, due to variations in wound 
severity between experimental conditions. Without a consistent wound size it would be very 
GLIILFXOWWRDVVHVVWKHZRXQGPRGHO¶VUHVSRQVHWR06&V 
 
The wound-healing model presented here is based on an existing model developed 
by a former student of Prof S. MacNeil. Claudia Marques' PhD thesis described a method 
for creating wounds in TE skin (Marques 2010), however I have made improvements upon 
her method to achieve greater consistency in wound size. For example, it is likely that Dr 
Marques experienced similar problems to me in that, due to the rocking action one had to 
perform to attain a full-thickness wound while using a rounded profile 22-blade, wound 
lengths could vary between samples; this difficulty was removed by opting for a 15A-blade 
which is a flatter blade. In addition, I added the extra step of sealing the underside of the 
dermis with fibrin glue before introducing cells into the wound. Therefore when cells 
encapsulated within fibrin were introduced into the wound cavity, no losses of cell volume 
were recorded. The issue of minimising leakage was important to address because 
leakages would reduce the number of cells retained in the wound and thus diminish their 
potential to ameliorate healing. Additionally, if leakage rates from the composites differed 
between samples, it would likely lead to differing results due to differences in the number of 
cells that remained in the wound cavities.  
 
Suitability of the Method for use with MSCs 
 
 MSCs could be effectively entrapped and delivered to the wound site in fibrin glue. 
Although a viability study was not performed to determine if fibrin had a negative effect on 
MSC viability, and functional capacity for differentiation, other authors have previously 
reported fibrin not to negatively affect these properties (Catelas et al, 2006; Neuss et al, 
2010; Colley et al, 2012). Indeed, Colley et al recently reported that MSCs expanded on 
fibrin substrates maintained their stem-cell like properties, thus indicating that fibrin 
substrates may more closely mimic the cells in vivo physiological microenvironment i.e. 
stem cell niche (Colley at al, 2012).  
 
 Since MSCs can home to sites of injury (Hong et al, 2012), it may have been 
important to assess if the MSCs were capable of migrating out from fibrin clots, to establish 
if the fibrin may prevent their relocation to the wider wound. Neuss et al demonstrated the 
fibrinolytic potential of MSCs to degrade fibrin clots, derived from a fibrinogen concentration 
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more than twice that which was used here (6 mg/ml vs. 20 mg/ml), within 24 h. The authors 
also reported that MSCs encapsulated in fibrin expressed both plasminogen activators (uPA 
and tPA) (Deng et al, 1996) and inhibitors (PAI) (Wei et al, 2001); plasminogen is a 
precursor to plasmin, which cleaves fibrin. Thus, they suggest MSCs exhibit control over 
fibrinolysis in an autocrine/paracrine manner (Neuss et al, 2011). Therefore, it is likely that 
the MSCs could behave similarly in the wound model and produce factors to facilitate their 
migration to the wider wound through self-regulation of fibrinolysis.  
 
 The finding that MSCs remained were found to remain viable in Green¶s medium was 
important because this medium is exclusively used to support the growth and differentiation 
of the keratinocytes in the TE skin, therefore MSCs must be able to tolerate the medium 
RQFHDWWKHZRXQGVLWH*UHHQ¶VPHGLXPLVVXSSOHPHQWHGZLWh additional compounds such 
as adenine, insulin, T3/transferrin, hydrocortisone, EGF and cholera toxin, which are absent 
from standard MSC media. These factors could have affected MSC viability, which in turn 
would affect the outcome of a wound healing study because MSCs exert their therapeutic 
benefit in a dose-dependent manner (Falanga et al, 2007). Although at the time of writing 
there are no reports in the literature concerning the effects of Green's medium upon MSCs 
to compare the results presented with here, there are data relating to the effects of some of 
the components of Green's medium on MSCs. For example, hydrocortisone is an essential 
steroid for enhancing MSC differentiation to endothelial cells (Gang et al, 2006), adipose 
(Oishi et al, 2009) and neuronal cells (Mareschi et al, 2006) in their respective inductive 
media, and EGF has been used as a supplement to support MSC proliferation in serum free 
medium (Chieregato et al, 2011). In addition, Meuller et al recently found that insulin could 
promote chondrogenesis in MSCs (0OOHU et al, 2012) at similar concentrations to that of 
*UHHQ
V PHGLXP  ȝJPO +RZHYHU DIWHU WDNLQJ LQWR FRQVLGHUDWLRQ WKDW VRPH RI WKH
additives common to Green's medium can be used in inductive media, it is unlikely that 
Green's medium would have exerted differentiate effects on the MSCs because each 
supplement alone is not capable of promoting differentiation; they must to be used in 
combination with many other supplements that are not present in Green's medium. For 
example, to achieve chondrogenic differentiation of MSCs using insulin, it is necessary to 
provide adequate concentrations of ascorbate 2-phosphate, dexamethasone and TGF-ȕLQ
the inductive medium (Meuller et al, 2012). Taken together, Green¶s medium can be used to 
support the TE skin composites after introduction of MSCs to the wound site. 
 
Considering Alternative Methods to Create Wounds in TE Skin 
 
 Ferraq et al recently stated: ''Wound-healing studies mainly rely on mechanical 
methods for wound induction which are difficult to standardise'' (Ferraq et al, 2007). With 
this in mind, the authors set out to investigate the potential of a laser-based method to 
create skin wounds with more control. Erbium: Yttrium-Aluminium-Garnet (Er:YAG) lasers 
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are capable of progressively ablating tissue a few microns at a time, without causing 
extensive photo-thermal induced damage; light energy (2940 nm) is selectively absorbed by 
water molecules which creates steam that generates an internal pressure enough to cause 
inorganic materials to explosively destruct before their melting points are reached (Hibst 
1992; Sasaki et al, 2002). This so-called 'microexplosion' theory accounts for the effects of 
Er:YAG ablation besides thermal effects alone i.e. burning tissue. Le et al demonstrated that 
a relationship exists between the pulse energy of the laser and ablation depth in a murine 
model (Lee et al, 2001). Other authors have shown that the entire epidermis can be 
removed by exposing skin to just three pulses of light with a fluence (energy/ unit area) of 5 
J/cm2 (Alster 1999; Drnovsek-Olup et al, 2004). By modulating the beam energy of the 
Er:YAG laser, Ferraq et al were able to create wounds in ex vivo skin to varying depths, up 
WRDPHDQPD[LPXPGHSWKRIȝP (Ferraq et al, 2007) Tissue, for example, could be 
removed from the following layers: the stratum corneum, epidermis/papillary dermis and 
reticular dermis using fluences of 10, 50 and 200 J/cm2 respectively. Although at the time of 
writing there are no reports where lasers have been used to create full thickness wounds in 
skin, it is possible nonetheless since Er:YAG lasers have been used to make complete 
defects in the calvarial bones of mice(Cloutier et al, 2010). Ferraq et al later found that 
Er:YAG lasers were able to create skin wounds in vivo with a more uniform depth and a less 
variable size than those created via suction blister methods, as evaluated by OCT; they also 
reported the wound healing rates to be similar between the two methods (Ferraq et al, 
2012).  
 
 The chief advantage of this method over the one developed here, is that one can 
generate wounds with precise dimensions very consistently. The laser for instance can be 
incorporated into a beam scanner so that the ablation of a defined area of the skin can be 
automated (Ferraq et al, 2012). Therefore this eliminates user-dependent variation, whereas 
the technique employed here, despite yielding consistent wound depth and lengths, requires 
skill and judgment from the researcher that only comes through careful practice. In addition, 
by using a scalpel, one can only produce full-thickness wounds, whereas wounds of varying 
depths can be produced from the laser as a function of fluence (Ferraq et al, 2007).  
 
 The main disadvantage of laser-based methods is the prohibitive cost of acquiring 
such specialist equipment; they can cost between £33,000 to £53,000 (according to 
emedicine.medscape.com). Additionally, although Er:YAG lasers are capable of creating 
wounds, the nature of the wound is very different from an incisional wound. For instance, 
laser ablation inevitably causes some thermal damage to the tissue, although it is very 
limited. Boppart et al observed that concentric rings of thermal injury were present around 
the site of ablation in a variety of tissues, regardless of the depth the laser penetrated, and 
suggested that the damage corresponded to the radial distribution of thermal energy 
(Boppart et al, 1999). Therefore, Er:YAG-created wounds are comparative to excisional 
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wounds, with concomitant lateral thermal injury. Whereas with the scalpel method presented 
here, no volume of tissue is removed; only the skin's structural integrity was compromised. 
This is an important distinction to note since the type of wound affects the healing response 
of the tissue (Monsaingeon and Molimard 1976). Burn wounds for example result in more 
extensive cell losses and necrosis, leading to scar formation, compared to those created via 
incision; thus this damage complicates the process of repair (Winter 1995). These 
observations were confirmed by Drapper et al after they reported consistently slower re-
epithelialisation of laser-induced full-thickness wounds in murine skin compared to those 
which received excisional wounds (Draper et al, 2002). Since wound healing of TE skin 
happens slowly over periods of up to 14 days, and TE skin is usually only cultured in vitro 
for a maximum of 28 days under static flow conditions, it is important that the method of 
wounding can yield healing on a timescale compatible with the 'life' of the TE skin. Thus, 
incisional wounding is still the most appropriate method to wound the TE skin to study 
wound healing. 
4.5. Summary 
 
x TE skin can be used as an incisional wound model.  
 
x Wound sizes could be kept consistent through appropriate blade selection.  
 
x Fibrin was able to introduce MSCs into the wound, and cell loss from the wound 
cavity was minimised by sealing the base of the wound with fibrin. 
 
x Wounds healed after 14 days and the presence of fibrin was required for wound 
healing.   
 
x 06&VUHPDLQHGYLDEOHLQ*UHHQ¶VPHGLXP 
 
x The wound model was taken forward to investigate the effects of MSCs upon 
healing in the model. 
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Chapter Five:  
Using Optical Coherence Tomography to Non-
Invasively Image Wound Models 
 
5.1. Aim 
 
The aim of this work was firstly; to develop a method by which optical coherence 
tomography could be applied to non-invasively image wounds created in tissue-engineered 
skin in a consistent manner, and secondly; to develop a method of sampling wounds and 
determine their areas.   
 
5.2. Introduction 
  
 There has always been a need to non-invasively image tissue especially when it 
comes to conducting experiments based on evaluating wound healing. In vitro for example, 
histology is the chief means by which healing can be evaluated, however it is not the most 
desirable method because performing a biopsy causes further trauma to the wound thus 
compounding wound healing. Furthermore tissue processing is time-consuming and may 
give rise to artifacts that can cloud microscopic evaluation. If histology is undertaken to 
assess an in vitro wound model, the sample is effectively 'sacrificed' and it is removed from 
the experiment. This therefore requires large numbers of samples to be used to examine 
tissues, particularly as they respond to injury in a time-dependent fashion.    
 
 In contrast, non-invasive imaging permits the evaluation of the same area of tissue 
over time. In vivo reflectance confocal microscopy has been applied to study wound healing 
in real-time with near-histological resolution, without the need to introduce fluorophores into 
the tissue, by detecting reflected light from endogenous chromophores. However, this 
technique is limited to acquiring en face (parallel to the surface) from the first few hundred 
microns into tissues, thus allowing epidermal evaluation only (Sugata et al, 2008; Terhorst 
et al, 2011). Alternatively non-linear confocal microscopy can be applied to image deeper 
into tissues and observe collagen fibre formation within a wound-bed via second harmonic 
generation (Zhou et al, 2010).  Ultrasound can image much deeper into tissue, however its 
use in imaging skin tissue is limited due to its poor axial resolution, and fine structural 
features of the skin, such as the epidermis, cannot be observed (Norisugi et al, 2011).  
 
 Optical coherence tomography (OCT) is a relatively new platform, which bridges the 
gap between confocal microscopy and ultrasound in terms of axial resolution and imaging 
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depth. OCT can produce real-time depth-resolved 2D cross-sectional images, from up to 3 
mm into tissues, in a non-invasive manner (Zysk et al, 2007). In OCT, near infrared light is 
directed into tissue, and light which is backscattered from the tissue is computationally 
processed to produce a grey-scale, cross-sectional, tissue map. In this respect, because 
OCT produces depth-resolved images, it is often described as the 'optical analogue' of 
ultrasound (Marcshall et al, 2011). OCT systems can generate images with axial resolutions 
of 1- ȝm, which is up to two orders of magnitude greater than can be achieved via 
conventional ultrasound, and lateral UHVROXWLRQVLQWKHRUGHURIȝm (Povazay et al, 2002; 
Drexler 2004).  As such, 'optical biopsies' of skin can be provided from OCT with good 
correspondence to histology; structures such as the stratum corneum, epidermis and dermis 
can all be clearly differentiated. Thus, OCT is becoming increasingly used in the field of 
dermatology (Gambichler et al, 2011) and for the evaluation of wound healing (Wang et al, 
2008; Barui et al, 2011; Ferraq et al, 2012). In this study Swept-Source OCT (SS-OCT) was 
used to provide non-invasive tissue assessments of wound models constructed from TE 
skin. 
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5.3. Results 
Structural Features of Skin as Observed by OCT 
 
 The ability of OCT to non-invasively image TE skin and identify its structural features 
was investigated. Figure 5.1 demonstrates that OCT is capable of imaging to a depth of 0.7 
mm into the tissue and structures such as the epithelium can clearly be differentiated from 
the underlying connective tissue; in addition OCT can reveal some topographical details. 
The epithelium can be identified as a band comprising two layers of signals that differ in 
intensity and morphology. The uppermost layer is high in pixel intensity and presents as 
bright strip in the image. This is most likely due to the higher reflective, or greater scattering, 
properties of the densely organised keratin of the stratum corneum. The greater the 
scattering from a tissue region, the brighter the pixels from that region are portrayed. Below 
the keratinized layer lies a band that has a faintly distinguishable wave-like appearance, 
which is similar in appearance to the rete ridges that can be identified by histology. This 
region is also composed from pixels that are sparser and of lesser intensity than the 
superseding layer. Taken together, this region most likely represents the area in which the 
proliferative epidermal keratinocytes reside. Collectively, these two distinct bands mark the 
region of the epidermis, which constitutes 200-ȝPRI WKH RYHUDOO GHSWK RI WKH LPDJH
which is almost one third of the total depth the OCT apparatus is able to image. This 
thickness of the epidermis determined by OCT is similar to that which is observed by 
histology. Below the epidermis, the pixel intensity becomes higher again; this junction 
describes the epidermal/dermal junction (DEJ) below which lies the dermis. The dermis is 
comprised of connective tissue, mainly collagens, and because the pixels pertaining to this 
area are higher in intensity than the overlying epithelium, this suggests that the connective 
tissue is able to scatter and/or reflect more light than the adjacent epithelium.  
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Figure 5.1. Comparison of OCT to histology of TE skin. TE skin was maintained at air-liquid 
interface for 7 days and imaged by OCT A) and by light micrograph following histology B) 
(scale bars: 1 mm). The depth to which OCT can visualise is marked on the histological 
section as a dotted line for comparison.  
 
Imaging the Wound Model 
 
Performing OCT on the wound model demonstrated that it was capable of clearly 
identifying the wound cavity and the presence of the fibrin clot within it (Figure 5.2). Figure 
5.2 however, is only a single slice through the tissue. One of the advantages of OCT is that, 
by moving the sample through the path of the imaging laser, multiple optical sections from 
the tissue can be acquired, which can provide visual information from a wide area of the 
tissue. 
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Figure 5.2. Wounded TE skin as seen by OCT. The fibrin clot can be seen within the v-
shaped wound cavity (scale bar: 1 mm).  
 
Consistency in Imaging  
 
One of the main challenges in using the OCT system to image TE skin wound 
models over time, was ensuring that the wound area was adequately sampled, and that the 
same area was imaged each time. To address the issue of consistency, it was decided that 
a reference point needed to be marked on the surface of each sample from which the laser 
could be aligned before imaging commenced. However, because the laser was in the near 
infrared (NIR) part of the spectrum of light, the laser was invisible to the naked eye. The 
only way therefore to determine the position of the laser was to place a photosensitive card 
(Figure 5.3) underneath the lens, however the card obscured the sample. The solution to 
WKLVSUREOHPZDVWRLQVWDOODYLVLEOHUHGµDLPLQJ¶ODVHULQWRWKHVDPHRSWLFDOSDWKDVWKH,5
OCT light-source. This way the visible laser could be aligned with a reference point on the 
sample by manually positioning the sample on the stage, until the aiming laser was at the 
center of the reference point.  
 
 As for the reference point itself, it had to be a marking that did not move or fade away 
over the course of a 14-day experiment. Initially the idea was to stick a small pin in the 
surface of the composite, however this was decided against because this would cause 
further trauma to the composite. DED was used to try to find the best way to mark the skin. 
A dot of permanent ink from a marker pen was made on the surface of the DED, however 
the dot of ink that could be placed became diffuse due to the surface of the DED being 
moist. However because TE skin has a water-repellent keratinised epithelium, it could be 
successfully marked. In addition, this method of marking the skin was thought to be non-
toxic to the composites due to the barrier action of their cornfield layer. Dark markers such 
as blue, black or green provided the best contrast against the red imaging laser and allowed 
the laser to be easily pin-pointed to the center of the reference point, which was placed 
adjacent to one edge of the wound margin at the head of the wound (Figure 5.4).   
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Figure 5.3. IR detector card. The photosensitive region of the card was placed under the IR 
ODVHU DQGHQHUJ\DEVRUEHGDW WKH ODVHU¶V IRFDO SRLQW VWLPXODWHGYLVLEOH UHG IOXRUHVFHQFH
from the region of the card where the beam was aimed.    
 
Sampling the Wound 
 
Next, the most appropriate way to sample the wound was determined. It was 
necessary to acquire images from the full length of the wound (10 mm) starting at the 
reference point, so that the widest portion of the wound was captured every time a wound 
sample was imaged. This was important because it was only from corresponding regions, 
within a sample imaged at different experimental time points, that measurements of wound 
volume could be made and compared for the purpose of evaluating wound healing.  
 
To start with, samples placed on the stage under the lens were manually moved a 
fixed lateral distance (0.01 mm) by turning a dial, so that an image could be captured and 
then the stage moved from the reference point (a fixed amount) before another one was 
taken. For a wound 1 mm in length, one could take up to 100 images manually. This method 
was very time consuming, especially with multiple samples, and as needs progressed, an 
automated motorised stage (ThorLabs, PT1-Z8) was introduced into the imaging apparatus. 
7KHPRWRULVHGVWDJHZDVFDSDEOHRIPRYLQJDQ\LQFUHPHQWIURPȝPWRFPDQGKDGD 
maximal linear travel of 25 mm (Figure 5.4). Therefore the stage could make up to 1000 
incremental movements over a 1 cm distance allowing for an equal number of images to be 
captured; an image could be acquired in between each movement of the stage. However in 
practice such a high level of sampling was neither possible nor practical. Firstly, the 
computer had insufficient memory to achieve this, therefore sampling volumes had to lie 
within the capabilities of the computer. Secondly, it would take a great deal of time to 
acquire such a quantity of images; OCT imaging itself is very rapid and images can be 
produced in a fraction of a second (A scan rate, 10,000 Hz), however the time it takes for 
the stage to move before each image can be captured was a rate-limiting factor.  
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Figure 5.4. OCT set-up. A) Photograph of a TE skin wound model resting on the motorized 
stage below the lens. The arrow indicates the direction the stage moved during image 
series acquisition. B) A close-up of the wound model. The green dot present at the wound 
edge is the reference point for the aiming laser. The red dotted arrow indicates the direction 
the sample moved relative to the imaging laser when the stage was moved. C) OCT images 
produced at points along the wound from the reference point; image 1 was taken closest to 
the reference point, and image 3 the furthest way from the reference point (scale bars: 1 
mm). 
 
 
Averaging was a parameter that was taken into consideration when deciding the 
best way to sample the wound. Averaging was a method that was used to 'clean-up' the 
image by reducing the amount of noise that was present in an image. A given section of 
skin could be imaged a set number of times (defined as the averaging factor), and the 
average pixel intensities from the image series could then be calculated and displayed. The 
maximum averaging factor that could be achieved by the system was 5. An averaging factor 
of 3 was used to acquire wound images because it provided a good compromise between 
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image quality and time (Figure 5.5). Again, it was not the increase in the amount of images 
taken of a given sample of skin that was a limiting factor, because of the rapidity with which 
OCT can image, but rather, the lag-time it takes for the computer to do the processing 
required to produce an image resulting from averaging.  
 
)LQDOO\ DFTXLULQJ  VOLFHV LPDJHV VSDFHG  ȝP DSDUW FDSWXUHG ZLWK DQ
averaging factor of 3 was settled on as the optimum sampling, because it provided a 
sufficient volume of images to be able to detect small changes in wound morphology 
between slices, and the imaging could be completed in a reasonable time scale. To image a 
sample took approximately 7 min, and in an experiment a minimum of three samples would 
be required to be imaged/ experimental condition, therefore this could take 21 min (3 
samples x 7 min); it was not desirable to have the wound models out of the incubator for 
longer than 30 min. 
 
 
 
Figure 5.5. The effect of image averaging. A) base-line image obtained from TE skin 
following wounding (Averaging factor 1). B) an OCT image of the area in A) acquired with 
an averaging of 5. The resulting image has an improved quality in terms of having a 
UHGXFHGOHYHORIµVSHFNOH¶SDUWLFXODUO\LQWKHGDUNHUUHJLRQVRIWKHLPDJH    
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Measuring the Wound 
Selecting the Widest Portion of the Wound 
 
 The most complete way to evaluate how wounds were healing would be to measure 
the total volume the wound occupied and monitor how the wound volume changes over 
time. This could be achieved by measuring the wound volume presented in each individual 
slice and adding the volume from each slice together, however this was not done for 
practical reasons. Since there was no way to automate image processing, each image had 
to be measured manually. For example, if 100 images were acquired at each time point 
over the course of healing (of which there were five) and there were three samples for three 
different experimental conditions (100 x 3 x 3 x 5 = 4500), one would have to manually 
measure over 4000 frames for the whole experiment which would be too time consuming.  
 
 Therefore it was decided to identify and compare the 'widest portion' of the wound 
that presented between time-points for any given sample (Figure 3.7), to quantify wound 
healing. To identify the 'widest portion', a montage was created in image J from a selection 
of images captured along the length of the wound, and the image that appeared by eye to 
contain the largest wound area was identified. Once identified, 10 additional images, 5 
earlier and 5 later in the sequence were also selected (Figure 3.6). These 11 images 
spanning D FRPELQHG GLVWDQFH RI  ȝP WKURXJK WKH ZRXQG  RI WKH WRWDO ZRXQG
length), could have their volumes measured. 
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Figure 5.6. Selecting the Widest Portion of the Wound. A montage was created in image J 
from series of images collected from performing OCT on a wound model. The numbers 
indicate the position each image was taken from the reference point. Image 53 in the yellow 
box shows the image in the series that hold the largest wound area. The images with the 
UHG RU EOXH ERUGHUV ZHUH DOVR VHOHFWHG &ROOHFWLYHO\ WKHVH LPDJHV KLJKOLJKW WKH µZLGHVW
SRUWLRQ¶RIWKHZRXQGDQGZRXQGDUHDPHDVXUHVZHUHWDNHQIURPWKLVUHJLRQRIWKHVDPSOH
This method was repeated for each sample and the areas were compared. 
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Achieving consistency in identifying the widest portion of the wound between 
time points 
 
In order to achieve consistency in measuring the change in wound volume in a 
sample over time, it was important to ensure that the identical region of the wound was 
identified at each time point so that a direct comparison could be made. Morphological 
features that were clearly distinguishable and common to all the imaging sequences, 
gathered from a sample at different experimental time points, were used as internal 
reference points (Figure 5.7). These internal reference points allowed corresponding 
sections of the wound to be compared as time progressed.  
  
For example, in Figure 5.7 the internal reference point identified at day one 
(indicated by the yellow arrow) was located 138 slices (6.85 mm) from the starting point 
(external marker), whereas the corresponding point could be found at slice 136 (6.75 mm) 
from the starting point at day 3. Therefore the starting points were different by 0.1 mm due 
to human error in aligning the aiming laser with the external marker on the surface of the 
composite between time points. Therefore this method provided accuracy and consistency 
in comparing like-for-like regions in wounded samples between experimental time points. 
 
7KHUHIRUHWRUHGXFHWKHHIIHFWWKLVHUURUKDGRQLGHQWLI\LQJWKHµZLGHVWSRUWLRQ¶RIWKH
wound between time points, the locations of the internal reference points were noted, and 
the shift in the location of internal reference between time points was used to determine 
ZKHUHWKHFRUUHVSRQGLQJµZLGHVWSRUWLRQ¶ZDVORFDWHG)RUH[DPSOHLQ)LJXUHWKHUHZDVD
difference of two slices between the corresponding internal reference points from the 
images attained at day one and day three. The reference point at day three was observed 
two slices earlier where it was observed at the previous time point. Therefore the 
corresponding 'widest portion' of the wound at day three (slice 32) was judged to lay two 
slices behind where it was identified at day one (slice 34). 
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Figure 5.7. Achieving consistency in identifying the widest portion of the wound between 
time points. The images in the left column show the internal reference points (yellow arrow) 
that were compared between time points (Day 1, 3 and 7). The images in the right hand 
column show slices from the widest regions of the wound. These could be identified from 
noting the distance the widest region lay from the internal reference point from the previous 
time point. The position of the slice within the series of images is shown within each image 
and the distance from the external reference point is indicated in brackets. Note- it was 
important that identifying features were located outside of the wound because the scattering 
in the wound becomes greater over time, which would make finding features at the wound 
site harder over time.(Scale bars: 1 mm) 
Measuring the Wound Area 
 
After identifying the widest portion of the wound, the area of each of the selected 
slices making up the 'widest portion' was determined in Image J. The outline/ margins of the 
wounds were manually traced using polygonal draw tool, selected form the toolbox (Figure 
8). The starting point for drawing was always the top of the keratinized epithelium (white 
band in the OCT image). Once the area was traced, the shape was saved as a region of 
LQWHUHVW52,LQWKH52,PDQDJHU2QFHDOO LPDJHVPDNLQJXSWKHµZLGHVWSRUWLRQ¶KDG
their wound margins demarcated and added to the ROI manager, the number of pixels the 
wound occupied in each image could be measured. Since each pixel is known to occupy an 
area of 1 µm2, the number of pixels within the wound therefore was equivalent to the area of 
the wound in µm2.  
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Figure 5.8. Measuring the Wound Area. The polygonal draw tool was selected from the 
toolbox in Image J (top left panel). The outline of the wound was drawn by manually starting 
from the top of the epidermis (marked by the arrow). Once the wound had been outlined, it 
was added to the ROI manager (Top right panel) and when all 11 images in the selection 
had been added to the ROI manager, the ROIs were selected and measured by clicking the 
measure button in the ROI manager. A results box then appeared (Lower left panel) which 
displayed the number of pixels in the area of each wound as well as the mean, minimum 
and maximum pixel intensities.  	  
Other Practical Considerations  
 
 One of the things that became apparent when OCT was first performed on the TE 
skin was that the top surface of the composite had to sit a maximum distance of 3 mm from 
the underside of the lid of the petri dish; because if the samples were outside this range, the 
image of the lid would obscure the sample as demonstrated by Figure 5.9. Because the 
thickness of the skin used to make the composites could vary, due to the difficulty in 
preparing split-thickness skin of consistent thicknesses from different donors, or even within 
a donor preparation, and the height of the grids used to maintain ALI were fixed, there was 
a need be able to adjust the distance of the skin to within 3 mm from the lid to prevent 
image obstruction by the artifact of the lid. 
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Figure 9. Artifacts from the tissue culture lid affecting OCT imaging. A) non-wounded TE 
skin. B) wounded TE skin The tissue culture lid, marked by the arrows in A) and B), was 
able to scatterer light, and partly obstructed the samples. (Scale bars: 1 mm). 
 
It was thought that an alternative material that could be cut to height could be used 
instead of the stainless steel grids whilst OCT imaging was performed. The material had to 
be porous to allow an ALI (air-liquid interface) to be maintained during imaging, non-toxic to 
the cells, easily manipulated and be able to be sterilised. Five different foams were tested 
for their suitability for use, because such materials are porous and can be easily cut to size. 
The materials¶ ability to uptake medium was observed. Sponges were compressed between 
forceps and the foams were scored on a 1-3 basis (with 1 being poor, 2 moderate and 3 
good) of their ability to uptake medium. Foams 1, 2 and 4 performed best and Figure 5.10 
shows them to uptake far more than the others. However after 24 h of contact with the 
medium, foam 4 produced some leachates that were visible in the medium, as too did foam 
5, thus suggesting that they were unstable in medium for prolonged periods. Therefore only 
foams 1 and 2 were taken forward to investigate if they could firstly be sterilised and 
maintain their integrity, and secondly not cause toxicity to fibroblasts. After 24 h in sterilising 
agent (70 % IMS, v/v), both appeared unchanged structurally and no visible leachates were 
reported. The foams were thoroughly washed from the IMS and then a toxicity study was 
carried out. Human dermal fibroblasts (HDFs) were cultured in 12 well-plates and transwell 
inserts containing foams were placed in contact with the medium surrounding the cells. After 
24 h, an MTT assay for cell viability was performed. The foams were found not to affect cell 
viability after 24 h, indicating that there were no leachates from the foams that were harmful 
to the cells (Figure 5.11).     
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Figure 5.10. Foams. A) The absorption of medium into each of the foams 1-5. The foams 
are listed as follows: 1) Boots fragrance free exfoliating facial sponge, 2)- Washing-up 
sponge, 3) Boots ear plugs, 4) Boots essentials sponge, 5) Boots Ramer sponge. B) 
Leachates from sponge 4 and 5 after 24 h in medium.  
 
 
 
Figure 5.11. Toxicity of Foams. A) HDFs in culture with the foams contained in Transwell 
inserts. B) Cell viability by MTT assay (data normalised to the control). Data represents the 
mean ± SEM (N=3, n=3).  
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5.4. Discussion  
 
  Two types of OCT were available to our research group: TD-OCT (Time domain 
OCT) and SS-OCT (Swept-source OCT). For these experiments SS-OCT was chosen over 
TD-OCT because it had been previously demonstrated to perform better; a former member 
of our group found it proved more sensitive than TD-OCT and was able to distinguish 
between the cellular and keratinized layers of the epidermis (Hearnden, 2010). OCT was 
capable of delineating the wound margins and identifying the fibrin clot within the wound. 
Compared to ex-vivo skin, the quality of the images obtained from TE skin was 
comparatively poorer; this observation was noted by previous authors (Krstajic et al, 2008; 
Smith et al, 2010). However, the images were of sufficient quality to discriminate structural 
features of the skin. A reason for this difference could EHGXHWRWKHDEVHQFHRIµPDWHULDOV¶
from TE skin, such as melanocytes and endothelial cells ZKLFK FRQWULEXWH WR VNLQ¶V
scattering properties (Lister et al, 2012).  
 
 OCT was demonstrated to be a simple way of obtaining gross structural information 
from skin without the need for histology. A limitation of histology is that it requires a sample 
to be removed from the experiment. OCT however, due to its non-invasive nature, allows 
wound healing to be tracked over time within a sample. Histology can also produce artifacts 
such as foldings, especially in the wound area where tissue integrity is compromised, and 
during processing, differential shrinkage between the tissue and the implanted material can 
result in fracture or detachment of the material; together these make objectifying wound 
healing difficult (Yuan 2010).     
 
 In addition the OCT apparatus was capable of imaging in series through the length of 
the wound in an automated fashion. The advantage of this is that information can be 
gathered over the entirety of the wound at any given time-point. The main challenge was 
achieving consistency in imaging to ensure that wound measurements could be compared 
between time points within a sample. Consistency was achieved by adding a reference 
point to the surface of the samples and adding a visible laser to the imaging beam path, in 
this way the laser could be aligned with a fixed point on the sample, thus imaging could 
proceed from a fixed position. The optimal sampling was determined based on the time it 
takes to image the samples, of course this could be adjusted by users in the future, 
depending on their requirements.  
 
 Gathering as many images from the wound area as possible would be the most 
complete way to evaluate the wound. The imaging system had an A-scan rate of 10,000 Hz, 
therefore it was capable of performing imaging in a fraction of a second, and the motorised 
stage could move at increments of 10 um, thus 1000 images could be acquired from the 1 
cm wound. Additionally the imaging processing software could perform an averaging 
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function from 5 B-scans which produced the clearest images. However it was neither 
possible nor practical to operate at this level of sampling due to limitations of time; it was 
important to perform imaging in a timely manner so that the samples were not out of the 
incubator for extended periods. Averaging took considerable time because it was very 
demanding on the computer's processing power, and the stage took several seconds to 
move each increment. Therefore a compromise was reached by sampling the wound every 
50 um using an averaging factor of 3. It is possible that advancements in computer 
processing performance and stage movement rapidity could increase the number of images 
that could be acquired in a given time. 
 
 Wound areas could be determined by firstly identifying the widest region of the 
wound, and segmenting the wound margins from a series of images within the widest region 
of the wound. 7KHVXPRIWKHZRXQGDUHDIURPWKHVOLFHVFRPSULVLQJWKHµZLGHVWSRUWLRQ¶
of the wound could then be compared between time points for a given sample to provide a 
quantitative assessment of wound closure over time. The wound area, as determined by 
OCT, on the day of wounding could then be normalised to 100 %, and reductions in wound 
size overtime could be reported as a percentage reduction from an earlier time point. Thus 
OCT allows wound healing to be quantified non-invasively (see Chapter 6). One limitation 
with this method was that manual segmentation is open to subjectivity in defining the wound 
margins. Manual segmentation of wound areas was opted for after automatic segmentation 
proved ineffective using Image J. Image segmentation is a key tool that contributes to 
diagnostic evaluations, however accurate segmentation of structures of interest within a 
tissue presents a major challenge for the following reasons. Firstly, as is the case with OCT 
images of skin, the target objects lack strong boundaries, and secondly, regions within a 
tissue often have similar intensity profiles (Song et al, 2013). In light of this need, Dr S.J. 
Matcher, Reader in Biomedical Engineering, is currently developing an automated 
segmentation plug-in for Image J that will work well with OCT images. The additional 
advantage of automatic image segmentation is that it vastly increases the speed data 
extraction from a series of images. 	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5.5. Summary  
 
x OCT could be effectively applied to image TE-skin wound models. Structural details 
can clearly be identified such as the epidermis, dermis and fibrin clot. 
 
x :RXQGVFRXOG EH DGHTXDWHO\ VDPSOHGE\2&7 7KH µODUJHVW SRUWLRQ¶ RI DZRXQG
could be identified and manually segmented to determine wound areas.  
 
x Consistency in the identification of the 'largest portion' of a wound was achieved by 
identifying internal reference points within images. Thus the same region of a 
wound could be compared over time to evaluate wound healing.  
  
x The OCT methodology was successfully carried forward to study the effects of 
MSCs in the wound model (Chapter 6).    
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Chapter Six:  
Investigating the Effects of MSCs in Model Wounds 
Derived from TE skin 
 
6.1. Aim 
 
 The aim of this work was to incorporate bone marrow-derived MSCs into TE skin 
wound models, and evaluate their benefit to the wound using OCT to assess wound healing 
in conjunction with standard histological methods.   
6.2. Introduction 
 
 In vivo wound models most closely simulate human wounds in that they make use of 
the hosts immune and vascular systems; as such they are widely used to evaluate 
therapeutics. However animal models such as mouse, rat, rabbit and guinea pig are not 
without their limitations (Lindblad 2008). Due to distinct physiological and anatomical 
differences in these animals from humans, wound healing proceeds largely through wound 
contraction, which is brought about via the panniculus carnosus. This subcutaneous 
muscular layer is absent from humans, and wound healing commences by granulation 
tissue formation followed by epithelialization (Wong et al, 2011). Also, studies using animal 
models require large numbers of animals (replicates/ experimental condition) to be used to 
account for intraspecies variation, which can be costly, and stress experienced by animals 
in laboratories can negatively influence wound healing (Steinstraesser et al, 2010). 
 
 Therefore, in vitro experimental wound models that are convenient, easy to use and 
reproducible form a vital part in evaluating novel therapeutics and establish their mechanism 
of action. Wound closure is most commonly simulated by the 'scratch' assay, whereby a gap 
is created in a monolayer of cells and cell migration/proliferation is monitored as the gap is 
closed (Laing et al, 2007). However this model lacks aspects multi-dimensional such as 
three-dimensional architecture and additional cell types. There are many models that 
achieve 3D culture, which are better representative of wound physiology than 2D systems. 
 
 These include: co-culture systems, and collagen gels seeded with both keratinocytes 
and fibroblasts (Khetani and Bhatia 2006; Schindler et al, 2006). However, fibroblasts 
cultured in 3D matrices, typically composed of type I collagen or fibrin, can alter their 
phenotype (Gillery et al, 1989). Human skin equivalents such as TE skin possess a 
differentiated epithelium, containing a stratum corneum, which is histologically similar to in 
vivo skin. TE skin is composed from human dermis onto which primary keratinocytes and 
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dermal fibroblasts are seeded. The so-FDOOHG µFRPSRVLWH¶ LV WKHQ cultured at an air-liquid 
interface to stimulate keratinocyte maturation. Chapter 4 demonstrated that a wound-
healing model could be developed from these TE constructs, and as such they may be used 
to evaluate novel therapeutics.  
 
 MSCs are biologically active therapeutics that are capable of accelerating wound 
healing, and they are considered to mediate their therapeutic effects via paracrine 
mechanisms (Hocking et al, 2010; Zou et al, 2012). Numerous studies conducted using so 
called MSC 'conditioned medium' have, both in vitro and in vivo, been shown to accelerate 
wound healing by their secreted factors (Kinnard et al, 2004; Chen et al, 2008; Volk et al, 
2008; Kwon et al, 2009; Walter et al, 2010;). For example, Chen et al demonstrated that 
MSCs produce a range of factors including: VEGF-Į IGF-1, EGF, KGF, angiopoietin-1, 
HGF, macrophage inflammatory protein-1alpha and beta, stromal derived factor-1 and 
erythropoietin, and they showed that conditioned medium could only stimulate cell migration 
and proliferation from keratinocytes and macrophages (Chen et al, 2008). 
 
 This chapter is an extension of the preceding work. Here, MSCs were incorporated 
into wound models derived from TE skin, as described in Chapter 4, and cell culture 
medium from the wound models was assessed by ELISA to detect the relative amounts of 
hepatocyte growth factor (HFG), Interleukin-8 (IL-8), and basic fibroblast growth factor 
(bFGF), all of which are essential to wound healing (Demidova-Rice et al, 2012), to 
determine if their presence could be associated with any benefit the MSC provided to 
wound healing in the model. OCT imaging was applied to non-invasively image wound 
healing outcomes in the presence or absence of MSCs. OCT had previously been shown 
capable of detecting the epidermis including the stratum corneum (Chapter 5).   
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6.3. Results 
Evaluation Wound-Healing Outcomes via OCT 
 
TE skin wound models were prepared as previously described (Chapter 4). Briefly, 
TE skin was maintained at an air-liquid interface for 5 days, and selected composites had 
10 mm incisional full-thickness wounds made in them. The wounded composites were then 
divided equally into two groups; one group received fibrin alone into to the wound cavity, the 
other group had 1 x 105 MSCs incorporated into the fibrin clot, which was also inserted into 
the wound. As a contro, a set of TE skin composites were not wounded. The samples were 
then imaged by OCT, as described in Chapter 5, over the course of 14 days, with sampling 
every 3-4 days. 
 
 OCT revealed that unwounded samples of TE skin showed a progressive thickening 
of the hypolucid band from D1 to D7, and thereafter it remained similar in thickness (Figure 
6.1). The hypolucid band presents as a bright white layer (high pixel intensity) in the 
uppermost region in the images, and results from the highly light-scattering properties of the 
layer. This layer was absent from decellularised dermis (DED), which contained no 
epithelium (Figure 6.2).  
  
 Of the TE skin samples that contained the wound, fibrin could clearly be seen within 
the wound as a region of lightly scattering material compared to the surrounding tissue, 
which was brighter due to it transmitting light less. OCT showed the cavity within the 
wounded TE samples to reduce in size over time, and by day 10 the cavities created by the 
wounds were almost indistinguishable in appearance from the surrounding tissue. In DED 
however there was no decrease in the size of the wound over time, thus indicating that cells 
were required for the clot to regress (Figure 6.2).  
 
 By day 3, wounds that contained MSCs showed the presence of an intense band over 
the top of the fibrin clot, which was similar in intensity to the hypolucid region either side of 
the wound; this was absent from the wounded samples without MSCs. This hypolucid 
region above the fibrin clot grew progressively thicker, and became continuous with the 
surrounding hypolucid material.  By day 7, the MSC containing group appeared to have a 
scattering layer over the area of the wound/clot that was continuous with the surrounding 
hypolucid band. A similar band only appeared in the wound samples (no MSCs) at a later 
time point of 7 days.  
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Figure 6.1. Wound healing of TE skin imaged by OCT over 14 days (D1-D14). Images are representative of one experiment (n=4 at D1; n= 3 at D3-D7; n= 2 
at D10- D14). The top row of images are controls where no wound was made. The middle row of images display wounds (W) which had fibrin (F) inserted into 
the wound cavity. The bottom row of images display wounds which had MSCs introduced via a fibrin clot. Images where acquired with and averaging of 3, 
DQGHDFKLPDJHUHSUHVHQWVWKHµZLGHVW¶SRUWLRQRIWKHZRXQGIRUPDUHSresentative sample (as described in the previous chapter) (Scale bars: 1 mm). (Arrow 
indicates the first appearance of a hypolucid band over the top of the fibrin clot).   
Nathan	  Walker	  (2013)	   	   Chapter	  Six	  	  
	   157	  
 
	  
Figure 6.2. OCT of wounded and unwounded DED. Images were acquired with an 
averaging of 3(DFKLPDJHSRUWUD\LQJDZRXQGVKRZVWKHµZLGHVW¶UHJLRQRIWKHZRXQGDV
determined by eye (Scale bar= 1 mm). (Arrowheads indicate reflections from the surface).	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Rate of Wound Healing 
 
Wound areas were determined from the OCT images as described in Chapter 5, 
and the reductions in wound areas between time points were calculated and plotted 
(Figure 6.3). MSCs were found not to reduce the time of wound closure. Under both wound 
conditions (+/- MSCs), the majority of wounds had closed by day 10. However, MSCs did 
accelerate the initail phase of wound healing. Over the first three days MSCs reduced the 
wound sizes by 18.31 % more than wounds without MSCs, but this difference was not 
statistically significant (p= 0.073) due to a low volume of samples (N=1). After day three, 
wound closure continued to proceed faster in the MSC group than wounds without MSCs, 
however this trend too was not statistically significant.  
 
 
 
 
Figure 6.3. Reduction in wound areas over 14 days. Wound areas were measured 
manually in image J using the method described in Chapter Five. Briefly, at each time 
SRLQW WKH µZLGHVW SRUWLRQ RI WKHZRXQGZDV LGHQWLILHG IURP D VHULHV RI LPDJHV FROOHFWHG
along the length of the wound, and the area this region occupied was calculated and 
compared the wound area of the corresponding region at subsequent time points. The 
wound areas at the first time point (D1) were normalized to 100 % to account for slight 
variations in wound sizes between samples, and the mean reduction wound sizes over 
time was expressed as a percentage of the original wound area (100 %).  Data represent 
mean wound areas ± SEM (N1, n=4, 3 and 2 at days 1, 3-7 and 10 respectively as some 
samples were removed for histology).  
 
 
Nathan	  Walker	  (2013)	   	   Chapter	  Six	  	  
	   159	  
Histology of Wound Models 
 
 Both conventional histology (H&E), and immunohistochemistry (IHC) were 
performed to evaluate wound healing on selected samples. Over the course of the 
experiment, the unwounded samples showed a progressive thickening in the cornified 
layer of the epidermis, and this was accompanied by depletion in keratinocyte number as 
they gradually committed to terminal differentiation (Figure 6.4). This was seen as an 
increase in the thickness of the pan-cytokeratin-rich layer above the basal cells as time 
progressed (Figure 6.5 and 6.6). 
 
 Fibrin clots could be clearly identified in the wounded samples the day following 
wounding, and the area that the clot occupied within the wound cavity decreased markedly 
between day 1 and 7. A similar observation however could not be made of wounded 
acellular dermis that had fibrin introduced to the wound cavity; the fibrin clot remained at its 
initial size throughout the duration of the experiment (Figure 6.4) Also by day 7, a small 
proportion of keratinocytes had migrated into the wounds (Figure 6.4), and those that had 
entered the dermis produced keratins (Figure 6.6). MSCs (RFP-labeled), could be seen 
throughout the wound (Figure 6.5), and the MSCs resided at the wound site for the 
duration of the experiment (Figure 6.6).  
 
Compared to wounds without MSCs, those with MSCs demonstrated that by day 
7, keratinocytes had migrated over the top of the fibrin clot and formed an epithelium, 
which contained cytokeratins (Figure 6.4, and Figure 6.6). By day 14 wound healing was 
complete. Fibrin was no longer present in the wounded area and therefore the dermis was 
no longer partitioned. In addition, a keratinised epithelium had now formed over the 
wounded area in samples without MSCs. However, the keratinised epithelium achieved 
from the wounds that contained MSCs was notably thicker than that formed from the 
wounds without MSCs, and the typical 'basket weave' appearance of cornified layer was 
less pronounced (Figure 6.4 and Figure 6.6).   
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Figure 6.4 H&E stained sections of wounded and unwounded TE skin in the presence of 
absence of MSCs at days 1, 7 and 14.  (x 10 magnification, scale bars: 3ȝm). TE skin 
was cultured at ALI for 5 days before 1 mm long full-thickness wounds were created, and 
1ȝPRIILEULQJOXH was added which contained, where appropriate, 1 x 105 MSCs. In the 
control where no wound was made the keratinised progressively thickened over 14 days. 
Where wounds were made in the absence of cells (DED+Fibrin), the fibrin clot remained 
for the duration of the experiment. The fibrin clot regressed over time in the wounded TE 
skin that contained or did not contain MSCs. An epithelium had formed over the top of the 
fibrin clot in the MSC-containing wound by day 7; this was not apparent until later (day 14) 
in the wounded TE skin without MSCs.   
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Figure 6.5. Immunohistochemisty of wound models at day 1. Sections of TE skin were 
stained for pancytokeratin (green) to highlight the epidermis, and RFP to detect the so-
labeled MSCs (red) (the concentration of the primary antibodies were 1: 50 and 1:100 
respectively). All sections were stained DAPI (blue) to highlight cell nuclei. The dotted line 
in the top right image represents the bottom of the wound. (RFP= Red fluorescent protein). 
(x 10  PDJQLILFDWLRQ6FDOHȝP.  
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Figure 6.6. Immunohistochemisty of wound models at days 7 and 14.  As in Figure 9, 
sections of TE skin were stained for pancytokeratin (green) to highlight the epidermis, and 
RFP to detect the MSCs (red) (the concentration of the primary antibodies were 1: 50 and 
1:100 respectively). All sections were stained DAPI (blue) to highlight cell nuclei. (x 10  
PDJQLILFDWLRQ6FDOHȝP  
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ELISA- Cytokine Analysis from the Wound Models 
 
During the course of wound healing, medium was collected from each sample (6, 
24, 72, 168 h after wounding), and an ELISA was run for the following cytokines: HGF, 
bFGF, and IL-8. All data presented are representative of one independent experiment 
performed in triplicate.  
Hepatocyte Growth Factor 
 
6 h after wounding, approx. 25% more HGF was detected in the culture medium 
from wounded TE skin containing MSCs than the other conditions (p < 0.001). By 24 h the 
amount of HGF produced by MSC-containing wounds were higher still (p < 0.001) and 
remained at a similar level at all subsequent time points (Figure 6.7). In summary, HGF in 
medium from MSC-containing wounds remained elevated above the other conditions 
throughout the first 7 days of wound healing.  
 
 
 
Figure 6.7. ELISA measurement for HFG.  Data are expressed as means ± SD (n=3, *p < 
0.1, **p < 0.01, ***p < 0.001,  after one-way ANOVA and post-KRF7XNH\¶VWHVWV). 
 
 
 
Fibroblast Growth Factor- basic 
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The amount of bFGF secreted into the culture medium did not vary significantly 
between conditions at each time point, and the levels of bFGF did not change significantly 
between time points over the course of wound healing (Figure 6.8).  
 
 
Figure 6.8. ELISA measurement for bFGF.  Data are expressed as means ± SD (n=3, *p < 
0.05, after one-way ANOVA and post-KRF7XNH\¶VWHVWV). 
 
Interleukin- 8 
 
After 6 h, the amount of IL-8 detected from MSC-containing wounds was slightly higher 
than wounds alone (p < 0.01), By 24 h, IL-8 levels had risen under all conditions; however 
only the rise detected in the medium from MSC-containing wounds was significantly 
different from 6 h (p < 0.01) At this time IL-8 was also detected at a concentration 3.6 fold 
higher than the other conditions. By 72 h, the amounts of IL-8 detected remained no 
different from 24 h, apart from unwounded samples where the concentration had risen 2.1 
fold (p < 0.01). The concentrations of IL-8 detected were highest by 168 h under all 
conditions, and the medium collected from each condition contained more than the 
previous time point (Figure 6.9). In summary, IL-8 was secreted by MSC-containing 
wounds in greater amounts than the other conditions following wounding up to 168 h, by 
which time similar levels of IL-8 between the unwounded samples and the MSC-containing 
samples were detected.  
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Figure 6.9. ELISA measurement for IL-8.  Data are expressed as means ± SD (n=3, *p < 
0.05, **p < 0.01, after one-way ANOVA and post-KRF7XNH\¶VWHVWV). 
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MSC Migration into the Wound 
 
To test whether MSCs could home to the site of injury, MSCs (1 x 105) were 
seeded in fibrin onto the reticular surface of the TE skin and their location in the wound 
was observed at days 1, 7 and 14 post-wounding. Figure 14 shows that there was very 
limited migration of MSCs into the dermis from where they were introduced. Over the 
course of the experiment, MSCs remained in the reticular region of the dermis. However it 
is noteworthy that although the MSCs did not home to the wound margins, they were still 
able to bring about wound healing in a similar fashion to those seeded directly into the 
wound (compare Figure 6.9 to Figure 6.6).   
 
 
 
Figure 6.10. Immunohistochemisty of wound models that contained reticular-seeded 
MSCs at days 1,7 and 14 post wounding. Blue= DAPI, Green= pan-cytokeratin, Red= 
RFP. (x 10  magnification). 
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6.4. Discussion 
Comparison of OCT to Histology 
 
 The use of OCT to non-invasively characterise wound healing in a wound model 
based on TE skin was evaluated in this study. Routine histology was still performed 
because this is the gold standard for assessment providing both cellular and structural 
information, and it was to this measure that the images acquired by OCT were compared.  
  
 OCT showed good correspondence to histological counterparts. OCT was able to 
discern essential morphological changes during wound healing of TE skin. Histology 
revealed the keratinised epithelium increased in thickness over time, and this matched the 
increase in the thickness of the hypolucid band (hyper reflective band) in the upper most 
region of the OCT images. By contrast, the acellular control samples (DED) did not exhibit 
a hypolucid band for the duration of the experiment. Similar observations have been made 
in previous studies in vitro using both collagen gels and TE skin (Jung et al, 2003; Yeh et 
al, 2004; Spoeler et al, 2006; Smith et al, 2010). In addition it has also been shown to be 
the case in vivo. Baui et al applied OCT to investigate wound healing/re-epithelialisation of 
DFUs and found that they were able to correlate the appearance of the hypolucid band 
with the onset of epidermal keratinisation and the expression of E-cadherin (Baui et al, 
2012). Therefore the presence of the hypolucid band observed in this study can be 
attributed to the presence of keratinised epithelium. Also in common with others was the 
observation that unlike in situ or ex vivo skin, fewer details could be seen in TE skin via 
OCT (Gambichler et al, 2005; Krstajic et al, 2008).  
 
However a novel finding of the study was that in the presence of MSCs, wounds 
reestablished their epithelium earlier and this event was detectable by OCT. Seven days 
after wounding, hypolucid bands were observed on top of the fibrin clots in both wound 
groups (with and without MSCs), however this band was much thinner in the wound-only 
group. Coincident with this observation was the finding that the MSC+ wounds contained a 
thicker epithelium and with more expression of pancytokeratin. Additionally, MSC+ wounds 
displayed a hypolucid band across the top of the fibrin clot several days earlier (day 3). 
Such a band was absent from the wound-only group. Although there was no histology 
(performed at D3) to verify that this was due to the presence of a thin keratinised 
epithelium, it is a plausible assumption given that this study and others have attributed the 
hypolucid band to the presence of epithelium. Therefore, OCT detected that MSCs 
accelerated re-epithelialisation in the wound model. The fact that MSCs accelerated 
epithelialisation holds clinical relevance because if keratinocytes fail to cover wounds, or if 
healing is considerably delayed, wounds are more susceptible to infection and 
dehydration, which adds further complications to healing.  
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Differences in Wound Healing: The Model Vs. in Vivo  
Epidermis 
 
 In vivo, following injury, keratinocytes migrate from the leading edges of the wound 
and migrate laterally along the edge of the provisional matrix and down into the center of 
the wound, and in doing so they separate the eschar from the underlying healing tissue. 
There are two models by which this it thought to occur: the 'sliding' model (Vaughan and 
Trinkaus 1966)  and the 'rolling' model (Krawczyk 1971). The sliding model proposes that 
the basal keratinocytes retract from the basement membrane and migrate into the wound, 
pulling the entire epidermis as sheets to close the wound by virtue of strong desmosomal 
attachments to the subprabasal keratinocytes and adjacent cells. In the rolling model, 
suprabasal cells are thought to be the primary participants in epidermal migration and they 
tumble over the basal keratinocytes pulling with them the overlying epidermis in a leapfrog 
fashion (Laplante et al, 2001).      
 
 One striking observation was that re-epithelialisation in the wound model occurred 
over the top of the fibrin clot as keratinocytes migrated across it and subsequently 
differentiated. This could be due to a number of limiting factors of the wound model. 
Although in vitro wound models are useful in studying many aspects of keratinocyte 
responses to injury, the model cannot fully mimic the complexity of the in vivo environment. 
For instance, there is no granulation tissue or activated platelets in the fibrin glue, and 
there are no macrophages/immune cells present in the wound model; all of these 
contribute a wealth of growth factors (Brissett and Hom 2003; Mosser and Edwards 2008). 
Therefore in the absence of the above cells, keratinocytes may be missing cues for 
migration under the clot. Nonetheless, lateral migration still occurred following wound 
healing and the epidermis could be reestablished over a short period in the model. 
Dermis 
 
 It is unclear from the study if the dermis 'healed'. Although OCT was able to chart a 
reduction in the size of the fibrin clot and a change in the optical properties of the wound 
area, with scattering increasing over time, it was not clear if this was due to collagen 
deposition. Histology confirmed that there was no coincident increase in cellularity in the 
dermis as the fibrin clot regressed; this observation is often reported to accompany wound 
healing (Singer and Clark 1999). Therefore this suggests that neocollagen production was 
not entirely responsible for the re-appearance of collagen in the wounded area. For 
instance, the fibrin clot could have merely been in-filled with cellular material and degraded 
by cells, and given the dermis' elastic nature, as the clot gradually retreated, the edges of 
the wound may have been brought into apposition. Both fibroblasts and keratinocytes are 
known to degrade fibrin through the production of urokinase-type plasminogen activator 
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(uPA) which activates the fibrinolytic enzyme plasminogen thus stimulating plasmin-
mediated fibrin degradation (Chen et al, 1993; Tuan et al, 1996). The clot did not regress 
in the absence of cells therefore cellular action is required for clot resolution.    
 
The presence of newly formed collagen at the wound margin could be detected 
however by staining for type-III collagen at the wound site. Collagen III predominates in 
areas of neocollagen production following wounding, and as wounds mature, the collagen 
is replaced by collagen I (Peacock 1984). MSCs have previously been reported to exhibit 
increased levels of mRNA for collagen III in wound sites (Fathke et al, 2004; Volk et al, 
2008). In addition wound-breaking strength (WBS) could be evaluated to determine if 
integrity was partly restored to the dermis. Several authors have demonstrated that after 
introducing MSCs into incisional wounds, the maximum force required to be applied across 
wounds to achieve breaking, was increased above that which was required to break 
tissues which healed without MSCs. Furthermore, the recorded WBSs in the presence of 
MSCs were closer to the WBS of unwounded tissue. (Stoff et al, 2008; Kwon et al, 2008; 
McFarlin et al, 2008), and these results have been associated with an increase in collagen 
production at the wound site (Kwon et al, 2008; McFarlin et al, 2008). Therefore it is 
expected that in the presence of MSCs, collagen production within the model would be 
increased. Furthermore, functional OCT may be applied to survey the wound area for 
collagen production in the model. Collagen is a birefringent (BF) material; it can polarise 
light into two parallel rays. Polarisation-sensitive OCT (PS-OCT) can detect the 
polarisation state of light backscattered from tissue in terms of BF amplitude and/or 
attenuation, and therefore can be used to monitor differences in collagen content between 
wounded and healthy tissue (Oh et al, 2006) .    
 
 MSCs have the capacity to home to wounds (Kwon et al, 2009; Sasaki et al, 2008; 
Verstappen et al, 2011), therefore their ability to locate to the site of injury was evaluated in 
the wound model. By seeding the MSCs to the reticular side of the dermis, IHC could 
confirm if they re-located from this region to the wound site. The results demonstrated 
MSCs remained in the reticular region throughout the course of healing. It is not likely that 
the MSCs remained trapped in the fibrin glue because MSCs encapsulated in fibrin have 
been shown previously to express both plasminogen activators, and thus are able to 
partake in fibrinolysis and migrate through fibrin meshes (Neuss et al, 2011).  
 
One possible explanation as to why the MSCs remained in situ is that the model 
may have been lacking in key chemokine/ growth factors to stimulate MSC mobilisation. 
Due to the absence of macrophages and endothelial cells in the model, factors such as 
PDGF-AB, RANTES, MDC (macrophage derived chemokine) and SDF-1 (stromal cell 
derived factor) may have been absent from the wound environment. Ponte et al 
demonstrated these factors positively affect BM-MSC migration, and in particular when the 
cells were pre-conditioned with TNF-Į, the effect of RANTES, MDC and SDF-1 upon BM-
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MSC mobilisation was potentiated via an increased expression of their respective 
receptors (Lopez Ponte et al, 2007).  
Advantages of OCT Vs. Histology 
 
 Histology remains the gold standard in tissue assessment because the images 
obtained are very clear and not subject to ambiguous interpretation. However it is not free 
from several unavoidable drawbacks, which make recording an objective measurement of 
wound healing hard to achieve. Artifacts such as folding and fracture commonly occur 
especially in the wound area where structural integrity is diminished and the tissue area is 
increased in fragility. These artifacts become more apparent when thin sections of tissue 
are microtomed; for example all the images in figure 10 show foldings in the epidermal 
wound area. Additionally, although not shown to be the case with fibrin glue in this study, 
differential shrinkage between the tissue and the implanted material can result during 
processing which can lead to fracture and detachment of the implant from the tissue, and 
this can adversely affect objectivity in wound healing evaluation (Yuan et al, 2010). 
Moreover, histology is an experimental endpoint. Once a sample is designated for 
histology, it is necessarily removed from the experiment and the tissue lost to further 
experimentation. In contrast, OCT can track wound healing within a given sample over 
time; something which cannot be done via histology. All the images in for example Figure 2 
are taken from one sample under each condition. Thus OCT has proven useful in this 
study in increasing the amount of data that can be rendered from a sample prior to 
histology.    
ELISA 
Hepatocyte Growth Factor 
 
 HGF, also known as scatter factor, was first characterised as a powerful hepatic 
mitogen and stimulator of epithelial cell dissociation (Sato et al, 1995). HGF is 
predominantly synthesised by mesenchymal cells and it is one of the most versatile 
dermis-derived growth factors involved in wound healing. As well as promoting 
keratinocyte proliferation and migration, under physiological calcium concentrations 
(Matsumoto et al, 1991), it also acts as a potent promoter of neoangiogensis (Conway et 
al, 2006), and can suppress inflammation (Di Nicola et al, 2002). As such, compromised 
HGF production is associated with impaired wound healing (Bevan et al, 2004).  
 
 ELISA performed on media from wound models containing MSCs, demonstrated 
HGF at levels above the controls over a period of 7 days. This observation is consistent 
with those of others that have previously shown human BM MSCs constitutively secrete 
HGF under standard culture conditions (Chen et al, 2008; Zang et al, 2010; Smith et al, 
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2012). Compared to dermal fibroblasts, MSCs secrete relatively greater amounts (Chen et 
al, 2008). Additionally, HGF can be found in elevated concentrations in wound 
environments that contained MSCs (Kinnaird et al, 2004; Nie et al, 2011). Therefore, given 
HGF's role in promoting keratinocyte migration, as outlined above, an elevated level of 
HGF may be associated with the earlier onset/ enhanced re-epithelialisation in the MSC 
wound models as observed by OCT and IHC.	  
Fibroblast Growth Factor- basic 
 
 bFGF, also known as FGF-2, is released into the wound environment in acute 
wounds. It is a potent mitogen and chemoattractant of endothelial cells, fibroblasts and 
keratinocytes, and plays an important role in granulation tissue formation, re-
epithelialisation and dermal remodeling (Powers et al, 2000). In vitro studies have shown 
bFGF to regulate the synthesis and deposition of ECM components, and promote 
keratinocyte motility (Werner and Grose 2003; Xie et al, 2008) and in vivo administration of 
recombinant bFGF can accelerate both acute and chronic wound healing(Akita et al, 2008; 
Tan et al, 2008), thus demonstrating its importance in wound healing.     
 
The results showed that levels of bFGF detected in the medium under all 
conditions remained similar to each other over seven days. One would have expected the 
level of bFGF to be found in elevated concentrations about the unwounded skin. It is 
possible that the wound environments did produce more bFGF than the control, though its 
effect may have been masked. Green's medium contains cholera toxin, an essential 
medium component for epithelial maturation, which amplifies levels of cyclic adenine 
monophosphate (cAMP) from cells, and such cAMP elevating agents have been shown to 
increase bFGF production from cells (Riva et al, 1997). 
  
	  
	  
Interlukin-8 
 
 IL-8 is a pro-inflammatory cytokine that plays an important role in wound healing by 
encouraging skin re-epithelialisation through the promotion of keratinocyte migration 
(Michel et al, 1992) and proliferation (Tuschil et al, 1992). IL-8 was produced in the MSC-
treated wounds at much greater concentrations than the other conditions over the first 72 
h. It is known that MSCs constitutively secrete low amounts of IL-8 under standard culture 
conditions (Chen et al, 2008), therefore one might have expected the MSC-treated wounds 
to produce a smaller increase in the concentration of IL-8 above the wound-only samples. 
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TNF- Į is another pro-inflammatory cytokine that is released during wound healing 
by keratinocytes and macrophages (Xu et al, 2013), and it has been shown to induce the 
secretion of a number of proteins from MSCs including: IL-6, IL-8, monocyte chemotactic 
protein-1, CXCL6, cathepsin L, and pentraxin-related protein 3, VEGF, IGF-1 and HGF 
(Wang et al, 2006; Lee et al, 2010). Heo et al (2011), recently demonstrated that if IL-6 or 
IL-8 were depleted from TNF-ĮFRQGLWLRQHGPHGLXP06&FXOWXUHPHGLXP71)-Į WKH
effects the medium had on stimulating wound closure via re-epithelialisation, angiogenesis, 
cell proliferation ad immune cell infiltration were largely attenuated. Thus they suggest that 
TNF-ĮDFWLYDWHVWKHKHDOLQJSRWHQWLDORI06&VYLD,/-6 and IL-8 (Wang et al, 2006; Lee et 
al, 2010; Heo et al, 2011). Therefore it is possible that in the wound model, even in the 
absence of macrophages, that the damaged keratinocytes provide a sufficient 
concentration of TNF-Į WRHQKDQFH ,/-8 production from the MSCs, thus the accelerated 
healing exhibited by the MSC containing wounds may be in part attributed to TNF-Į, but 
this would require further investigation. 
Limitations of the Data 
 
 Due to the constraints of time, the wound healing experiment was only performed 
once, therefore it is necessary to repeat the experimental series at least twice more to 
confirm if the data are reproducible and perform a reliable statistical analysis. However, 
despite this flaw the data appear to show some striking trends, which have been 
discussed, although it is necessary for much of the work to be repeated before solid 
conclusions can be drawn.     
 
 A further limitation was that the ELISA data was not normalised to cell number, 
therefore one cannot ascertain if the increased levels HGF and IL-8 observed in the wound 
models that contained MSCs arose simply because these models contained a greater 
number of cells which have the capacity to produce these soluble factors. It was however 
not possible to normalise the data to cell number because the number of cells that were 
present in the tissue are the start of the experiment was unknown; wounds were made in 
the tissue 7 days after seeding DED with fibroblasts and keratinocytes, and they would 
have proliferated over this time. Equally, the number of cells present at each experimental 
time-point was unknown because the extent to which the cells within the tissues and 
proliferated/ died was unquantifiable. For example, histology shows that over time the 
cellular make-up of the epidermis reduces as the keratinocytes committed to terminal 
differentiation, while the proportion of fibroblasts generally increases.  
 
To understand if the MSC-containing wound models produced more HGF and IL-8 
than wound models without MSCs in a manner that was not purely a product of an 
increased cell number in the tissue, it would be necessary to have an additional control i.e. 
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wound models containing an equal number of fibroblast to MSCs. Thus, if the wound 
models containing fibroblasts produced similar data to the MSC-containing would models, 
then one could say that the difference in results between wounded skin alone and 
wounded skin that contained cells was due to an increase in cell number and not due to 
the presence of a specific cell type.	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6.5. Summary 
 
x OCT could effectively be applied to evaluate wound healing. OCT could identify 
the regression of the fibrin clot from the wound area, and the re-establishment of 
the epithelium. 
 
x MSCs did not benefit the wound in terms of advancing fibrin clot regression, 
however they did accelerate re-epithelialisation. In the presence of MSCs the 
epithelium was shown to be present, via OCT, as early as day 3. In the absence of 
MSCs the epithelium was only evident at day 7.  
 
x The observation that MSCs accelerated re-epithelialisation was associated with 
increases in the wound-beneficial cytokines HGF and IL-8 found in the medium of 
wounds containing MSCs. I hypothesise that the production of these cytokines 
may be linked to the presence of TNF-Į LQ WKH ZRXQG however further 
investigation would be required.  
 
x There were key differences between the healing of the model and how wounds 
would be expected to heal in vivo, which reflected some of the limitations of the 
model.  Differences could be accounted for by the absence of endothelial cells, 
immune cells and true granulation tissue from the model. Future works could 
incorporate these cell types into the model to better model the in vivo environment. 
 
x Further investigation would be required to determine the extent of neocollagen 
formation in the wounds and determine if there were differences between wound 
conditions.
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Chapter Seven: 
Future Work and Conclusions 
 
7.1. Cell Delivery  
 
 Despite the promise of using MSCs as therapies to treat chronic skin conditions, there 
is still no consensus as to which is the most effective approach for cell delivery. Achieving 
efficient and safe cell delivery is essential to the success of cell therapies. The work 
undertaken in Chapter 3 was conducted as part of an EU consortium, which aimed to 
'develop efficient, safe and secured methods of cultivating autologous and allogeneic MSCs 
DFFRUGLQJ WR *03 VWDQGDUGV¶ LQ RUGHU WR H[SHGLDWH WKH HQWU\ RI µRIf WKH VKHOI¶ FHOO-based 
therapeutics into the clinic. 
 
 Plasma polymerised acrylic acid (ppAAc) functionalised silicone substrates were 
found to promote the attachment of MSCs to medical grade silicone and it was found that 
ppAAc surfaces could effectively facilitate the transfer of MSCs to model wound beds 
composed of decellularised human dermis. Importantly, it was also discovered that the 
surface chemistry did not negatively affect the MSCs phenotype of functionality, and that 
once the MSCs arrived at the model wound bed they remained viable. Based on findings in 
the literature, I hypothesise that the ECM protein fibronectin, as opposed to vitronectin, 
which is adsorbed to the materials surface form serum, plays an essential role in facilitating 
MSC attachment. It would be interesting to test this hypothesis by performing functional 
blocking studies using antibodies directed to each ECM protein.   
 
 The findings of the study are of importance because these so-called celOµFDUULHUV¶DUH
composed entirely from synthetic materials. This is a desirable characteristic as far as 
entering the clinic is concerned, since its manufacture is less open to batch-to-batch 
variation, as is the case with animal-based products, thus making adherence to GMP more 
easily achievable. In addition, the avoidance of animal based products reduces the risk to 
the patient. In the future, if this cell-delivery platform is introduced into the clinic it could be 
combined with the use of serum-free medium, so that animal based components are 
removed all together.  
 
 Since the publication of the work in Tissue Engineering, the carriers have been used 
to deliver adipose tissue derived stem cells to wounds in vivo (Jiang i 2013). Therefore it is 
possible that the carriers could be used to deliver stem cells from other origins to wounds, 
such as umbilical cord blood; MSCs derived from this tissue a have been shown to be 
beneficial in wound healing (Luo et al, 2010) In the future (next 2-5 years), I envisage there 
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will be 'off the shelf' MSC-derived products for the treatment of non-healing wounds.  
 
 An interesting finding of the study was that in the absence of keratinocytes, MSCs 
could not penetrate the basement membrane (BM). I propose that MSCs may behave 
similarly to dermal fibroblasts in that they may only express MMP-9, a gelatinase that can 
cleave collagen IV, which is the main constituent of the BM, when there is cross-talk with 
keratinocytes. This hypothesis could be tested firstly in a simple transwell study. 
Keratinocytes could be seeded in one chamber of the transwell and MSCs on the other, and 
an ELISA could be performed for MMP-9. The concentration of MMP-9 could then be 
compared to that detected from each cell type cultured in isolation. (Human dermal 
fibroblasts would also be co-cultured with the keratinocytes so that the MSCV¶ behavior 
could be compared to this other mesodermal cell type). In addition, it would be important to 
perform PCR for MMP-9 mRNA on the samples, to determine each cell types relative 
contribution to the protease concentration as detected via ELISA in the co-culture. Without 
this measure one could not confirm which cell-type had up-regulated MMP-9 production (if 
at all).  
 
 A further step would be to perform an ELISA for MMP-9 on the culture medium used 
to support co-cultures of keratinocytes and MSCs on decellularised dermis (DED), to 
determine if an increase in MMP-9 was associated with the observation that in the presence 
of keratinocytes the MSCs were able to traverse the BM. If this was found to be the case, 
one could provide evidence for a causal link between MMP-9 elevation and BM penetration 
by introducing specific inhibitors to MMP-9 to determine if MMP-9 retardation impacts the 
06&V¶PLJUDWRU\FDSDFLW\ 
7.2. Wound Model  
 
 TE skin could be used to study wound healing in vitro using fibrin glue to partly 
recreate the initial stages of wound healing. Because the wound model was able to 
demonstrate differences in the rate of re-epithelialisation between conditions, the model 
could be used to evaluate the potential of novel therapeutics, such as topical creams or 
hydrogels containing bioactive factors, to ameliorate wound healing. Therefore the wound 
model is not limited to the study of stem cell interactions and it has wider applications. For 
example, M. Shahbudin in our group is currently using the model developed herein to test 
the therapeutic potential of glucomannan, a naturally occurring plant-derived 
polysaccharide.  
 
 One of the main limitations of the model is that were no immune cells present such as 
macrophages, and there were no endothelial cells present. This limits the models 
reproduction of the in vivo environment. However, it may be possible to incorporate 
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macrophages and endothelial cells into the model to improve the models representation of 
the in vivo situation.  Studies by the MacNeil group on incorporating endothelial cells are 
ongoing as are studies to incorporate immune cells. Also unlike in vivo wound healing, 
activated platelets were absent from the fibrin clot. Activated platelets release many growth 
factors into the wound, the chief one being PDGF, which stimulates keratinocyte 
proliferation. However in future studies it might be possible to produce a more 
physiologically relevant fibrin matrix through the incorporation of human recombinant PDGF 
into the fibrin clot.    
7.3. The Use of MSCs in the Wound Model 
 
 A key finding of the study was that in the presence of MSCs, the wound re-
epithelialised slightly earlier. This observation was associated with elevated levels of the 
cytokines IL-8 and HGF in the culture medium; both of these are beneficial to wound 
healing. I hypothesise that TNF-Į may be responsible for the elevation in the production of 
these factors from the MSCs because it can increase the expression of these factors in 2D 
culture from MSCs (Wang et al, 208; Heo et al, 2011). Further investigation would be 
required to establish to what extent TNF-Į was present in the medium from the wound 
models (+/- MSCs), and if this cytokine could stimulate IL-8 and HFG production in the 
wound model containing MSCs. I predict TNF-Į would be present in elevated 
concentrations in the wound environment compared to undamaged tissue, even in the 
absence of macrophages (the main source of this inflammatory cytokine), because it is 
released from injured keratinocytes.    
 
 As mentioned previously, one of the limitations of the wound model was that there are 
no immune and endothelial cells present; this may have accounted for the observation that 
MSCs were not recruited to the wound site from the reticular dermis because factors 
secreted by these cells such as PDGF-AB, RANTES, MDC (macrophage derived 
chemokine) and SDF-1 (stromal cell derived factor) may have been absent from the wound 
environment. If macrophages and endothelial cells were incorporated into the wound 
models, MSC mobilisation may have been observed. An additional ELISA for the above 
factors would be required to substantiate the hypothesis that the MSCs did not migrate due 
to a lack of chemokines in the model.   
 
 One of the main reasons why chronic wounds fail to heal is due to poor vasculature, 
therefore attempts to re-establish vasculature in the wound bed is the mainstay of clinical 
intervention. MSCs have been shown to promote neo-angiogenesis, which can restore limb 
function and reduce the incidence of limb amputation. It would be interesting to incorporate 
endothelial cells into the wound model to evaluate if, in the wound environment, the MSCs 
could enhance their proliferation in the wound and the formation of vascular tubules. 
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Currently our lab is investigating the role MSCs play in making vasculature in TE skin by 
seeding MSCs with endothelial cells in TE skin. This is important to evaluate because 
MSCs, if incorporated into skin grafts for example, may encourage grafts to 'take', by 
stimulating angiogenesis and effectively integrating the grafted tissue into the wound site.   
7.4. The Future of OCT 
 
 OCT could successfully be applied to image the TE wound model over the course of 
wound healing, and it could monitor wound healing both in terms of tracking the shrinkage 
of fibrin clots, and detecting the re-establishment of an epithelium over the wounded area. It 
is likely that in the future OCT will be preferred over histology as a method where the need 
to make gross morphological assessments of tissue is required, due to it being a rapid and 
non-invasive imaging platform. The OCT system employed in this thesis had an axial 
resolution of 10 ȝm, DQG D ODWHUDO UHVROXWLRQ RI  ȝm, which means that individual cells 
could not be resolved. However, recent developments in ultra-high resolution OCT have 
DFKLHYHGUHVROXWLRQVHTXLYDOHQWWRȝm axiall\DQGȝm transversely, which has allowed 
cells/cell nuclei to be identified (Pan et al, 2007). Furthermore through advancements in 
technology it may also be possible to couple functional OCT imaging into conventional OCT 
systems so that spatial and structural information can be gained from wounds (in vitro and 
in vivo) through the use of a single apparatus. Advancements in software and image 
processing in the future may also lead to faster image acquisition, allowing data to be 
collected and analysed more rapidly; in the current study the speed of processing was the 
main factor which determined and limited the number of image acquisitions from a sample.    
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